0001144204-12-028631.txt : 20120514 0001144204-12-028631.hdr.sgml : 20120514 20120514161542 ACCESSION NUMBER: 0001144204-12-028631 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20120331 FILED AS OF DATE: 20120514 DATE AS OF CHANGE: 20120514 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MGT CAPITAL INVESTMENTS INC CENTRAL INDEX KEY: 0001001601 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 133758042 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-32698 FILM NUMBER: 12838892 BUSINESS ADDRESS: STREET 1: 500 MAMARONECK AVENUE - SUITE 204 CITY: HARRISON STATE: NY ZIP: 10528 BUSINESS PHONE: (914) 630-7430 MAIL ADDRESS: STREET 1: 500 MAMARONECK AVENUE - SUITE 204 CITY: HARRISON STATE: NY ZIP: 10528 FORMER COMPANY: FORMER CONFORMED NAME: MEDICSIGHT INC DATE OF NAME CHANGE: 20021113 FORMER COMPANY: FORMER CONFORMED NAME: HTTP TECHNOLOGY INC DATE OF NAME CHANGE: 20001016 FORMER COMPANY: FORMER CONFORMED NAME: INTERNET HOLDINGS INC DATE OF NAME CHANGE: 19980520 10-Q 1 v312851_10q.htm FORM 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

S	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2012.

£	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 0-26886

MGT CAPITAL INVESTMENTS, INC.

(Exact name of Registrant as specified in its charter)

Delaware		13-4148725
(State of Incorporation)		(I.R.S. Employer Identification No.)

500 Mamaroneck Avenue, Suite 204, Harrison, NY, 10528 USA

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: 914-630-7431

Indicate by check whether the Registrant (1) has filed all reports to be filed by Section 13 or 15(d) of the Securities and Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, non-accelerated filer or a smaller reporting company. See definition of “large accelerated filer”, “accelerated filer”, “non-accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act:

Large Accelerated Filer ¨		Accelerated filer ¨

Non-accelerated Filer ¨		Smaller reporting company x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

As of May 14, 2012 the registrant had outstanding 2,105,187 shares of common stock, $0.001 par value.

Table of Contents

NOTE REGARDING FORWARD LOOKING STATEMENTS

This Form 10-Q, including “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 2, contains forward-looking statements that involve risks and uncertainties, as well as assumptions that, if they never materialize or prove incorrect, could cause the results of MGT Capital Investments, Inc. and its consolidated subsidiaries (the “Company”) to differ materially from those expressed or implied by such forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including any projections of revenue, gross profit, expenses, earnings or losses from operations, synergies or other financial items; any statements of the plans, strategies and objectives of management for future operations, including the rate of market development and acceptance of medical imaging technology; the execution of restructuring plans; any statement concerning developments, performance or industry rankings relating to products or services; any statements regarding future economic conditions or performance; any statements of expectation or belief; and any statements of assumptions underlying any of the foregoing. The risks, uncertainties and assumptions referred to above include the performance of contracts by suppliers, customers and partners; employee management issues; the difficulty of aligning expense levels with revenue changes; and other risks that are described herein, including but not limited to the specific risk areas discussed in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 2 of this report, and that are otherwise described from time to time in the Company’s Securities and Exchange Commission (the “Commission”) reports filed after this report. The Company assumes no obligation and does not intend to update these forward-looking statements.

The Company’s main operating currency is U.K. Sterling (£) (“GBP”).

INDEX

PART I — FINANCIAL INFORMATION

Item 1	Condensed Consolidated Balance Sheets — March 31, 2012 (unaudited) and December 31, 2011	4

	Condensed Consolidated Statements of Operations and Comprehensive loss — for the three months ended March 31, 2012 (unaudited) and 2011 (unaudited)	5

	Condensed Consolidated Statement of Stockholders’ (Deficit) — for the three months ended March 31, 2012 (unaudited)	6

	Condensed Consolidated Statements of Cash Flows — for the three months ended March 31, 2012 (unaudited) and 2011 (unaudited)	7

	Notes to Condensed Consolidated Financial Statements	8

Item 2	Management’s Discussion and Analysis of Financial Condition and Results of Operations	17

Item 3	Quantitative and Qualitative Disclosure About Market Risk	23

Item 4	Controls & Procedures	23

PART II — OTHER INFORMATION

Item 1	Legal Proceedings	24

Item 1A	Risk Factors	24

Item 2	Unregistered Sale of Equity Securities and Use of Proceeds	25

Item 3	Defaults Upon Senior Securities	25

Item 4	[Removed and Reserved]	25

Item 5	Other Information	25

Item 6	Exhibits	25

SIGNATURES		26

All financial amounts are in thousands except share and per share data.

Item 1. Financial Statements.

MGT CAPITAL INVESTMENTS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands except share and per share amounts)

	March 31,			December 31,
	2012			2011*
	(unaudited)
Assets
Current assets:
Cash and cash equivalents	$	3,342		$	3,704
Accounts receivable		118			84
Prepaid expenses and other current assets		155			327
Inventory		56			89
Total current assets		3,671			4,204
Property and equipment, at cost, net		32			28
Security deposits		65			201
Total assets	$	3,768		$	4,433
Liabilities
Current liabilities:
Accounts payable		261			213
Accrued expenses		395			502
Other payables		44			71
Total current liabilities		700			786
Stockholders’ (deficit)/equity
Common stock, $0.001 par value: 75,000,000 shares authorized; 2,105,187 and 2,108,732 shares issued and outstanding at March 31, 2012 and December 31, 2011 respectively.		2			2
Additional paid-in capital		285,644			283,240
Accumulated other comprehensive loss		(5,828	)		(4,861	)
Accumulated deficit		(280,497	)		(280,027	)
Total stockholders’ deficit		(679	)		(1,646	)
Non-controlling interest		3,747			5,293
Total equity		3,068			3,647

Total stockholders’ equity, liabilities and non-controlling interest	$	3,768		$	4,433

The accompanying notes are an integral part of these condensed consolidated financial statements.

* Derived from audited financial information

MGT CAPITAL INVESTMENTS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(In thousands, except share and per share amounts)

(Unaudited)

	Three months ended March 31,
	2012			2011

Revenues	$	213		$	47
Cost of revenue		36			4
Gross profit		177			43

Operating expenses
Selling, general and administrative		813			2,198
Research and development cost		41			440
		854			2,638

Operating loss		(677	)		(2,595	)

Interest and other (expense)/income, net		(2	)		21
Gain on sale of Moneygate		—			81
		(2	)		102

Net loss before income taxes		(679	)		(2,493	)

Income tax benefit/(expense)		—			—

Net loss before non-controlling interest		(679	)		(2,493	)

Net loss attributable to non-controlling interest		209			1,001

Net loss attributable to MGT Capital Investments, Inc.	$	(470	)	$	(1,492	)

Net loss as reported	$	(679	)	$	(2,493	)
Other comprehensive loss
Unrealized foreign exchange gain/(loss)		73			350
Comprehensive loss		(606	)		(2,143	)
Comprehensive loss attributable to non-controlling interest		(175	)		(854	)
Comprehensive loss attributable to MGT Capital Investments, Inc.	$	(431	)	$	(1,289	)

Per share data:

Basic and diluted loss per share	$	(0.22	)	$	(1.27	)

Weighted average number of common shares outstanding		2,108,338			1,171,518

The accompanying notes are an integral part of these condensed consolidated financial statements.

MGT CAPITAL INVESTMENTS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ (DEFICIT)/EQUITY

(In thousands)

(Unaudited)

	Common stock					Additional paid-in			Accumulated other comprehensive			Accumulated			Total stockholders’			Non- controlling			Total
	Shares			Amount		capital			income/(loss)			deficit			(deficit)			interest			equity
BALANCE, DECEMBER 31, 2011		2,109		$	2	$	283,240		$	(4,861	)	$	(280,027	)	$	(1,646	)	$	5,293		$	3,647

Cash in lieu of fractional shares for MGT reverse/ forward split		(4	)		—		(5	)		—			—			(5	)		—			(5	)
Acquisition of subsidiary shares from non-controlling interest							2,392			(1,006	)					1,386			(1,386	)		—
Stock option compensation							17									17			15			32
Net loss for the period		—			—		—			—			(470	)		(470	)		(209	)		(679	)
Translation adjustment		—			—		—			39			—			39			34			73
BALANCE, March 31, 2012		2,105		$	2	$	285,644		$	(5,828	)	$	(280,497	)	$	(679	)	$	3,747		$	3,068

The accompanying notes are an integral part of these condensed consolidated financial statements.

MGT CAPITAL INVESTMENTS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

	Three months ended March 31,
	2012			2011

Cash flows from operating activities:
Net loss before non-controlling interest	$	(679	)	$	(2,493	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation		7			16
Loss on disposal of property and equipment		2			—
Stock-based compensation expense		32			17
Gain on sale of loan receivable — related party		—			(81	)
(Increase)/decrease in assets
Accounts receivable		(31	)		23
Other receivable — related party		—			16
Prepaid expenses and other current assets		166			(469	)
Inventory		36			—
Security deposits		128			—
Increase/(decrease) in liabilities
Accounts payable		42			372
Accrued expenses		(108	)		(228	)
Other payables		(10	)		(37	)
Net cash used in operating activities		(415	)		(2,864	)

Cash flows from investing activities:
Repayment of Dunamis loan		—			1,100
Purchase of property and equipment		(10	)		—
Receipts from sale of Moneygate		—			401
Receipts of deferred consideration for sale of assets		—			370
Net cash provided by/(used in) investing activities		(10	)		1,871

Cash flows from financing activities:
Cash paid in lieu of fractional shares reverse/ forward split		(5	)		—
Net cash flows used in financing activities		(5	)		—

Effects of exchange rates on cash and cash equivalents		68			392
Net change in cash and cash equivalents		(362	)		(601	)
Cash and cash equivalents, beginning of period		3,704			8,434
Cash and cash equivalents, end of period	$	3,342		$	7,833

The accompanying notes are an integral part of these condensed consolidated statements.

MGT CAPITAL INVESTMENTS, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands except share and per share amounts)

1. Organization, basis of presentation and liquidity

The accompanying unaudited condensed consolidated financial statements of MGT Capital Investments, Inc. (“MGT”, “the Company”, “the Group”, “we”, “us”) have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, they do not include all of the information and notes required by accounting principles generally accepted in the United States of America. In the opinion of management, all adjustments, consisting only of normal recurring adjustments, have been included. Operating results for the three months ended March 31, 2012, are not necessarily indicative of the results that may be expected for any subsequent quarter or for the year ending December 31, 2012. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2011. The condensed consolidated financial statements include the accounts of the Company and its majority owned subsidiaries. All intercompany accounts and transactions have been eliminated.

MGT Capital Investments, Inc. is a holding company comprised of MGT, the parent company, and its wholly-owned subsidiary: MGT Capital Investments (U.K.) Limited. MGT closed the following non-essential subsidiaries during the quarter ended March 31, 2012, as part of its expense reduction plan: Medicsight Nominees Limited, MGT Investments (Gibraltar) Limited and MGT Capital Investments Limited a subsidiary of MGT Capital Investments (U.K.) Limited. In addition we also have a controlling interest in our operating subsidiary, Medicsight Ltd, (“Medicsight”) including its wholly owned subsidiaries.

Medicsight is a medical technology company focusing on medical imaging software development and medical hardware devices. The Company commercializes Computer-Aided Detection (“CAD”) applications which analyze Computer Tomography (“CT”) scans to assist radiologists in the early detection and measurement of colorectal polyps. The CAD software received a CE Mark in 2009, which allows for sales in the European Union. In 2011, Medicsight’s software also received clearance from the U.S. Food and Drug Administration. Revenue is presently limited as Medicsight attempts to commercialize its recent U.S. approval. In late July 2011, Medicsight was informed by the Japanese Ministry of Health, Labor and Welfare (“MHLW”) that several statistical data errors were encountered in their review of the application for approval of its ColonCAD software for use in CT Colonography procedures. Following informal guidance from MHLW, during August 2011, the Company decided to withdraw the current submission and is assessing the next course of action. In the meantime, the Board of Directors of Medicsight closed the Tokyo office as part of an overall program of expense reduction and corporate simplification. In addition to closing the Tokyo office, management of Medicsight has closed several non-essential subsidiaries; Medicsight KK and Medicsight PTY Limited, citing the unjustifiably high legal, regulatory and accounting costs of maintaining such entities. However, in order to better exploit the recent FDA approval of ColonCAD, Medicsight has opened a U.S. subsidiary (Medicsight, Inc.) in New York. Medicsight has also developed an automated CO₂medical inflation device and associated disposable tubing (MedicCO ₂LON) that is being commercialized via a global distributor.

On March 21, 2012, MGT effected a reverse split (the “Reverse Split”), immediately followed by a forward split (the “Forward Split” and together with the Reverse Split, the “Reverse/Forward Split”). At our March 20, 2012, Special Meeting of Stockholders, the Company’s stockholders approved the proposal to amend the Company’s Certificate of Incorporation to effect a Reverse/Forward Split of the Company’s Common Stock, $0.01 par value per share at an exchange ratio of 1-for-500 shares of the Company’s outstanding Common Stock, immediately followed by a forward split of the Company’s outstanding Common Stock, at an exchange ratio of 15-for-1 shares of the Company’s outstanding Common Stock. The amendment did not change the par value per share or the number of authorized shares of Common Stock. As a result of the Reverse Split, stockholders holding fewer than 500 shares of Common Stock, at the time of the reversal, received a cash payment instead of fractional shares and would no longer have an interest in the Company. All share and per share amounts have been retrospectively adjusted for all periods presented to give effect to the Reverse/Forward Split.

On March 26, 2012, at Medicsight’s General Meeting, stockholders approved a resolution to Reverse Split the Company’s existing ordinary shares of £0.05 par value per share into 1 new ordinary share of £16,250 par value per share (the “New Ordinary Shares”) and for MGT to acquire all New Ordinary Shares representing the fractions of shares left over following the Reverse Split.

The exchange ratio for the Reverse Split was 1-for-325,000. As a result of the Reverse Split, stockholders holding fewer than 325,000 shares were cancelled and not entitled to a cash payment for fractional shares. As of March 31, 2012, MGT holds 318 shares (66.5%) of the 478 issued share capital of Medicsight. Medicsight was previously listed on the AIM market of the London Stock Exchange until September 2011, when its shares were cancelled based upon a duly passed shareholder resolution and Medicsight became private. All share amounts have been retrospectively adjusted for all periods presented to give effect to the Reverse Split.

The Company has incurred significant operating losses since inception and continues to generate losses from operations. As a result, the Company has generated negative cash flows from operations and has an accumulated deficit of $280,497 at March 31, 2012. The Company is operating in a developing industry based on new technology and its primary source of funds to date has been through the issuance of securities. While the Company is optimistic and believes appropriate actions are being taken, there can be no assurance that management’s efforts will be successful or that the products the Company develops and markets will be accepted by consumers.

At March 31, 2012, Medicsight’s and MGT’s cash and cash equivalents were $3,021 and $321, respectively. Management believes that the current level of working capital will be sufficient to allow the Company to maintain its operations into May 2013.

2. Summary of significant accounting policies

Principles of consolidation

The consolidated financial statements include the accounts of our Company plus wholly owned subsidiaries and our majority owned subsidiary Medicsight. The functional currency of our majority owned subsidiary is their local currency, GBP. All intercompany transactions and balances have been eliminated. All foreign currency translation gains and losses arising on consolidation were recorded in stockholders’ equity as a component of accumulated other comprehensive income/ (loss). Non-controlling interest represents the minority equity investment in any of the MGT group of companies, plus the minorities’ share of the net operating result and other components of equity relating to the non-controlling interest.

Use of estimates

The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amount of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Cash and cash equivalents

The Company considers investments with original maturities of three months or less to be cash equivalents.

Revenue Recognition

Medicsight

The Company recognizes revenue when it is realized or realizable and earned. The Company considers revenue realized or realizable and earned when there is persuasive evidence of an arrangement and that the product has been shipped or the services have been provided to the customer, the sales price is fixed or determinable and collectability is probable.

Software — License fee revenue is derived from the licensing of computer software. Maintenance revenue is derived from software maintenance. Our software licenses are generally sold as part of an arrangement that includes maintenance and support.

The Company licenses software and sells maintenance contracts through visualization solution partners and original equipment manufacturers. The Company receives regular sales reporting detailing the number of licenses sold by original equipment manufacturers, value-added resellers and independent distributors (collectively, “Resellers”) to end users. The Company generally offers terms that require payment 30-45 days from invoicing. Provided the Reseller: (i) assumes all risk of the purchase, (ii) has the ability and obligation to pay regardless of receiving payment from the end user, and (iii) all other revenue recognition criteria are met, license revenue from Resellers is recognized upon shipment of its product to vendors (“sell-in basis”).

Revenue from license fees is recognized when notification of shipment to the end user has occurred, there are no significant Company obligations with regard to implementation and the Company’s services are not considered essential to the functionality of other elements of the arrangement.

Services — Revenue from maintenance and support arrangements is deferred and recognized rateably over the term of the maintenance and support arrangements.

Multiple-element arrangements — the Company enters into arrangements with resellers that include a combination of software products, maintenance and support. For such arrangements, the Company recognizes revenue using the Multiple-Deliverable Revenue Arrangements. The Company allocates the total arrangement fee among the various elements of the arrangement based on the fair value of each of the undelivered elements. The fair value of maintenance and support services is established based on renewal rates.

Hardware — Revenue is derived from the sale of our MedicCO ₂ LON product. This product is an automated CO ₂ insufflation device, and is generally sold as part of an arrangement that includes a one year warranty. The risk of incurring warranty related expense is mitigated by the warranty contractually agreed with the supplier. The Company reviews the risk of warranty liabilities on a regular basis, and makes any and all appropriate provisions accordingly. At the present time, the Company feels that the warranty liability is insignificant and has therefore not made any provision.

MedicCO ₂ LON is sold exclusively through our distribution partner Medrad Inc. Revenue is recognized as orders are satisfied and goods are delivered to our distribution partner. The Company generally offers terms which require payments within 30-45 days from invoicing.

Equity-based compensation

The Company recognizes compensation expense for all equity-based payments. Under fair value recognition provisions, the Company recognizes equity-based compensation net of an estimated forfeiture rate and recognizes compensation cost only for those shares expected to vest over the requisite service period of the award.

The fair value of each option award is estimated on the date of grant using the Black-Scholes option valuation model. The Black-Scholes option valuation model requires the development of assumptions that are input into the model. These assumptions are the expected stock volatility, the risk-free interest rate, the option’s expected life and the dividend yield on the underlying stock. Expected volatility is calculated based on the historical volatility of our common stock over the expected option life and other appropriate factors. Risk-free interest rates are calculated based on continuously compounded risk-free rates for the appropriate term. The dividend yield is assumed to be zero as the Company has never paid or declared any cash dividends on our common stock and does not intend to pay dividends on our common stock in the foreseeable future. The expected forfeiture rate is estimated based on historical experience.

Determining the appropriate fair value model and calculating the fair value of equity-based payment awards requires the input of the subjective assumptions described above. The assumptions used in calculating the fair value of equity-based payment awards represent management’s best estimates, which involve inherent uncertainties and the application of management’s judgment. As a result, if factors change and the Company uses different assumptions, our equity-based compensation expense could be materially different in the future. In addition, the Company is required to estimate the expected forfeiture rate and recognize expense only for those shares expected to vest. If our actual forfeiture rate is materially different from our estimate, the equity-based compensation expense could be significantly different from what the Company has recorded in the current period.

Inventory

We account for inventory at the lower of cost (first-in, first-out) or market. Cost is determined to be purchased cost for the finished MedicCO ₂LON product from the third party supplier. We perform full physical inventory counts to maintain controls and obtain accurate data. The MedicCO ₂ LON product is either (i) sold to our exclusive distributor or (ii) placed in an external third party secure warehouse facility and remains our property. Once the units are shipped to the distributor it is deemed that the ownership is transferred to the distributor and the goods are delivered. Reserves for slow-moving and obsolete inventories are provided based on historical experience and product demand. Management evaluates the adequacy of these reserves periodically based on forecasted sales and market trends.

Research and development

The Company incurs costs in connection with the development of software products that are intended for sale. Costs incurred prior to technological feasibility being established for the product are expensed as incurred. Technological feasibility is established upon completion of a detail program design or, in its absence, completion of a working model. Thereafter, all software production costs are capitalized and subsequently reported at the lower of unamortized cost or net realizable value. Capitalized costs are amortized based on current and future revenue for each product with an annual minimum equal to the straight-line amortization over the remaining estimated economic life of the product. Amortization commences when the product is available for general release to customers.

The Company concluded that capitalizing such expenditures on completion of a working model was inappropriate because the Company did not incur any material software production costs and therefore expenses were all research and development costs. Our research and development costs are comprised of staff, consultancy and other costs expensed on the Medicsight products.

Property and equipment

Property and equipment are stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method on the various asset classes over their estimated useful lives, which range from two to five years. Leasehold improvements are depreciated over the term of the lease.

Foreign currency translation

The accounts of the Company’s foreign subsidiaries are maintained using the local currency as the functional currency. For these subsidiaries, assets and liabilities are translated into U.S. dollars at period-end exchange rates, and income and expense accounts are translated at average monthly exchange rates. Net gains and losses from foreign currency translation are excluded from operating results and are accumulated as a separate component of stockholders’ equity.

Gains and losses on foreign currency transactions are reflected in selling, general and administrative expenses in the income statement.

Income taxes

The Company applies the elements of FASB ASC 740-10 “Income Taxes — overall” regarding accounting for uncertainty in income taxes. This clarifies the accounting for uncertainty in income taxes recognized in financial statements and requires the impact of a tax position to be recognized in the financial statements if that position is more likely than not of being sustained by the taxing authority. As of March 31, 2012 and December 31, 2011, the Company did not have any unrecognized tax benefits. The Company does not expect that the amount of unrecognized tax benefits will significantly increase or decrease within the next twelve months. The Company’s policy is to recognize interest and penalties related to tax matters in the income tax provision in the Consolidated Statements of Operations. There was no interest and penalties for the three months ended March 31, 2012 and 2011. Tax years beginning in 2009 are generally subject to examination by taxing authorities, although net operating losses from all years are subject to examinations and adjustments for at least three years following the year in which the attributes are used.

Deferred taxes are computed based on the tax liability or benefit in future years of the reversal of temporary differences in the recognition of income or deduction of expenses between financial and tax reporting purposes. The net difference, if any, between the provision for taxes and taxes currently payable is reflected in the balance sheet as deferred taxes. Deferred tax assets and/or liabilities, if any, are classified as current and non-current based on the classification of the related asset or liability for financial reporting purposes, or based on the expected reversal date for deferred taxes that are not related to an asset or liability. Valuation allowances are recorded to reduce deferred tax assets to that amount which is more likely than not to be realized.

Loss per share

Basic loss per share is calculated by dividing net loss attributable to the ordinary shareholders by the weighted average number of common shares outstanding during the period. Diluted loss per share is calculated by dividing the net loss attributable to the ordinary shareholders by the sum of the weighted average number of common shares outstanding and the diluted potential ordinary shares.

The computation of diluted loss per share for the three months ended March 31, 2012, and 2011, excludes all options at our Medicsight subsidiary as they are anti-dilutive. For the three months ended March 31, 2012, there were 6 options excluded with a weighted average exercise price of $46,376 per share. For the three months ended March 31, 2011, there were 33 options excluded with a weighted average exercise price of $71,500 per share.

Comprehensive income / (loss)

Comprehensive income/ (loss) includes net income/ (loss) and items defined as other comprehensive income/ (loss). Items defined as other comprehensive income/ (loss), include foreign currency translation adjustments and are separately classified in the consolidated financial statements. Such items are reported in the Condensed Consolidated Statement of Comprehensive Loss.

In June 2011, the Financial Accounting Standards Board (“FASB”) issued ASU 2011-05 which provides new guidance on the presentation of comprehensive income. ASU 2011-05 eliminates the option to report other comprehensive income and its components in the statement of changes in stockholders’ equity and instead requires an entity to present the total of comprehensive income, the components of net income and the components of other comprehensive income either in a single continuous statement or in two separate but consecutive statements. This guidance is effective for fiscal years, and interim period within those years, beginning after December 15, 2011, with early adoption permitted. The adoption of this ASU only requires a change in the format of the current presentation. The Company adopted this guidance on January 1, 2012, and its adoption did not significantly impact the Company’s condensed consolidated financial statements.

Segment reporting

The Company operates in one main operational segment, Medicsight, a medical imaging and device hardware company, with MGT providing corporate management services.

3. Divestment of investments

On March 31, 2010, the Company sold its stock in Medicexchange and various non-core investments for consideration of £750 ($1,136). This consideration was deferred and to be paid in installments, with the final installment of £244 ($370) paid in March 2011.

In Fiscal 2009, we purchased 49% of the share capital of Moneygate Group Limited (“Moneygate”), which was accounted for under the equity method. In March 2011, we sold our entire interest in Moneygate to Committed Capital Nominees Limited for total consideration of £250 ($401), resulting in a gain on sale of £51 ($81).

4. Cash and cash equivalents

We invest our cash in short-term deposits with major banks. As of March 31, 2012, we held $3,342 of cash and cash equivalents.

Cash and cash equivalents consist of cash and temporary investments with maturities of 90 days or less when purchased.

Concentrations

The Company held $3,021 and $3,123 of its cash and cash equivalents at March 31, 2012 and December 31, 2011, respectively, through Medicsight, its majority owned subsidiary, at financial institutions in Europe and United Arab Emirates (“UAE”). Cash held in foreign institutions is not insured by the Federal Deposit Insurance Corporation.

5. Loans receivable — related party

Dunamis Capital

On September 6, 2010, Medicsight made a short-term loan of $1,100 (£711) to Dunamis repayable by December 31, 2010, along with $36 (£23) of interest. Dunamis paid back the principal of $1,100 (£711) and interest of $48 (£31) on February 6, 2011 and February 10, 2011 respectively. Dunamis had provided the assets of the business as collateral against the loan made by Medicsight. Dunamis was considered a related party, as two former directors of Medicsight were also directors of Dunamis Capital (see note 10).

6. Inventory

At March 31, 2012 and December 31, 2011, MedicCO ₂ LON Limited, a subsidiary of Medicsight, held finished goods inventory comprised of insufflation devices and administration kits totaling $56 and $89, respectively.

7. Interest and other income/ (expense)

For the three months ended March 31, 2012, interest and other income/ (expense) was comprised of interest expense of $2. For the same period last year, interest income and other income/ (expenses) included interest income of $21.

8. Stock-based compensation

Cancellation of certain share option plans of the Company

Following Medicsight’s general meeting on March 26, 2012 (see Note 1), a shareholder resolution approving the Reverse Split of 1-for-325,000 of the Company’s existing ordinary shares of £ 0.05 par value into one new ordinary share was duly passed. As a result of the reverse split, option holders under certain existing share option plans are no longer entitled to options under those plans as option holders’ share entitlement is now less than one as a result of the Reverse Split. Following the share reversal, the Company cancelled with immediate effect all redundant option plans with the exception of Plan J. All previously unrecognized stock based compensation expense was accelerated.

Medicsight has the following Stock Option Plan:

Plan J — on May 14, 2009, we approved and subsequently granted options for 24 shares under stock option plan “J”. Options under this plan vest in equal one-sixths for each six months that employees have been employed for 6, 12, 18, 24, 30 and 36 months from the grant date. At March 31, 2012, there were 6 options outstanding, of which 5 were exercisable.

No grants were issued in the three months ended March 31, 2012.

The following table summarizes stock option activity for the three months ended March 31, 2012, under all option plans:

	Outstanding					Exercisable
	Number of Shares		Weighted-Average Exercise Price			Number of Shares		Weighted-Average Exercise Price

Outstanding at December 31, 2011		11	£	35,750 ($58,500)			10	£	78,000 ($68,250	)

Granted		—		—
Exercised		—		—
Forfeited/ Cancelled		5	£	19,500 ($30,917	)

Outstanding at March 31, 2012		6	£	29,250 ($46,376	)		5	£	29,250 ($46,376	)

The following is a summary of the status of stock options outstanding at March 31, 2012:

Outstanding options

Exercisable options

Number

Remaining

contractual life

(years)

Average

exercise price

Number

Average

exercise price

Medicsight Plan J

7.2

29,250

46,376

29,250

46,376

On November 30, 2010, David Sumner, Chairman of Medicsight Limited, resigned from his position within the group. Immediately after his resignation, a two year consultancy agreement was signed whereby Mr. Sumner would continue to assist the group in its commercial needs. As part of this agreement, Mr. Sumner was to continue to vest in his existing Medicsight Plan J options throughout the consultancy period. A modification of the 6 existing options has been accounted for, and is not considered to be material to the overall financial statements. The Company is no longer receiving services under this consulting agreement. As such, all expenses and related stock-based compensation were accelerated at December 31, 2011.

The Company has recorded the following amounts related to its share-based compensation expense in the accompanying Condensed Consolidated Statements of Operations:

	Three months ended March 31,
	2012		2011
Selling, general and administrative	$	25	$	3
Research and development		7		14
Total	$	32	$	17

Of the stock-based expense for the three months ended March 31, 2012, $15 was allocated to non-controlling interest.

The aggregate intrinsic value for options outstanding and exercisable at March 31, 2012 and 2011, was $nil.

A summary of non-vested options at March 31, 2012, and the change during the three months ended March 31, 2012, is presented below:

	Options		Weighted Average Grant Date Fair Value
Nonvested options at January 1, 2012		1	£	45,500	$	71,500
Granted		—		—		—
Vested		—	£	—	$	—
Forfeited/Cancelled		—	£	—	$	—
Nonvested options at March 31, 2012		1	£	45,500	$	71,500

Unrecognized compensation cost

As of March 31, 2012, there was no unrecognized compensation cost related to non-vested share-based compensation arrangements.

9. Stockholders equity and non-controlling interest

The Company has non-controlling investors in Medicsight as follows:

	Medicsight
Non-controlling interest at January 1, 2012	$	5,293
Non-controlling share of losses		(209	)
Non-controlling interest share of stock-based compensation expense		15
Non-controlling interest share of other comprehensive income		34
Decrease in non-controlling interest from share consolidation of Medicsight’s stock		(1,386	)
Non-controlling interest at March 31, 2012	$	3,747

In January 2012, the Company purchased 1 share of Medicsight ordinary shares from a shareholder for consideration of £0.01 ($ .016).

The following schedule presents the effects of changes in MGT’s ownership interest in Medicsight on the equity attributable to MGT:

	Three months ended
	March 31, 2012			March 31, 2011
Net loss attributable to MGT Capital Investments, Inc.	$	(470	)	$	(1,492	)
Transfers (to) from the non-controlling interest:
Increase in MGT’s paid in capital from Medicsight Share Consolidation		2,392			—
Changes from the net loss attributable to MGT Capital Investments, Inc. and transfers from non-controlling interest	$	1,922		$	(1,492	)

10. Related party transactions

Moneygate Group

In Fiscal 2009, we purchased 49% of the share capital of Moneygate. On acquisition we provided loan facilities of £250 ($387) for working capital and £2,000 ($3,094) for acquisitions and subsequently entered into various transactions with Moneygate and other non-related parties.

Through its disposal in March 2011, Moneygate was a related party as the Company had significant influence over its operations as a result of representation on Moneygate’s board of directors. Due to this significant influence, we accounted for it under the equity method. In March 2011, we sold our entire interest in Moneygate to Committed Capital Nominees Limited for total consideration of £250 ($401), resulting in a gain on sale of £51 ($81).

Dunamis Capital

Allan Rowley, former Chief Executive Officer and former Chief Financial Officer of MGT and former Chief Executive Officer of Medicsight, along with David Sumner, former Chairman of Medicsight, are both directors of Dunamis. Dunamis is a United Arab Emirates (“UAE”) registered company regulated by the Dubai Financial Services Authority (“DFSA”). Dunamis is 100% owned by David Sumner and was set up by Mr. Sumner with Allan Rowley’s financial consulting assistance, as a corporate financing and advisory firm. On September 6, 2010, Medicsight made a short-term loan of $1,100 (£711) to Dunamis. Dunamis paid back the principal of $1,100 (£711) and interest of $48 (£30) on February 6, 2011 and February 10, 2011, respectively.

In February 2011, the Company, following consultation with its nominated advisor noted that as a result of Mr. Sumner’s relationships with both Dunamis and Medicsight, the Loan constituted a related party transaction under Rule 13 of AIM Rules for Companies. Rule 13 requires that an AIM company must issue notification without delay as soon as the terms of a transaction with a related party are agreed. The independent directors, having consulted with the Company’s nominated adviser, considered the terms of the transaction fair and reasonable insofar as shareholders were concerned. On February 18, 2011, the Company issued a notice detailing the terms of the transaction with the related party.

Laddcap Value Partners III LLC (“Laddcap”)

On April 12, 2011, the Company entered into a Revolving Line of Credit and Security Agreement with Laddcap for up to $500 for a fifteen month term. The Agreement encompasses a standby commitment fee of two (2%) percent of the maximum loan amount along with an eight (8%) percent interest charge on any funds drawn. Laddcap is a related party as the Managing Partner and beneficial owner of Laddcap is a 10% plus shareholder and CEO of MGT. No amounts have been drawn down against the facility as of the date of the filing of the Company’s Form 10-Q for the quarterly period ended March 31, 2012.

D4D Limited

Effective July 2010, the Company entered into a service agreement with D4D Limited (“D4D”), a company that offers Executive Services for small and mid-cap companies. D4D is owned by Tim Paterson-Brown and Allan Rowley, and pursuant to the agreement, provided the services of Chairman, Chief Executive Officer and Chief Financial Officer of the Company at such time. The D4D service agreement provided the services of Tim Paterson-Brown and Allan Rowley on similar remuneration to their previous employment contracts with MGT. On executing the contract with D4D, Tim Paterson-Brown and Allan Rowley terminated their employment contracts with MGT, but still held the offices of Chairman and Chief Executive Officer and Chief Financial Officer, respectively.

In December 2010, Mr. Paterson-Brown resigned as Chairman and CEO, and was replaced by Mr. Rowley as CEO. In February 2011, Mr. Rowley resigned as CEO.

In April 2011, the agreement with D4D was renegotiated and a settlement agreement between MGT and D4D, Messrs. Paterson-Brown and Rowley was executed and delivered. The financial terms included payments to be made by the Company to D4D of a £110 ($170) settlement fee, a £80 ($124) payment for recoverable local taxes, £17 ($25) for estimated legal expenses, and the assignment of 3 shares of MDST common stock held by the Company to D4D. The common stock was delivered to D4D in April 2011, and had a fair value of $71 on the date of transfer. The parties, upon the terms and subject to the conditions of the settlement agreement and to the extent permitted by law, settled all claims arising out of the D4D Agreement and the respective directorships and employment arrangements with the Company and certain of its affiliates. The Company has fully accrued and expensed all related costs. During the three months ended March 31, 2011, MGT and Medicsight made payments to D4D, totaling $304.

11. Operating leases, commitments and security deposit

In 2006, we executed a 10-year agreement with Pirbright Holdings Limited, to lease office space in London, United Kingdom. Under this lease agreement, the property rent, services and related costs were approximately £330 ($516) per annum, paid quarterly in advance. The Company exercised its right to terminate the lease upon completion of the fifth year (August 2011) and has found an alternative UK office location with no long-term lease commitment. This commitment is on a month-to-month basis and began on August 1, 2011 with total monthly rental payments of £8 ($13) along with a rental deposit of £16 ($25). In February, 2012, the Company moved to a smaller office in the same location with month-to-month rental payments of £2 ($4) and a rental deposit of £4 ($6).

In September 2011, the Company entered into a 39 month lease agreement for office space located in Harrison, New York, United States terminating on November 30, 2014. Under the agreement our total rental payments over the 39 month lease period are $240, inclusive of three months of free rent and a refundable rental deposit of $39.

A satellite office in Tokyo, Japan, was closed in January 2012, and the rental deposit of $128 was refunded to us.

In January 2012, the Company entered into a two year employment agreement with an employee at a base salary of $10,000 per month, with potential bonus payments as outlined in the agreement. This agreement provides for a maximum severance period of 12 months in the event of termination without cause as defined in the agreement.

On March 12, 2012, the Company entered into a one year financial advisory and consulting agreement with a national investment banking firm. The agreement can be canceled with two weeks written notice, three months from the date of the agreement. Under the agreement our total payments over the twelve month period are $60.

The following is a schedule of the future minimum payments required under operating leases and commitments that have initial or remaining non-cancellable terms in excess of one year:

Year Ending

2012 (remaining nine months)	$	95
2013		78
2014		56
Total	$	229

The total lease rental expense was $36 and $143 for the three months ended March 31, 2012 and 2011, respectively.

12. Line of credit facility

On April 12, 2011, the Company entered into a Revolving Line of Credit and Security Agreement with Laddcap for up to $500 for a fifteen month term. The Agreement encompasses a standby commitment fee of two (2%) percent of the maximum loan amount along with an eight (8%) percent interest charge on any funds drawn. The Company has fully accrued the commitment fee of $10 and expensed $2 associated to the facility for the three months ended March 31, 2012. Laddcap is a related party as the Managing Partner and beneficial owner of LaddCap is a 10% plus shareholder and Chief Executive Officer of MGT. No amounts have been drawn down against the facility as of the date of the filing of the Company’s Form 10-Q for the quarterly period ended March 31, 2012.

13. Subsequent events

On April 30, 2012, the Company filed a preliminary proxy statement (PRE-14A) and will hold its Annual Meeting of Stockholders on May 30, 2012.

On May 10, 2012, the Company announced that its Board of Directors has decided to pursue the acquisition of patents and underlying technologies with the intent of commercializing and/or enforcing the economic rights to such inventions.

On the same date, MGT also announced that it has agreed to acquire U.S. Patent #7,892,088, entitled “Gaming Device Having a Second Separate Bonusing Event.” The patent acquisition was made via a newly formed subsidiary, MGT Gaming, Inc., in which MGT will hold a majority interest. The invention specifically relates to gaming systems linked to an interactive sign, and includes all filed continuation patents. The sellers will retain a significant minority stake in MGT Gaming, Inc.; full terms will be disclosed upon the closing of the transactions contemplated in the agreement, which is subject to customary closing conditions.

Major financial terms include an upfront payment by MGT of $200,000, plus the issuance of 350,000 four-year common stock warrants with a $4.00 exercise price.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the unaudited interim condensed financial statements and notes thereto contained in Item 1 of Part I of this Quarterly Report on Form 10-Q and our audited financial statements and notes thereto as of and for the fiscal year ended December 31, 2011, included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2011 (the "2011 Form 10-K"), filed with the SEC to provide an understanding of our results of operations, financial condition and cash flows.

This quarterly report on Form 10-Q contains forward-looking statements made in reliance upon the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements may be identified by the use of words such as “anticipate”, “estimates”, “should”, “expect”, “guidance”, “project”, “intend”, “plan”, “believe” and other words and terms of similar meaning, in connection with any discussion of our financial statements, business, results of operations, liquidity and future operating or financial performance. Please also refer to our “Note Regarding Forward Looking Statements” at the front of this Form.

Executive summary

MGT Capital Investments, Inc. is a holding company comprised of MGT, the parent company, and its wholly-owned subsidiary: MGT Capital Investments (U.K.) Limited. MGT closed the following non-essential subsidiaries during the quarter ended March 31, 2012, as part of its expense reduction plan: Medicsight Nominees Limited, MGT Investments (Gibraltar) Limited and MGT Capital Investments Limited, as subsidiary of MGT Capital Investments (U.K.) Limited. In addition, we also have a controlling interest in our operating subsidiary, Medicsight Ltd (“Medicsight”), including its wholly owned subsidiaries. In March 2011, the Company disposed of its 49% holding in Moneygate Group Limited, a United Kingdom based firm of independent financial advisors.

Medicsight is a medical technology company focusing on medical imaging software development and medical hardware devices. Medicsight develops and commercializes enterprise-wide Computer-Aided Detection (“CAD”) applications which analyze Computer Tomography (“CT”) scans to assist radiologists in the early detection and measurement of colorectal polyps and lung lesions.

The CAD software received a CE Mark in 2009, which allows for sales in the European Union.

On May 19, 2011, Medicsight’s software received clearance from the U.S. Food and Drug Administration (the “FDA”).

In July 2011, Medicsight was unofficially informed by the Japanese Ministry of Health, Labor and Welfare (“MHLW”) that several statistical data errors were encountered in their review of the application for approval of its ColonCAD software for use in CT Colonography procedures. Following informal guidance from MHLW, during August 2011, the Company decided to withdraw the current submission and is assessing the next course of action.

During August 2011, the Board of Directors of Medicsight closed the Tokyo office as part of an overall program of expense reduction and corporate simplification. In addition to closing the Tokyo office, management of Medicsight has closed several non-essential subsidiaries; Medicsight KK and Medicsight PTY Limited, citing the unjustifiably high legal, regulatory and accounting costs of maintaining such entities. However, in order to better exploit the recent FDA approval of ColonCAD, Medicsight has opened a U.S. subsidiary (Medicsight, Inc.) in New York.

Medicsight has also developed an automated CO ₂medical insufflation device and associated disposable tubing (MedicCO ₂ LON) that is being commercialized via a global distributor.

Revenue is presently limited as Medicsight attempts to commercialize its recent U.S. approval. On March 31, 2012, the Company held 318 shares (66.5%) of the 478 issued share capital of Medicsight.

On June 8, 2011, the Company received notice from the Exchange notifying that it is not in compliance with the following Exchange continued listing standards: Section 1003(a)(i) of the Company Guide, resulting from stockholders' equity on March 31, 2011, of less than $2.0 million and losses from continuing operations and/or net losses in two of its three most recent fiscal years; Section 1003(a)(ii) of the Company Guide with stockholders' equity of less than $4.0 million and losses from continuing operations and/or net losses in three of its four most recent fiscal years; and Section 1003(a)(iii) with stockholders' equity of less than $6.0 million and losses from continuing operations and/or net losses in its five most recent fiscal years.

The Exchange further notified the Company that its common stock had fallen to a low trading price for a significant period of time and that the Company was therefore not in compliance with Section 1003 (f)(v) of the Company Guide. The Exchange noted that the Company could regain compliance by effectuating a reverse-split of its common stock prior to February 23, 2012. On February 17, 2012, the Company received notice from the staff of the Exchange that the Company was granted an extension until March 31, 2012, to comply with Section 1003 (f)(v) of the Exchange’s Company Guide. The Company’s shareholders approved a reverse/forward split of its common stock at a special meeting of the stockholders held on March 20, 2012. The Company was notified by the Exchange on April 13, 2012, that the Section 1003 (f) (v) low price deficiency was resolved.

On January 3, 2012, the Company was notified that it is not in noncompliance with Section 704 of the Company Guide in that it failed to hold an annual meeting of its stockholders during 2011, for the fiscal year ended December 31, 2010. The Company's plan of compliance detailing actions which it had taken, or intended to take, to regain compliance with the continued listing standards was accepted by the Exchange via letter dated January 26, 2012, granting the Company until July 3, 2012 to regain compliance with Section 704 of the Exchange’s Company Guide. On April 30, 2012, the Company filed a preliminary proxy statement on Schedule 14A with the Commission in connection with the Company’s annual meeting to be held on May 30, 2012. The record date for the annual meeting was set as April 24, 2012. Once the meeting is held, this deficiency will be resolved.

The Company will be subject to periodic review by Exchange staff during the extension period and prior to compliance with Sections 704, 1003(a)(i), (ii), (iii) and (f)(v) of the Exchange’s Company Guide. Failure to make progress consistent with the plans of compliance or to regain compliance with the continued listing standards by the end of the extension period could result in the Company being delisted from the NYSE Amex LLC.

The Company's stock trading symbol remains MGT, but now includes ".BC" appendage to denote its noncompliance. The trading symbol will continue to bear this additional indicator until the Company regains its compliance with the Exchange continued listing requirements.

In July 2011, the Company announced in a Current Report on Form 8-K that it had initiated an internal investigation through a Special Committee regarding the potential misappropriation and/or misdirection of Company funds. In August 2011, the Company issued a press release based upon the substantially completed results of the investigation. The Company had concluded that no adjustments or restatements of prior issued financial statements were required. Although the investigation remains on-going, management is confident that the Company’s financial statements will not require a material restatement as a result of any additional irregularities that may be uncovered in the future.

In the event the investigation results in any finding of wrongdoing, the Company plans, consistent with the best interests of the Company and its stockholders, to pursue recovery and/or restitution to the fullest extent provided by law. However, in such an event, there can be no assurance of any recovery, or that any recovery will exceed the costs of collection, the costs of any litigation (including settlements as well as legal fees) relating to this matter, or any other costs associated with this matter, including but not limited to payment of taxes or fines, and the findings of unreported claims on the Company’s assets.

As a result of a general meeting of shareholders on September 14, 2011, Medicsight’s shares were cancelled on The London Stock Exchange effective September 22, 2011, Medicsight PLC status changed to a limited company, now known as Medicsight Ltd.

At March 31, 2012, Medicsight’s and MGT’s cash and cash equivalents were $3,021 and $321, respectively compared to $3,123 and $571 at December 31, 2011.

The Company entered into a Revolving Line of Credit and Security (“Agreement”) with Laddcap Value Partners III LLC (“Laddcap”) on April 12, 2011 for up to $500 for a fifteen month term. The Agreement encompasses a standby commitment fee of two (2%) percent of the maximum loan amount along with an eight (8%) percent interest charge on any funds drawn. Laddcap is a related party as the Managing Partner and beneficial owner of Laddcap is a 10% plus shareholder and CEO of MGT. No funds have been drawn against the facility as of the filing of quarterly report on Form 10-Q.

Management believes that the current level of working capital will be sufficient to allow the Company to maintain its operations through May 2013. The Company continues to explore all strategic alternatives with respect to its majority interest in Medicsight. The Company is also analyzing potential acquisition opportunities of various intellectual property assets, as well in healthcare marketing and technology. There can be no assurance that any additional acquisitions will occur at all, or that any such acquisitions will be accretive to earnings, book value and other financial metrics, or that any such acquisitions will generate positive returns for Company shareholders. Furthermore, it is contemplated that any acquisitions may require the Company to raise additional capital; such capital may not be available on terms acceptable to the Company, if at all.

The Company achieved the following results in the three months ended March 31, 2012:

Revenue from license and other sales was $213 compared to $47 for the same period in 2011. Gross profit on revenues was $177 compared with $43 in 2011. Revenue remains limited as Medicsight awaits commercial development in the U.S.

Operating expenses decreased to $854 compared to $2,638 in 2011.

Net loss attributable to MGT Capital Investments, Inc. decreased to $470 and resulted in a loss per share of $0.22 compared to a net loss of $1,492 and net loss per share of $1.27 in 2011.

Critical accounting policies and estimates

The Company’s financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP). Certain accounting policies have a significant impact on amounts reported in the financial statements. A summary of those significant accounting policies can be found in Note 2 to the Company’s financial statements contained in the 2011, Annual Report on Form 10-K and Part I (Note 2) contained in the 2012, Quarterly Report on Form 10-Q.

Results of Operations

Three months ended March 31, 2012 and March 31, 2011

Revenue and gross margin

The Company generated revenues of $213 and gross margin of $177 for the three months ended March 31, 2012, compared to $47 and $43 for the same period in 2010.

In the three months ended March 31, 2012, Medicsight sold CAD licenses primarily in Europe where it has regulatory approvals. Sales of our CAD products increased to $123 compared to $47 for the same period last year.

In the three months ended March 31, 2012, additional revenue of $70 was recognized through MedicCO ₂ LON administrative kit sales and $20 from other revenue, compared to $ nil and $ nil for the same period in 2011.

Operating expenses

Our selling, general & administrative expenses were reduced to $813 in 2012, compared to $2,198 for the period ending March 31, 2011. Management substantially reduced headcount and streamlined operations in 2011. Several satellite offices and subsidiaries were closed and our London office relocated to a significantly smaller space. The majority of the impact of these decisions were reflected in the statement of operations for the three months ended 2012. The Company expects that SG&A costs will increase modestly for the remainder of 2012, as it pursues its acquisition strategy due primarily to higher professional fees.

Research and development costs decreased to $41 compared to $440 in 2011, primarily due to the reduction of headcount and associated overhead.

Interest and other income/(expense) was $(2) for the three months ended March 31, 2012, as a result of Medicsight’s lower cash balances versus $21 for the period ending March 31, 2011.

Operational currency

The Company’s main operating currency is UK sterling (£). Medicsight’s results of operations are affected by changes in the $: £ rates used to translate the operational results. For the three months ended March 31, 2012 and March 31, 2011, the average rate was $1.5855: £1.00 and $1.5430 respectively, a decrease of 3% in the value of the dollar against sterling.

Other investments

Moneygate Group Limited:

Medicsight:

On February 10, 2011, the Company announced its decision to explore all alternatives with respect to maximizing the value of its holding in Medicsight; this analysis is on-going. Our consolidated financial statements include the results and financial condition of our subsidiary, Medicsight.

Medicsight was previously listed on the AIM Market of the London Stock Exchange through September 22, 2011, when its shares were cancelled based on a duly passed shareholder resolution and Medicsight became private.

Liquidity and Capital Resources

Working Capital information

	March 31, 2012			December 31, 2011
Working capital summary
Cash and cash equivalents	$	3,342		$	3,704
Current assets		3,671			4,204
Current liabilities		(700	)		(786	)
Working capital surplus	$	2,971		$	3,418

	Three month ended March 31,
	2012			2011
Cash flow summary
Cash (used in) provided by
Operating activities	$	(415	)	$	(2,864	)
Investing activities		(10	)		1,871
Financing activities		(5	)		—
Effects of exchange rates on cash and cash equivalents		68			392
Net decrease in cash and cash equivalents	$	(362	)	$	(601	)

On March 31, 2012, Medicsight’s and MGT’s cash and cash equivalents were $3,021 and $321, respectively. The Company continues to exercise discipline with respect to current expense levels, as revenues remain limited.

On April 12, 2011, the Company entered into an Agreement with Laddcap, a related party, for up to $500 for a fifteen month term. The Agreement encompasses a standby commitment fee of two (2%) percent of the maximum loan amount along with an eight (8%) percent interest charge on any funds drawn. No amounts have been drawn down against the facility on the date of the filing of the Company’s Form 10-Q for the quarterly period ended March 31, 2012.

On December 27, 2011, the Company raised approximately $639 net of associated costs of $142, in a direct rights offering to its shareholders. All 937,214 (post-split) shares subject to the subscription rights were sold pursuant to the Basic Subscription Privilege and the Oversubscription Privilege described in the Prospectus, as filed with the Commission on November 22, 2011.

Risks and uncertainties related to our future capital requirements

To date we have primarily financed our operations through private placements of equity securities. To the extent that additional capital is raised through the sale of equity or equity-related securities of the Company or its subsidiaries, the issuance of such securities could result in dilution to our stockholders.

No assurance can be given, however, that we will have access to the capital markets in the future, or that financing will be available on acceptable terms, if at all, to satisfy our cash requirements to implement our business strategies.

If we are unable to access the capital markets or obtain acceptable financing, our results of operations and financial conditions could be materially and adversely affected. We may be required to raise substantial additional funds through other means.

Commercial results have been limited and we have not generated significant revenues. We cannot assure our stockholders that our revenues will be sufficient to fund our operations.

If adequate funds are not available to us, we may be required to curtail operations significantly or to obtain funds through entering into arrangements with collaborative partners or others that may require us to relinquish rights to certain of our technologies or products that we would not otherwise relinquish.

Currently the Company anticipates it has sufficient cash on hand to continue operations at least through May 2013, at which point the Company may need to seek additional sources of financing. There is no guarantee that additional sources of financing will be available or on terms acceptable to the Company, if at all.

Operating Activities

Our cash and cash equivalents have decreased during 2012, predominantly because of the $(415) used in operating activities. Our net cash used in operating activities differs from net loss predominantly because of various non-cash adjustments such as depreciation, stock-based compensation and movements in working capital.

Investing Activities

Investment in Medicexchange

MGT received the final payment of £244 ($370) on March 25, 2011, for the sale of Medicexchange and other assets.

Investment in Moneygate

Loan Receivable from Dunamis Capital

On September 6, 2010, Medicsight made a short-term loan of $1,100 (£711) to Dunamis repayable by December 31, 2010, along with $36 (£23) of interest. Dunamis paid back the principal of $1,100 (£711) and interest of $48 (£31) on February 6, 2011 and February 10, 2011, respectively. Dunamis had provided the assets of the business as collateral against the loan made by Medicsight. Dunamis was considered a related party, as two former directors of Medicsight were also directors of Dunamis Capital (see note 11).

Commitments

In 2006, we executed a 10-year agreement with Pirbright Holdings Limited, to lease office space in London, United Kingdom. Under this lease agreement, the property rent, services and related costs were approximately £330 ($516) per annum, paid quarterly in advance. The Company exercised its right to terminate the lease upon completion of the fifth year (August 2011) and has found an alternative UK office location with no long-term lease commitment. This commitment is on a month-to-month basis and began on August 1, 2011, with total monthly rental payments of £8 ($13) along with a rental deposit of £16 ($25). In February, 2012, the Company moved to a smaller office in the same location with month-to-month rental payments of £2 ($4) and a rental deposit of £4 ($6). As such minimum rental payments subsequent to this date have not been included in the schedule below.

A satellite office in Tokyo, Japan was closed in January 2012, and the rental deposit of $128 was returned.

The following table analyzes our contractual obligations:

	Payments due by period
Contractual obligations	Total		Less than 1 year		1-3 years		3-5 years
Obligations	$	229	$	95	$	134	$	—

Total	$	229	$	95	$	134	$	—

Recent accounting pronouncements

Item 3. Quantitative and qualitative disclosures about market risk

Not applicable.

Item 4. Controls and Procedures

(a) Evaluation of disclosure controls and procedures. Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) or 15d-15(e) of the Exchange Act of 1934. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures as of March 31, 2012 (the end of the period covered by this Quarterly Report on Form 10-Q), have been designed and are functioning effectively to provide reasonable assurance that the information required to be disclosed by us in our reports filed or submitted under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and (ii) that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

(b) Changes in internal control over financial reporting. There have been no changes in our internal control over financial reporting that occurred during the quarter ended March 31, 2012, that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal proceedings

None.

Item 1A. Risk factors

The reader should carefully consider, in connection with the other information in this report, the factors discussed in Part I, “Item 1A: Risk Factors” on pages 8 through 12 of the Company’s 2011 Annual Report on Form 10-K. These factors could cause our actual results to differ materially from those stated in forward-looking statements contained in this document and elsewhere.

Current deficiency in the Listing Standards of the NYSE Amex Market.

The staff of NYSE-Amex LLC (the “Exchange”) has notified the Company that it is not in compliance with the following Exchange continued listing standards: Section 1003(a)(i) of the Company Guide, resulting from stockholders' equity on March 31, 2011, of less than $2.0 million and losses from continuing operations and/or net losses in two of its three most recent fiscal years; Section 1003(a)(ii) of the Company Guide with stockholders' equity of less than $4.0 million and losses from continuing operations and/or net losses in three of its four most recent fiscal years; and Section 1003(a)(iii) with stockholders' equity of less than $6.0 million and losses from continuing operations and/or net losses in its five most recent fiscal years.

On August 23, 2011, the Exchange accepted the Company’s plan of compliance submitted to the Exchange in response to the deficiency letter. The Exchange granted the Company an extension until December 8, 2012, to regain compliance with Sections 1003(a) (i)-(iii) of the Exchange’s Company Guide. The Company would have the right to appeal any such determination. However, there is no assurance of success throughout this process.

On January 3, 2012, the Company was notified that it is not in noncompliance with Section 704 of the Company Guide in that it failed to hold an annual meeting of its stockholders during 2011 for the fiscal year ended December 31, 2010. The Company's plan of compliance detailing actions which it had taken, or intended to take, to regain compliance with the continued listing standards was accepted by the Exchange via letter dated January 26, 2012, granting the Company until July 3, 2012, to regain compliance with Section 704 of the Exchange’s Company Guide. On April 30, 2012, the Company filed a preliminary proxy statement on Schedule 14A with the Commission in connection with the Company’s annual meeting to be held on May 30, 2012. The record date for the annual meeting was set as April 24, 2012. Upon holding the meeting, this deficiency will be resolved.

Item 2. Unregistered sales of equity securities and use of proceeds

In the three months ended March 31, 2012, no shares of common stock were issued.

Item 3. Defaults upon senior securities

None.

Item 4. Mine Safety Disclosures

Not Applicable.

Item 5. Other information

None

Item 6. Exhibits

31.1	Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

SIGNATURE

In accordance with the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	MGT CAPITAL INVESTMENTS, INC
May 14, 2012

	By:	/s/ ROBERT B. LADD
		Robert B. Ladd
		Chief Executive Officer (Principal Executive Officer)
May 14, 2012

	By:	/s/ ROBERT P. TRAVERSA
		Robert P. Traversa
		Chief Financial Officer (Principal Financial Officer)

In accordance with the Exchange Act, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

EX-31.1 2 v312851_ex31-1.htm EXHIBIT 31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO SARBANES-OXLEY ACT OF 2002

I, Robert Ladd, certify that:

1. I have reviewed this quarterly report on Form 10-Q of MGT Capital Investments, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

	By:	/s/ ROBERT B. LADD
		Robert B. Ladd
		Chief Executive Officer
May 14, 2012

EX-31.2 3 v312851_ex31-2.htm EXHIBIT 31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO SARBANES-OXLEY ACT OF 2002

I, Robert P. Traversa, certify that:

1. I have reviewed this quarterly report on Form 10-Q of MGT Capital Investments, Inc.;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

	By:	/s/ ROBERT P. TRAVERSA
		Robert P. Traversa
		Chief Financial Officer
May 14, 2012

EX-32.1 4 v312851_ex32-1.htm EXHIBIT 32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

I, Robert Ladd, Interim Chief Executive Officer of MGT Capital Investments, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to the best of my knowledge:

(1) the Quarterly Report on Form 10-Q of the Company for the period ended March 31, 2012 (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

	By:	/s/ ROBERT B. LADD
		Robert B. Ladd
		Chief Executive Officer
May 14, 2012

EX-32.2 5 v312851_ex32-2.htm EXHIBIT 32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

I, Robert P. Traversa, Principal Financial Officer of MGT Capital Investments, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to the best of my knowledge:

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

	By:	/s/ ROBERT P. TRAVERSA
		Robert P. Traversa
		Chief Financial Officer
May 14, 2012

EX-101.INS 6 mgt-20120331.xml XBRL INSTANCE DOCUMENT 0001001601 2011-01-01 2011-03-31 0001001601 2011-12-31 0001001601 2012-01-01 2012-03-31 0001001601 us-gaap:CommonStockMember 2012-01-01 2012-03-31 0001001601 us-gaap:AdditionalPaidInCapitalMember 2012-01-01 2012-03-31 0001001601 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-01-01 2012-03-31 0001001601 us-gaap:RetainedEarningsMember 2012-01-01 2012-03-31 0001001601 us-gaap:StockholdersEquityTotalMember 2012-01-01 2012-03-31 0001001601 us-gaap:NoncontrollingInterestMember 2012-01-01 2012-03-31 0001001601 2012-03-31 0001001601 2012-05-14 0001001601 2010-12-31 0001001601 2011-03-31 0001001601 us-gaap:CommonStockMember 2011-12-31 0001001601 us-gaap:CommonStockMember 2012-03-31 0001001601 us-gaap:AdditionalPaidInCapitalMember 2011-12-31 0001001601 us-gaap:AdditionalPaidInCapitalMember 2012-03-31 0001001601 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2011-12-31 0001001601 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-03-31 0001001601 us-gaap:RetainedEarningsMember 2011-12-31 0001001601 us-gaap:RetainedEarningsMember 2012-03-31 0001001601 us-gaap:StockholdersEquityTotalMember 2011-12-31 0001001601 us-gaap:StockholdersEquityTotalMember 2012-03-31 0001001601 us-gaap:NoncontrollingInterestMember 2011-12-31 0001001601 us-gaap:NoncontrollingInterestMember 2012-03-31 xbrli:shares iso4217:USD iso4217:USDxbrli:shares MGT CAPITAL INVESTMENTS INC 0001001601 --12-31 Smaller Reporting Company mgt 2105187 10-Q false 2012-03-31 Q1 2012

3704000

3342000

8434000

7833000

84000

118000

327000

155000

4204000

3671000

28000

32000

201000

65000

4433000

3768000

89000

56000

213000

261000

502000

395000

71000

44000

786000

700000

2000

283240000

285644000

-4861000

-5828000

-280027000

-280497000

-1646000

-679000

5293000

3747000

3647000

3068000

2000

283240000

285644000

-4861000

-5828000

-280027000

-280497000

-1646000

-679000

5293000

3747000

4433000

3768000

0.001

75000000

2108732

2105187

2108732

2105187

47000

213000

4000

36000

43000

177000

2198000

813000

440000

41000

2638000

854000

-2595000

-677000

21000

-2000

81000 0

102000

-2000

-2493000

-679000

-470000

-209000

-1001000

-209000

-1492000

-470000

-1.27

-0.22

1171518 2108338

17000

32000

16000

7000

-2000

81000 0

-23000

31000

-16000 0

469000

-166000

-36000

372000

42000

-228000

-108000

-37000

-10000

-2864000

-415000

392000

68000

-1100000

10000

401000

370000 0

1871000

-10000

-5000

-601000

-362000

1.           Organization, basis of presentation and liquidity   The accompanying unaudited condensed consolidated financial statements of MGT Capital Investments, Inc. (“MGT”, “the Company”, “the Group”, “we”, “us”) have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, they do not include all of the information and notes required by accounting principles generally accepted in the United States of America. In the opinion of management, all adjustments, consisting only of normal recurring adjustments, have been included. Operating results for the three months ended March 31, 2012, are not necessarily indicative of the results that may be expected for any subsequent quarter or for the year ending December 31, 2012.  These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2011. The condensed consolidated financial statements include the accounts of the Company and its majority owned subsidiaries. All intercompany accounts and transactions have been eliminated.   MGT Capital Investments, Inc. is a holding company comprised of MGT, the parent company, and its wholly-owned subsidiary:  MGT Capital Investments (U.K.) Limited. MGT closed the following non-essential subsidiaries during the quarter ended March 31, 2012, as part of its expense reduction plan: Medicsight Nominees Limited, MGT Investments (Gibraltar) Limited and MGT Capital Investments Limited a subsidiary of MGT Capital Investments (U.K.) Limited. In addition we also have a controlling interest in our operating subsidiary, Medicsight Ltd, (“Medicsight”) including its wholly owned subsidiaries.   <table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 17.85pt;"></td> <td style="width: 17.85pt;">·</td> <td style="text-align: justify;">Medicsight is a medical technology company focusing on medical imaging software development and medical hardware devices. The Company commercializes Computer-Aided Detection (“CAD”) applications which analyze Computer Tomography (“CT”) scans to assist radiologists in the early detection and measurement of colorectal polyps. The CAD software received a CE Mark in 2009, which allows for sales in the European Union. In 2011, Medicsight’s software also received clearance from the U.S. Food and Drug Administration.  Revenue is presently limited as Medicsight attempts to commercialize its recent U.S. approval. In late July 2011, Medicsight was informed by the Japanese Ministry of Health, Labor and Welfare (“MHLW”) that several statistical data errors were encountered in their review of the application for approval of its ColonCAD software for use in CT Colonography procedures. Following informal guidance from MHLW, during August 2011, the Company decided to withdraw the current submission and is assessing the next course of action. In the meantime, the Board of Directors of Medicsight closed the Tokyo office as part of an overall program of expense reduction and corporate simplification. In addition to closing the Tokyo office, management of Medicsight has closed several non-essential subsidiaries; Medicsight KK and Medicsight PTY Limited, citing the unjustifiably high legal, regulatory and accounting costs of maintaining such entities. However, in order to better exploit the recent FDA approval of ColonCAD, Medicsight has opened a U.S. subsidiary (Medicsight, Inc.) in New York. Medicsight has also developed an automated CO2 medical inflation device and associated disposable tubing (MedicCO 2 LON) that is being commercialized via a global distributor.</td> </tr> </table>   <table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 17.85pt;"></td> <td style="width: 17.85pt;">·</td> <td style="text-align: justify;">On March 21, 2012, MGT effected a reverse split (the “Reverse Split”), immediately followed by a forward split (the “Forward Split” and together with the Reverse Split, the “Reverse/Forward Split”).  At our March 20, 2012, Special Meeting of Stockholders, the Company’s stockholders approved the proposal to amend the Company’s Certificate of Incorporation to effect a Reverse/Forward Split of the Company’s Common Stock, $0.01 par value per share at an exchange ratio of 1-for-500 shares of the Company’s outstanding Common Stock, immediately followed by a forward split of the Company’s outstanding Common Stock, at an exchange ratio of 15-for-1 shares of the Company’s outstanding Common Stock.  The amendment did not change the par value per share or the number of authorized shares of Common Stock. As a result of the Reverse Split, stockholders holding fewer than 500 shares of Common Stock, at the time of the reversal, received a cash payment instead of fractional shares and would no longer have an interest in the Company.  All share and per share amounts have been retrospectively adjusted for all periods presented to give effect to the Reverse/Forward Split.</td> </tr> </table>   <table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 17.85pt;"></td> <td style="width: 17.85pt;">·</td> <td style="text-align: justify;">On March 26, 2012, at Medicsight’s General Meeting, stockholders approved a resolution to Reverse Split the Company’s existing ordinary shares of £0.05 par value per share into 1 new ordinary share of £16,250 par value per share (the “New Ordinary Shares”) and for MGT to acquire all New Ordinary Shares representing the fractions of shares left over following the Reverse Split. </td> </tr> </table>   The exchange ratio for the Reverse Split was 1-for-325,000. As a result of the Reverse Split, stockholders holding fewer than 325,000 shares were cancelled and not entitled to a cash payment for fractional shares. As of March 31, 2012, MGT holds 318 shares (66.5%) of the 478 issued share capital of Medicsight.  Medicsight was previously listed on the AIM market of the London Stock Exchange until September 2011, when its shares were cancelled based upon a duly passed shareholder resolution and Medicsight became private. All share amounts have been retrospectively adjusted for all periods presented to give effect to the Reverse Split.   The Company has incurred significant operating losses since inception and continues to generate losses from operations. As a result, the Company has generated negative cash flows from operations and has an accumulated deficit of $280,497 at March 31, 2012. The Company is operating in a developing industry based on new technology and its primary source of funds to date has been through the issuance of securities. While the Company is optimistic and believes appropriate actions are being taken, there can be no assurance that management’s efforts will be successful or that the products the Company develops and markets will be accepted by consumers.   At March 31, 2012, Medicsight’s and MGT’s cash and cash equivalents were $3,021 and $321, respectively. Management believes that the current level of working capital will be sufficient to allow the Company to maintain its operations into May 2013.

2.           Summary of significant accounting policies   Principles of consolidation   The consolidated financial statements include the accounts of our Company plus wholly owned subsidiaries and our majority owned subsidiary Medicsight.  The functional currency of our majority owned subsidiary is their local currency, GBP.  All intercompany transactions and balances have been eliminated.  All foreign currency translation gains and losses arising on consolidation were recorded in stockholders’ equity as a component of accumulated other comprehensive income/ (loss). Non-controlling interest represents the minority equity investment in any of the MGT group of companies, plus the minorities’ share of the net operating result and other components of equity relating to the non-controlling interest.   Use of estimates   The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amount of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period.  Actual results could differ from those estimates.   Cash and cash equivalents   The Company considers investments with original maturities of three months or less to be cash equivalents.   Revenue Recognition   Medicsight   The Company recognizes revenue when it is realized or realizable and earned.  The Company considers revenue realized or realizable and earned when there is persuasive evidence of an arrangement and that the product has been shipped or the services have been provided to the customer, the sales price is fixed or determinable and collectability is probable.   Software — License fee revenue is derived from the licensing of computer software.  Maintenance revenue is derived from software maintenance.  Our software licenses are generally sold as part of an arrangement that includes maintenance and support.   The Company licenses software and sells maintenance contracts through visualization solution partners and original equipment manufacturers.  The Company receives regular sales reporting detailing the number of licenses sold by original equipment manufacturers, value-added resellers and independent distributors (collectively, “Resellers”) to end users.  The Company generally offers terms that require payment 30-45 days from invoicing. Provided the Reseller: (i) assumes all risk of the purchase, (ii) has the ability and obligation to pay regardless of receiving payment from the end user, and (iii) all other revenue recognition criteria are met, license revenue from Resellers is recognized upon shipment of its product to vendors (“sell-in basis”).   Revenue from license fees is recognized when notification of shipment to the end user has occurred, there are no significant Company obligations with regard to implementation and the Company’s services are not considered essential to the functionality of other elements of the arrangement.   Services — Revenue from maintenance and support arrangements is deferred and recognized rateably over the term of the maintenance and support arrangements.   Multiple-element arrangements — the Company enters into arrangements with resellers that include a combination of software products, maintenance and support.  For such arrangements, the Company recognizes revenue using the Multiple-Deliverable Revenue Arrangements. The Company allocates the total arrangement fee among the various elements of the arrangement based on the fair value of each of the undelivered elements. The fair value of maintenance and support services is established based on renewal rates.   Hardware — Revenue is derived from the sale of our MedicCO 2 LON product. This product is an automated CO 2 insufflation device, and is generally sold as part of an arrangement that includes a one year warranty. The risk of incurring warranty related expense is mitigated by the warranty contractually agreed with the supplier. The Company reviews the risk of warranty liabilities on a regular basis, and makes any and all appropriate provisions accordingly. At the present time, the Company feels that the warranty liability is insignificant and has therefore not made any provision.   MedicCO 2 LON is sold exclusively through our distribution partner Medrad Inc.  Revenue is recognized as orders are satisfied and goods are delivered to our distribution partner. The Company generally offers terms which require payments within 30-45 days from invoicing.   Equity-based compensation   The Company recognizes compensation expense for all equity-based payments.  Under fair value recognition provisions, the Company recognizes equity-based compensation net of an estimated forfeiture rate and recognizes compensation cost only for those shares expected to vest over the requisite service period of the award.   The fair value of each option award is estimated on the date of grant using the Black-Scholes option valuation model.  The Black-Scholes option valuation model requires the development of assumptions that are input into the model.  These assumptions are the expected stock volatility, the risk-free interest rate, the option’s expected life and the dividend yield on the underlying stock. Expected volatility is calculated based on the historical volatility of our common stock over the expected option life and other appropriate factors.  Risk-free interest rates are calculated based on continuously compounded risk-free rates for the appropriate term.  The dividend yield is assumed to be zero as the Company has never paid or declared any cash dividends on our common stock and does not intend to pay dividends on our common stock in the foreseeable future.  The expected forfeiture rate is estimated based on historical experience.   Determining the appropriate fair value model and calculating the fair value of equity-based payment awards requires the input of the subjective assumptions described above.  The assumptions used in calculating the fair value of equity-based payment awards represent management’s best estimates, which involve inherent uncertainties and the application of management’s judgment.  As a result, if factors change and the Company uses different assumptions, our equity-based compensation expense could be materially different in the future.  In addition, the Company is required to estimate the expected forfeiture rate and recognize expense only for those shares expected to vest.  If our actual forfeiture rate is materially different from our estimate, the equity-based compensation expense could be significantly different from what the Company has recorded in the current period.   Inventory   We account for inventory at the lower of cost (first-in, first-out) or market. Cost is determined to be purchased cost for the finished MedicCO 2 LON product from the third party supplier. We perform full physical inventory counts to maintain controls and obtain accurate data. The MedicCO 2 LON product is either (i) sold to our exclusive distributor or (ii) placed in an external third party secure warehouse facility and remains our property. Once the units are shipped to the distributor it is deemed that the ownership is transferred to the distributor and the goods are delivered. Reserves for slow-moving and obsolete inventories are provided based on historical experience and product demand. Management evaluates the adequacy of these reserves periodically based on forecasted sales and market trends.   Research and development   The Company incurs costs in connection with the development of software products that are intended for sale. Costs incurred prior to technological feasibility being established for the product are expensed as incurred. Technological feasibility is established upon completion of a detail program design or, in its absence, completion of a working model. Thereafter, all software production costs are capitalized and subsequently reported at the lower of unamortized cost or net realizable value. Capitalized costs are amortized based on current and future revenue for each product with an annual minimum equal to the straight-line amortization over the remaining estimated economic life of the product. Amortization commences when the product is available for general release to customers.   The Company concluded that capitalizing such expenditures on completion of a working model was inappropriate because the Company did not incur any material software production costs and therefore expenses were all research and development costs.  Our research and development costs are comprised of staff, consultancy and other costs expensed on the Medicsight products.   Property and equipment   Property and equipment are stated at cost less accumulated depreciation.  Depreciation is calculated using the straight-line method on the various asset classes over their estimated useful lives, which range from two to five years.  Leasehold improvements are depreciated over the term of the lease.   Foreign currency translation   The accounts of the Company’s foreign subsidiaries are maintained using the local currency as the functional currency. For these subsidiaries, assets and liabilities are translated into U.S. dollars at period-end exchange rates, and income and expense accounts are translated at average monthly exchange rates.  Net gains and losses from foreign currency translation are excluded from operating results and are accumulated as a separate component of stockholders’ equity.   Gains and losses on foreign currency transactions are reflected in selling, general and administrative expenses in the income statement.   Income taxes   The Company applies the elements of FASB ASC 740-10 “Income Taxes — overall” regarding accounting for uncertainty in income taxes. This clarifies the accounting for uncertainty in income taxes recognized in financial statements and requires the impact of a tax position to be recognized in the financial statements if that position is more likely than not of being sustained by the taxing authority. As of March 31, 2012 and December 31, 2011, the Company did not have any unrecognized tax benefits. The Company does not expect that the amount of unrecognized tax benefits will significantly increase or decrease within the next twelve months. The Company’s policy is to recognize interest and penalties related to tax matters in the income tax provision in the Consolidated Statements of Operations. There was no interest and penalties for the three months ended March 31, 2012 and 2011. Tax years beginning in 2009 are generally subject to examination by taxing authorities, although net operating losses from all years are subject to examinations and adjustments for at least three years following the year in which the attributes are used.   Deferred taxes are computed based on the tax liability or benefit in future years of the reversal of temporary differences in the recognition of income or deduction of expenses between financial and tax reporting purposes. The net difference, if any, between the provision for taxes and taxes currently payable is reflected in the balance sheet as deferred taxes. Deferred tax assets and/or liabilities, if any, are classified as current and non-current based on the classification of the related asset or liability for financial reporting purposes, or based on the expected reversal date for deferred taxes that are not related to an asset or liability. Valuation allowances are recorded to reduce deferred tax assets to that amount which is more likely than not to be realized.    Loss per share   Basic loss per share is calculated by dividing net loss attributable to the ordinary shareholders by the weighted average number of common shares outstanding during the period.  Diluted loss per share is calculated by dividing the net loss attributable to the ordinary shareholders by the sum of the weighted average number of common shares outstanding and the diluted potential ordinary shares.   The computation of diluted loss per share for the three months ended March 31, 2012, and 2011, excludes all options at our Medicsight subsidiary as they are anti-dilutive.  For the three months ended March 31, 2012, there were 6 options excluded with a weighted average exercise price of $46,376 per share.  For the three months ended March 31, 2011, there were 33 options excluded with a weighted average exercise price of $71,500 per share.   Comprehensive income / (loss)    Comprehensive income/ (loss) includes net income/ (loss) and items defined as other comprehensive income/ (loss).  Items defined as other comprehensive income/ (loss), include foreign currency translation adjustments and are separately classified in the consolidated financial statements.  Such items are reported in the Condensed Consolidated Statement of Comprehensive Loss.   In June 2011, the Financial Accounting Standards Board (“FASB”) issued ASU 2011-05 which provides new guidance on the presentation of comprehensive income. ASU 2011-05 eliminates the option to report other comprehensive income and its components in the statement of changes in stockholders’ equity and instead requires an entity to present the total of comprehensive income, the components of net income and the components of other comprehensive income either in a single continuous statement or in two separate but consecutive statements. This guidance is effective for fiscal years, and interim period within those years, beginning after December 15, 2011, with early adoption permitted. The adoption of this ASU only requires a change in the format of the current presentation. The Company adopted this guidance on January 1, 2012, and its adoption did not significantly impact the Company’s condensed consolidated financial statements.   Segment reporting    The Company operates in one main operational segment, Medicsight, a medical imaging and device hardware company, with MGT providing corporate management services.

3.       Divestment of investments   On March 31, 2010, the Company sold its stock in Medicexchange and various non-core investments for consideration of £750 ($1,136).  This consideration was deferred and to be paid in installments, with the final installment of £244 ($370) paid in March 2011.   In Fiscal 2009, we purchased 49% of the share capital of Moneygate Group Limited (“Moneygate”), which was accounted for under the equity method. In March 2011, we sold our entire interest in Moneygate to Committed Capital Nominees Limited for total consideration of £250 ($401), resulting in a gain on sale of £51 ($81).

4.           Cash and cash equivalents   We invest our cash in short-term deposits with major banks.  As of March 31, 2012, we held $3,342 of cash and cash equivalents.   Cash and cash equivalents consist of cash and temporary investments with maturities of 90 days or less when purchased.   Concentrations   The Company held $3,021 and $3,123 of its cash and cash equivalents at March 31, 2012 and December 31, 2011, respectively, through Medicsight, its majority owned subsidiary, at financial institutions in Europe and United Arab Emirates (“UAE”).   Cash held in foreign institutions is not insured by the Federal Deposit Insurance Corporation.

6.            Inventory    At March 31, 2012 and December 31, 2011, MedicCO 2 LON Limited, a subsidiary of Medicsight, held finished goods inventory comprised of insufflation devices and administration kits totaling $56 and $89, respectively.

9.           Stockholders equity and non-controlling interest   The Company has non-controlling investors in Medicsight as follows:   <table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td> </td> <td style="font-weight: bold; padding-bottom: 1pt;"> </td> <td style="font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2">Medicsight</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #ccffcc;"> <td style="width: 85%; text-indent: -27pt; padding-left: 27pt;">Non-controlling interest at January 1, 2012</td> <td style="width: 1%;"> </td> <td style="width: 1%; text-align: left;">$</td> <td style="width: 12%; text-align: right;">5,293</td> <td style="width: 1%; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-indent: -27pt; padding-left: 27pt;">Non-controlling share of losses</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">(209</td> <td style="text-align: left;">)</td> </tr> <tr style="vertical-align: bottom; background-color: #ccffcc;"> <td style="text-indent: -27pt; padding-left: 27pt;">Non-controlling interest share of stock-based compensation expense</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">15</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; text-indent: -27pt; padding-left: 27pt;">Non-controlling interest share of other comprehensive income</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">34</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #ccffcc;"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -27pt; padding-left: 27pt;">Decrease in non-controlling interest from share consolidation of Medicsight’s stock</td> <td style="padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid; text-align: left;"> </td> <td style="border-bottom: black 1pt solid; text-align: right;">(1,386</td> <td style="padding-bottom: 1pt; text-align: left;">)</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="padding-bottom: 1pt; text-indent: -27pt; padding-left: 27pt;">Non-controlling interest at March 31, 2012</td> <td style="padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid; text-align: left;">$</td> <td style="border-bottom: black 1pt solid; text-align: right;">3,747</td> <td style="padding-bottom: 1pt; text-align: left;"> </td> </tr> </table>   In January 2012, the Company purchased 1 share of Medicsight ordinary shares from a shareholder for consideration of £0.01 ($ .016).   The following schedule presents the effects of changes in MGT’s ownership interest in Medicsight on the equity attributable to MGT:   <table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td> </td> <td style="font-weight: bold; padding-bottom: 1pt;"> </td> <td style="font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="6">Three months ended</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td style="font-weight: bold; padding-bottom: 1pt;"> </td> <td style="font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2">March   31, 2012</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="font-weight: bold; padding-bottom: 1pt;"> </td> <td style="font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2">March   31, 2011</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #ccffcc;"> <td style="width: 74%; text-align: left;">Net loss attributable to MGT Capital Investments, Inc.</td> <td style="width: 1%;"> </td> <td style="width: 1%; text-align: left;">$</td> <td style="width: 10%; text-align: right;">(470</td> <td style="width: 1%; text-align: left;">)</td> <td style="width: 1%;"> </td> <td style="width: 1%; text-align: left;">$</td> <td style="width: 10%; text-align: right;">(1,492</td> <td style="width: 1%; text-align: left;">)</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; padding-left: 9pt;">Transfers (to) from the non-controlling interest:</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #ccffcc;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in;">Increase in MGT’s paid in capital from Medicsight Share Consolidation</td> <td style="padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid; text-align: left;"> </td> <td style="border-bottom: black 1pt solid; text-align: right;">2,392</td> <td style="padding-bottom: 1pt; text-align: left;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid; text-align: left;"> </td> <td style="border-bottom: black 1pt solid; text-align: right;">—</td> <td style="padding-bottom: 1pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 9pt;">Changes from the net loss attributable to MGT Capital Investments, Inc. and transfers from non-controlling interest</td> <td style="padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid; text-align: left;">$</td> <td style="border-bottom: black 1pt solid; text-align: right;">1,922</td> <td style="padding-bottom: 1pt; text-align: left;"></td> <td style="padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid; text-align: left;">$</td> <td style="border-bottom: black 1pt solid; text-align: right;">(1,492</td> <td style="padding-bottom: 1pt; text-align: left;">)</td> </tr> </table>   7.            Interest and other income/ (expense)   For the three months ended March 31, 2012, interest and other income/ (expense) was comprised of interest expense of $2. For the same period last year, interest income and other income/ (expenses) included interest income of $21.

8.           Stock-based compensation   Cancellation of certain share option plans of the Company   Following Medicsight’s general meeting on March 26, 2012 (see Note 1), a shareholder resolution approving the Reverse Split of 1-for-325,000 of the Company’s existing ordinary shares of £ 0.05 par value into one new ordinary share was duly passed. As a result of the reverse split, option holders under certain existing share option plans are no longer entitled to options under those plans as option holders’ share entitlement is now less than one as a result of the Reverse Split.  Following the share reversal, the Company cancelled with immediate effect all redundant option plans with the exception of Plan J. All previously unrecognized stock based compensation expense was accelerated.   Medicsight has the following Stock Option Plan:   Plan J — on May 14, 2009, we approved and subsequently granted options for 24 shares under stock option plan “J”.  Options under this plan vest in equal one-sixths for each six months that employees have been employed for 6, 12, 18, 24, 30 and 36 months from the grant date.  At March 31, 2012, there were 6 options outstanding, of which 5 were exercisable.   No grants were issued in the three months ended March 31, 2012.   The following table summarizes stock option activity for the three months ended March 31, 2012, under all option plans:   <table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"> <tr> <td style="vertical-align: bottom; text-indent: 9pt; padding-bottom: 1pt;" nowrap="nowrap"> </td> <td style="vertical-align: top; padding-bottom: 1pt;" nowrap="nowrap"> </td> <td style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="6" nowrap="nowrap">Outstanding</td> <td style="vertical-align: top; padding-bottom: 1pt;" nowrap="nowrap"> </td> <td style="vertical-align: top; padding-bottom: 1pt;" nowrap="nowrap"> </td> <td style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="6" nowrap="nowrap">Exercisable</td> <td style="vertical-align: top; padding-bottom: 1pt;" nowrap="nowrap"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-bottom: 1pt;" nowrap="nowrap"> </td> <td style="vertical-align: top; padding-bottom: 1pt;" nowrap="nowrap"> </td> <td style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2" nowrap="nowrap">Number of Shares</td> <td style="vertical-align: top; padding-bottom: 1pt;" nowrap="nowrap"> </td> <td style="vertical-align: top; padding-bottom: 1pt;" nowrap="nowrap"> </td> <td style="vertical-align: bottom; border-bottom: black 1pt solid;" colspan="2" nowrap="nowrap"> Weighted-Average Exercise Price </td> <td style="vertical-align: top; padding-bottom: 1pt;" nowrap="nowrap"> </td> <td style="vertical-align: top; padding-bottom: 1pt;" nowrap="nowrap"> </td> <td style="vertical-align: bottom; border-bottom: black 1pt solid;" colspan="2" nowrap="nowrap"> Number of Shares </td> <td style="vertical-align: top; padding-bottom: 1pt;" nowrap="nowrap"> </td> <td style="vertical-align: top; padding-bottom: 1pt;" nowrap="nowrap"> </td> <td style="vertical-align: bottom; border-bottom: black 1pt solid;" colspan="2" nowrap="nowrap"> Weighted-Average Exercise Price </td> <td style="vertical-align: top; padding-bottom: 1pt;" nowrap="nowrap"> </td> </tr> <tr> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: bottom;" colspan="2"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: bottom;" colspan="2"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: bottom;" colspan="2"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: bottom;" colspan="2"> </td> <td style="vertical-align: top;"> </td> </tr> <tr style="background-color: #ccffcc;"> <td style="width: 40%; vertical-align: bottom;">Outstanding at December 31, 2011</td> <td style="width: 1%; vertical-align: top; text-align: right;"> </td> <td style="width: 1%; vertical-align: top;"> </td> <td style="width: 12%; vertical-align: top; text-align: right;">11</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="width: 1%; vertical-align: top; text-align: right;"> </td> <td style="width: 1%; vertical-align: top;">£</td> <td style="width: 12%; vertical-align: top;">35,750 ($58,500)</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="width: 1%; vertical-align: top; text-align: right;"> </td> <td style="width: 1%; vertical-align: top;"> </td> <td style="width: 12%; vertical-align: top; text-align: right;">10</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="width: 1%; vertical-align: top; text-align: right;"> </td> <td style="width: 1%; vertical-align: top;">£</td> <td style="width: 12%; vertical-align: top; text-align: right;">78,000 ($68,250</td> <td style="width: 1%; vertical-align: top;">)</td> </tr> <tr style="background-color: white;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top; text-align: right;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top; text-align: right;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top; text-align: right;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top; text-align: right;"> </td> <td style="vertical-align: top;"> </td> </tr> <tr style="background-color: #ccffcc;"> <td style="vertical-align: bottom; padding-left: 0.5in; text-indent: -27pt;">Granted</td> <td style="vertical-align: top; text-align: right;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top; text-align: right;">—</td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top; text-align: right;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top; text-align: right;">—</td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top; text-align: right;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top; text-align: right;"> </td> <td style="vertical-align: top;"> </td> </tr> <tr style="background-color: white;"> <td style="vertical-align: bottom; padding-left: 0.5in; text-indent: -27pt;">Exercised</td> <td style="vertical-align: top; text-align: right;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top; text-align: right;">—</td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top; text-align: right;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top; text-align: right;">—</td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top; text-align: right;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top; text-align: right;"> </td> <td style="vertical-align: top;"> </td> </tr> <tr style="background-color: #ccffcc;"> <td style="vertical-align: bottom; padding-left: 0.5in; text-indent: -27pt; padding-bottom: 1pt;">Forfeited/ Cancelled</td> <td style="vertical-align: top; text-align: right; padding-bottom: 1pt;"> </td> <td style="vertical-align: top; border-bottom: black 1pt solid;"> </td> <td style="vertical-align: top; text-align: right; border-bottom: black 1pt solid;">5</td> <td style="vertical-align: top; padding-bottom: 1pt;"> </td> <td style="vertical-align: top; text-align: right; padding-bottom: 1pt;"> </td> <td style="vertical-align: top; border-bottom: black 1pt solid;">£</td> <td style="vertical-align: top; text-align: right; border-bottom: black 1pt solid;">19,500 ($30,917</td> <td style="vertical-align: top; padding-bottom: 1pt;">)</td> <td style="vertical-align: top; padding-bottom: 1pt;"> </td> <td style="vertical-align: top; border-bottom: black 1pt solid;"> </td> <td style="vertical-align: top; text-align: right; border-bottom: black 1pt solid;"> </td> <td style="vertical-align: top; padding-bottom: 1pt;"> </td> <td style="vertical-align: top; padding-bottom: 1pt;"> </td> <td style="vertical-align: top; border-bottom: black 1pt solid;"> </td> <td style="vertical-align: top; text-align: right; border-bottom: black 1pt solid;"> </td> <td style="vertical-align: top; padding-bottom: 1pt;"> </td> </tr> <tr style="background-color: white;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top; text-align: right;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top; text-align: right;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top; text-align: right;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top;"> </td> <td style="vertical-align: top; text-align: right;"> </td> <td style="vertical-align: top;"> </td> </tr> <tr style="background-color: #ccffcc;"> <td style="vertical-align: bottom; padding-left: 27pt; text-indent: -27pt; padding-bottom: 1pt;">Outstanding at March 31, 2012</td> <td style="vertical-align: top; text-align: right; padding-bottom: 1pt;"> </td> <td style="vertical-align: top; border-bottom: black 1pt solid;"> </td> <td style="vertical-align: top; text-align: right; border-bottom: black 1pt solid;">6</td> <td style="vertical-align: top; padding-bottom: 1pt;"> </td> <td style="vertical-align: top; text-align: right; padding-bottom: 1pt;"> </td> <td style="vertical-align: top; border-bottom: black 1pt solid;">£</td> <td style="vertical-align: top; text-align: right; border-bottom: black 1pt solid;">29,250 ($46,376</td> <td style="vertical-align: top; padding-bottom: 1pt;">)</td> <td style="vertical-align: top; text-align: right; padding-bottom: 1pt;"> </td> <td style="vertical-align: top; border-bottom: black 1pt solid;"> </td> <td style="vertical-align: top; text-align: right; border-bottom: black 1pt">5</td> <td style="vertical-align: top; padding-bottom: 1pt;"> </td> <td style="vertical-align: top; text-align: right; padding-bottom: 1pt;"> </td> <td style="vertical-align: top; border-bottom: black 1pt solid;">£</td> <td style="vertical-align: top; text-align: right; border-bottom: black 1pt solid;">29,250 ($46,376</td> <td style="vertical-align: top; padding-bottom: 1pt;">)</td> </tr> </table>    The following is a summary of the status of stock options outstanding at March 31, 2012:   <table align="center" style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="padding-bottom: 1pt;"> </td> <td style="font-weight: bold; padding-bottom: 1pt;"> </td> <td style="font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="14">Outstanding options</td> <td style="font-weight: bold; padding-bottom: 1pt;"> </td> <td style="font-weight: bold; padding-bottom: 1pt;"> </td> <td style="font-weight: bold; text-align: center;" colspan="10">Exercisable options</td> <td style="font-weight: bold; padding-bottom: 1pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="padding-bottom: 1pt;"> </td> <td style="font-weight: bold; padding-bottom: 1pt;"> </td> <td style="font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2">Number</td> <td style="font-weight: bold; padding-bottom: 1pt;"> </td> <td style="font-weight: bold; padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid;" colspan="2"> Remaining contractual life (years) </td> <td style="font-weight: bold; padding-bottom: 1pt;"> </td> <td style="font-weight: bold; padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid;" colspan="6"> Average exercise price </td> <td style="font-weight: bold; padding-bottom: 1pt;"> </td> <td style="font-weight: bold; padding-bottom: 1pt;"> </td> <td style="font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2">Number</td> <td style="font-weight: bold; padding-bottom: 1pt;"> </td> <td style="font-weight: bold; padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid;" colspan="6"> Average exercise price </td> <td style="font-weight: bold; padding-bottom: 1pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #ccffcc;"> <td style="width: 28%;">Medicsight Plan J</td> <td style="width: 1%; text-align: right;"> </td> <td style="width: 1%;"> </td> <td style="width: 9%; text-align: right;">6</td> <td style="width: 1%;"> </td> <td style="width: 1%; text-align: right;"> </td> <td style="width: 1%;"> </td> <td style="width: 9%; text-align: right;">7.2</td> <td style="width: 1%;"> </td> <td style="width: 1%; text-align: right;"> </td> <td style="width: 1%;">£</td> <td style="width: 6%; text-align: right;">29,250</td> <td style="width: 1%;"> </td> <td style="width: 1%; text-align: right;"> </td> <td style="width: 1%;">$</td> <td style="width: 6%; text-align: right;">46,376</td> <td style="width: 1%;"> </td> <td style="width: 1%; text-align: right;"> </td> <td style="width: 1%;"> </td> <td style="width: 9%; text-align: right;">5</td> <td style="width: 1%;"> </td> <td style="width: 1%; text-align: right;"> </td> <td style="width: 1%;">£</td> <td style="width: 6%; text-align: right;">29,250</td> <td style="width: 1%;"> </td> <td style="width: 1%; text-align: right;"> </td> <td style="width: 1%;">$</td> <td style="width: 6%; text-align: right;">46,376</td> <td style="width: 1%;"> </td> </tr> </table>   On November 30, 2010, David Sumner, Chairman of Medicsight Limited, resigned from his position within the group. Immediately after his resignation, a two year consultancy agreement was signed whereby Mr. Sumner would continue to assist the group in its commercial needs. As part of this agreement, Mr. Sumner was to continue to vest in his existing Medicsight Plan J options throughout the consultancy period. A modification of the 6 existing options has been accounted for, and is not considered to be material to the overall financial statements. The Company is no longer receiving services under this consulting agreement. As such, all expenses and related stock-based compensation were accelerated at December 31, 2011.   The Company has recorded the following amounts related to its share-based compensation expense in the accompanying Condensed Consolidated Statements of Operations:   <table align="center" style="width: 70%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: center; border-bottom: black 1pt solid;" colspan="6"> Three months ended  March   31, </td> <td style="padding-bottom: 1pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td style="font-weight: bold; padding-bottom: 1pt;"> </td> <td style="font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2">2012</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="font-weight: bold; padding-bottom: 1pt;"> </td> <td style="font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2">2011</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #ccffcc;"> <td style="width: 70%; text-align: left; text-indent: -27pt; padding-left: 27pt;">Selling, general and administrative</td> <td style="width: 1%;"> </td> <td style="width: 1%; text-align: left;">$</td> <td style="width: 12%; text-align: right;">25</td> <td style="width: 1%; text-align: left;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%; text-align: left;">$</td> <td style="width: 12%; text-align: right;">3</td> <td style="width: 1%; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -27pt; padding-left: 27pt;">Research and development</td> <td style="padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid; text-align: left;"> </td> <td style="border-bottom: black 1pt solid; text-align: right;">7</td> <td style="padding-bottom: 1pt; text-align: left;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid; text-align: left;"> </td> <td style="border-bottom: black 1pt solid; text-align: right;">14</td> <td style="padding-bottom: 1pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #ccffcc;"> <td style="padding-bottom: 1pt; text-indent: -27pt; padding-left: 27pt;">Total</td> <td style="padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid; text-align: left;">$</td> <td style="border-bottom: black 1pt solid; text-align: right;">32</td> <td style="padding-bottom: 1pt; text-align: left;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid; text-align: left;">$</td> <td style="border-bottom: black 1pt solid; text-align: right;">17</td> <td style="padding-bottom: 1pt; text-align: left;"> </td> </tr> </table>   Of the stock-based expense for the three months ended March 31, 2012, $15 was allocated to non-controlling interest.   The aggregate intrinsic value for options outstanding and exercisable at March 31, 2012 and 2011, was $nil.   A summary of non-vested options at March 31, 2012, and the change during the three months ended March 31, 2012, is presented below:   <table align="center" style="width: 80%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td> </td> <td style="font-weight: bold; padding-bottom: 1pt;"> </td> <td style="font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="2">Options</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="font-weight: bold; padding-bottom: 1pt;"> </td> <td style="font-weight: bold; text-align: center; border-bottom: black 1pt solid;" colspan="6">Weighted Average Grant Date Fair Value</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #ccffcc;"> <td style="width: 61%; text-indent: -27pt; padding-left: 27pt;">Nonvested options at January 1, 2012</td> <td style="width: 1%;"> </td> <td style="width: 1%; text-align: left;"> </td> <td style="width: 10%; text-align: right;">1</td> <td style="width: 1%; text-align: left;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%; text-align: left;">£</td> <td style="width: 10%; text-align: right;">45,500</td> <td style="width: 1%; text-align: left;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%; text-align: left;">$</td> <td style="width: 10%; text-align: right;">71,500</td> <td style="width: 1%; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-indent: -27pt; padding-left: 27pt;">Granted</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">—</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">—</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">—</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #ccffcc;"> <td style="text-indent: -27pt; padding-left: 27pt;">Vested</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">—</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;">£</td> <td style="text-align: right;">—</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;">$</td> <td style="text-align: right;">—</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="padding-bottom: 1pt; text-indent: -27pt; padding-left: 27pt;">Forfeited/Cancelled</td> <td style="padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid; text-align: left;"> </td> <td style="border-bottom: black 1pt solid; text-align: right;">—</td> <td style="padding-bottom: 1pt; text-align: left;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid; text-align: left;">£</td> <td style="border-bottom: black 1pt solid; text-align: right;">—</td> <td style="padding-bottom: 1pt; text-align: left;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid; text-align: left;">$</td> <td style="border-bottom: black 1pt solid; text-align: right;">—</td> <td style="padding-bottom: 1pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #ccffcc;"> <td style="padding-bottom: 1pt; text-indent: -27pt; padding-left: 27pt;">Nonvested options at March 31, 2012</td> <td style="padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid; text-align: left;"> </td> <td style="border-bottom: black 1pt solid; text-align: right;">1</td> <td style="padding-bottom: 1pt; text-align: left;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid; text-align: left;">£</td> <td style="border-bottom: black 1pt solid; text-align: right;">45,500</td> <td style="padding-bottom: 1pt; text-align: left;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid; text-align: left;">$</td> <td style="border-bottom: black 1pt solid; text-align: right;">71,500</td> <td style="padding-bottom: 1pt; text-align: left;"> </td> </tr> </table>   Unrecognized compensation cost   As of March 31, 2012, there was no unrecognized compensation cost related to non-vested share-based compensation arrangements.

11.         Operating leases, commitments and security deposit   In 2006, we executed a 10-year agreement with Pirbright Holdings Limited, to lease office space in London, United Kingdom.  Under this lease agreement, the property rent, services and related costs were approximately £330 ($516) per annum, paid quarterly in advance. The Company exercised its right to terminate the lease upon completion of the fifth year (August 2011) and has found an alternative UK office location with no long-term lease commitment.  This commitment is on a month-to-month basis and began on August 1, 2011 with total monthly rental payments of £8 ($13) along with a rental deposit of £16 ($25). In February, 2012, the Company moved to a smaller office in the same location with month-to-month rental payments of £2 ($4) and a rental deposit of £4 ($6).   In September 2011, the Company entered into a 39 month lease agreement for office space located in Harrison, New York, United States terminating on November 30, 2014.  Under the agreement our total rental payments over the 39 month lease period are $240, inclusive of three months of free rent and a refundable rental deposit of $39.   A satellite office in Tokyo, Japan, was closed in January 2012, and the rental deposit of $128 was refunded to us.   In January 2012, the Company entered into a two year employment agreement with an employee at a base salary of $10,000 per month, with potential bonus payments as outlined in the agreement. This agreement provides for a maximum severance period of 12 months in the event of termination without cause as defined in the agreement.   On March 12, 2012, the Company entered into a one year financial advisory and consulting agreement with a national investment banking firm. The agreement can be canceled with two weeks written notice, three months from the date of the agreement. Under the agreement our total payments over the twelve month period are $60.   The following is a schedule of the future minimum payments required under operating leases and commitments that have initial or remaining non-cancellable terms in excess of one year:   <table align="center" style="width: 85%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="font-weight: bold;">Year Ending</td> <td> </td> <td colspan="2"> </td> <td> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: #ccffcc;"> <td style="width: 87%; text-indent: -27pt; padding-left: 27pt;">2012 (remaining nine months)</td> <td style="width: 1%;"> </td> <td style="width: 1%; text-align: left;">$</td> <td style="width: 10%; text-align: right;">95</td> <td style="width: 1%; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; text-indent: -27pt; padding-left: 27pt;">2013</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">78</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #ccffcc;"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -27pt; padding-left: 27pt;">2014</td> <td style="padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid; text-align: left;"> </td> <td style="border-bottom: black 1pt solid; text-align: right;">56</td> <td style="padding-bottom: 1pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="padding-bottom: 1pt; text-indent: -27pt; padding-left: 27pt;">Total</td> <td style="padding-bottom: 1pt;"> </td> <td style="border-bottom: black 1pt solid; text-align: left;">$</td> <td style="border-bottom: black 1pt solid; text-align: right;">229</td> <td style="padding-bottom: 1pt; text-align: left;"> </td> </tr> </table>   The total lease rental expense was $36 and $143 for the three months ended March 31, 2012 and 2011, respectively.

10.         Related party transactions   Moneygate Group   In Fiscal 2009, we purchased 49% of the share capital of Moneygate.  On acquisition we provided loan facilities of £250 ($387) for working capital and £2,000 ($3,094) for acquisitions and subsequently entered into various transactions with Moneygate and other non-related parties.   Through its disposal in March 2011, Moneygate was a related party as the Company had significant influence over its operations as a result of representation on Moneygate’s board of directors. Due to this significant influence, we accounted for it under the equity method. In March 2011, we sold our entire interest in Moneygate to Committed Capital Nominees Limited for total consideration of £250 ($401), resulting in a gain on sale of £51 ($81).   Dunamis Capital   Allan Rowley, former Chief Executive Officer and former Chief Financial Officer of MGT and former Chief Executive Officer of Medicsight, along with David Sumner, former Chairman of Medicsight, are both directors of Dunamis. Dunamis is a United Arab Emirates (“UAE”) registered company regulated by the Dubai Financial Services Authority (“DFSA”). Dunamis is 100% owned by David Sumner and was set up by Mr. Sumner with Allan Rowley’s financial consulting assistance, as a corporate financing and advisory firm. On September 6, 2010, Medicsight made a short-term loan of $1,100 (£711) to Dunamis.  Dunamis paid back the principal of $1,100 (£711) and interest of $48 (£30) on February 6, 2011 and February 10, 2011, respectively.   In February 2011, the Company, following consultation with its nominated advisor noted that as a result of Mr. Sumner’s relationships with both Dunamis and Medicsight, the Loan constituted a related party transaction under Rule 13 of AIM Rules for Companies. Rule 13 requires that an AIM company must issue notification without delay as soon as the terms of a transaction with a related party are agreed. The independent directors, having consulted with the Company’s nominated adviser, considered the terms of the transaction fair and reasonable insofar as shareholders were concerned. On February 18, 2011, the Company issued a notice detailing the terms of the transaction with the related party.   Laddcap Value Partners III LLC (“Laddcap”)   On April 12, 2011, the Company entered into a Revolving Line of Credit and Security Agreement with Laddcap for up to $500 for a fifteen month term. The Agreement encompasses a standby commitment fee of two (2%) percent of the maximum loan amount along with an eight (8%) percent interest charge on any funds drawn.  Laddcap is a related party as the Managing Partner and beneficial owner of Laddcap is a 10% plus shareholder and CEO of MGT. No amounts have been drawn down against the facility as of the date of the filing of the Company’s Form 10-Q for the quarterly period ended March 31, 2012.   D4D Limited   Effective July 2010, the Company entered into a service agreement with D4D Limited (“D4D”), a company that offers Executive Services for small and mid-cap companies.  D4D is owned by Tim Paterson-Brown and Allan Rowley, and pursuant to the agreement, provided the services of Chairman, Chief Executive Officer and Chief Financial Officer of the Company at such time. The D4D service agreement provided the services of Tim Paterson-Brown and Allan Rowley on similar remuneration to their previous employment contracts with MGT. On executing the contract with D4D, Tim Paterson-Brown and Allan Rowley terminated their employment contracts with MGT, but still held the offices of Chairman and Chief Executive Officer and Chief Financial Officer, respectively.   In December 2010, Mr. Paterson-Brown resigned as Chairman and CEO, and was replaced by Mr. Rowley as CEO. In February 2011, Mr. Rowley resigned as CEO.    In April 2011, the agreement with D4D was renegotiated and a settlement agreement between MGT and D4D, Messrs. Paterson-Brown and Rowley was executed and delivered. The financial terms included payments to be made by the Company to D4D of a £110 ($170) settlement fee, a £80 ($124) payment for recoverable local taxes, £17 ($25) for estimated legal expenses, and the assignment of 3 shares of MDST common stock held by the Company to D4D. The common stock was delivered to D4D in April 2011, and had a fair value of $71 on the date of transfer.  The parties, upon the terms and subject to the conditions of the settlement agreement and to the extent permitted by law, settled all claims arising out of the D4D Agreement and the respective directorships and employment arrangements with the Company and certain of its affiliates.  The Company has fully accrued and expensed all related costs. During the three months ended March 31, 2011, MGT and Medicsight made payments to D4D, totaling $304.

5.           Loans receivable — related party   Dunamis Capital   On September 6, 2010, Medicsight made a short-term loan of $1,100 (£711) to Dunamis repayable by December 31, 2010, along with $36 (£23) of interest.  Dunamis paid back the principal of $1,100 (£711) and interest of $48 (£31) on February 6, 2011 and February 10, 2011 respectively.  Dunamis had provided the assets of the business as collateral against the loan made by Medicsight. Dunamis was considered a related party, as two former directors of Medicsight were also directors of Dunamis Capital (see note 10). 12.           Line of credit facility   On April 12, 2011, the Company entered into a Revolving Line of Credit and Security Agreement with Laddcap for up to $500 for a fifteen month term. The Agreement encompasses a standby commitment fee of two (2%) percent of the maximum loan amount along with an eight (8%) percent interest charge on any funds drawn. The Company has fully accrued the commitment fee of $10 and expensed $2 associated to the facility for the three months ended March 31, 2012. Laddcap is a related party as the Managing Partner and beneficial owner of LaddCap is a 10% plus shareholder and Chief Executive Officer of MGT. No amounts have been drawn down against the facility as of the date of the filing of the Company’s Form 10-Q for the quarterly period ended March 31, 2012.

13.          Subsequent events   On April 30, 2012, the Company filed a preliminary proxy statement (PRE-14A) and will hold its Annual Meeting of Stockholders on May 30, 2012.   On May 10, 2012, the Company announced that its Board of Directors has decided to pursue the acquisition of patents and underlying technologies with the intent of commercializing and/or enforcing the economic rights to such inventions.   On the same date, MGT also announced that it has agreed to acquire U.S. Patent #7,892,088, entitled “Gaming Device Having a Second Separate Bonusing Event.” The patent acquisition was made via a newly formed subsidiary, MGT Gaming, Inc., in which MGT will hold a majority interest. The invention specifically relates to gaming systems linked to an interactive sign, and includes all filed continuation patents. The sellers will retain a significant minority stake in MGT Gaming, Inc.; full terms will be disclosed upon the closing of the transactions contemplated in the agreement, which is subject to customary closing conditions.   Major financial terms include an upfront payment by MGT of $200,000, plus the issuance of 350,000 four-year common stock warrants with a $4.00 exercise price.

128000

-2143000

-606000

-1289000

-431000

0 5000

350000

2109000

2105000

-5000 0 -5000 0 0 -5000 0

-4000

2392000

-1006000

1386000

-1386000

32000

17000

15000

73000

39000

34000

-854000

-175000

-2493000

EX-101.SCH 7 mgt-20120331.xsd XBRL TAXONOMY EXTENSION SCHEMA 001 - Document - DOCUMENT AND ENTITY INFORMATION link:presentationLink link:definitionLink link:calculationLink 002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:definitionLink link:calculationLink 003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] link:presentationLink link:definitionLink link:calculationLink 004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS link:presentationLink link:definitionLink link:calculationLink 005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' (DEFICIT)/EQUITY link:presentationLink link:definitionLink link:calculationLink 006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Organization, basis of presentation and liquidity link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Summary of significant accounting policies link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Divestment of investments link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Cash and cash equivalents link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Loans receivable - related party link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Inventory link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Interest and other income / (expense) link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Stock-based compensation link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Stockholders equity and non-controlling interest link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Related party transactions link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Operating leases, commitments and security deposit link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Line of credit facility link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Subsequent events link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 mgt-20120331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 mgt-20120331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 mgt-20120331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document and Entity Information [Abstract] Document and Entity Information [Abstract] Statement [Table] Statement [Table] Statement [Line Items] Statement [Line Items] Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Trading Symbol Trading Symbol Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Document Fiscal Period Focus Document Fiscal Period Focus Document Fiscal Year Focus Document Fiscal Year Focus Statement Of Financial Position [Abstract] Statement of Financial Position [Abstract] Assets [Abstract] Assets Cash and Cash Equivalents, At Carrying Value Cash and cash equivalents Cash and cash equivalents Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Accounts Receivable, Net, Current Accounts receivable Accounts receivable Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Prepaid expenses and other current assets Inventory, Net Inventory Assets, Current Total current assets Total current assets Property, Plant and Equipment, Net Property and equipment, at cost, net Property and equipment, at cost, net Property, Plant and Equipment, Net, Beginning Balance Property, Plant and Equipment, Net, Ending Balance Security Deposit Security deposits Assets Total assets Total assets Liabilities [Abstract] Liabilities Accounts Payable, Current Accounts payable Accounts Payable, Current, Total Accrued Liabilities, Current Accrued expenses Accrued Liabilities, Current, Total Other Liabilities, Current Other payables Other payables Liabilities, Current Total current liabilities Total current liabilities Stockholders Equity, Including Portion Attributable To Noncontrolling Interest [Abstract] Stockholders' (deficit)/equity Common Stock, Value, Issued Common stock, $0.001 par value: 75,000,000 shares authorized; 2,105,187 and 2,108,732 shares issued and outstanding at March 31, 2012 and December 31, 2011 respectively. Common Stock, Value, Issued, Total Common Stock, Value, Issued, Beginning Balance Common Stock, Value, Issued, Ending Balance Additional Paid In Capital, Common Stock Additional paid-in capital Additional Paid in Capital, Common Stock, Beginning Balance Additional Paid in Capital, Common Stock, Ending Balance Accumulated Other Comprehensive Income (Loss), Net Of Tax Accumulated other comprehensive loss Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax, Beginning Balance Accumulated Other Comprehensive Income (Loss), Net of Tax, Ending Balance Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit), Beginning Balance Retained Earnings (Accumulated Deficit), Ending Balance Stockholders Equity Attributable To Parent Total stockholders' (deficit) / equity Total stockholders' deficit BALANCE BALANCE Stockholders Equity Attributable To Noncontrolling Interest Non-controlling interest Non-controlling interest Stockholders' Equity Attributable to Noncontrolling Interest, Beginning Balance Stockholders' Equity Attributable to Noncontrolling Interest, Ending Balance Stockholders Equity, Including Portion Attributable To Noncontrolling Interest Balance Total equity BALANCE BALANCE Liabilities and Equity Total stockholders' equity, liabilities and non-controlling interest Total stockholders' equity, liabilities and non-controlling interest Balance Sheet Parenthetical [Abstract] Balance Sheet Parenthetical [Abstract] Amount of Dunamis Capital loans receivable-related party by entity during the reporting period Common Stock, Par Or Stated Value Per Share Common stock, par value (in dollars per share) Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Issued, Total Common Stock, Shares, Outstanding Common stock, shares outstanding Common Stock, Shares, Outstanding, Beginning Balance Common Stock, Shares, Outstanding, Ending Balance Income Statement [Abstract] Income Statement [Abstract] Sales Revenue, Goods, Net Revenues Revenues Cost Of Goods and Services Sold Cost of revenue Cost of revenue Cost of revenue Cost of revenue Gross Profit Gross profit Gross profit Operating Expenses [Abstract] Operating expenses Selling, General and Administrative Expense Selling, general and administrative Selling, general and administrative Research and Development Expense Research and development cost Research and development cost Operating Expenses Operating Expenses, Total Operating Expenses, Total Operating Income (Loss) Operating loss Operating loss Other Nonoperating Income (Expense) Interest and other income/(expense), net Interest and other (expense)/income, net Interest and other income/(expense), net Gain On Sale Of Moneygate Gain on sale of Moneygate The net amount of the gain received on sale of moneygate during the period. Nonoperating Income (Expense) Nonoperating Income (Expense) Nonoperating Income (Expense) Income (Loss) From Continuing Operations Before Income Taxes, Extraordinary Items, Noncontrolling Interest Net loss before income taxes Net loss before income taxes Income Tax Expense (Benefit) Income tax benefit/(expense) Income tax benefit Income tax benefit/(expense) Net Income (Loss), Including Portion Attributable To Noncontrolling Interest Net loss as reported Net loss for the period Net loss before non-controlling interest Net loss before non-controlling interest Net loss before non-controlling interest Net Income (Loss) Attributable To Noncontrolling Interest Net loss attributable to non-controlling interest Net loss attributable to non-controlling interest Net loss attributable to non-controlling interest Net loss attributable to non-controlling interest Net Income (Loss) Attributable To Parent Net loss as reported dont use Net loss as reported Net loss attributable to MGT Capital Investments, Inc. Other Comprehensive Income (Loss), Net Of Tax [Abstract] Other comprehensive loss Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Unrealized foreign exchange gain/(loss) Translation adjustment Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Comprehensive loss Comprehensive loss Comprehensive loss Comprehensive Income (Loss), Net Of Tax, Attributable To Parent Comprehensive loss attributable to MGT Capital Investments, Inc. Comprehensive loss attributable to MGT Capital Investments, Inc. Earnings Per Share [Abstract] Per share data: Earnings Per Share, Basic and Diluted Basic and diluted loss per share (in dollars per share) Basic and diluted loss per share Weighted Average Number Of Common Shares Outstanding Basic and Diluted Weighted average number of common shares outstanding (in shares) Weighted average number of common shares outstanding The average number of shares or units issued and outstanding that are used in calculating basic and diluted EPS. Statement Of Stockholders Equity [Abstract] Statement of Stockholders' Equity [Abstract] Statement, Scenario [Axis] Statement, Scenario [Axis] Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] Common Stock [Member] Additional Paid-In Capital [Member] Accumulated Other Comprehensive Income (Loss) [Member] Retained Earnings [Member] Stockholders Equity, Total [Member] Noncontrolling Interest [Member] Shares, Outstanding BALANCE (in shares) BALANCE (in shares) Shares, Outstanding Adjustments To Additional Paid In Capital Reverse Stock Split Cash in lieu of fractional shares for MGT reverse/ forward split Aggregate adjustment to additional paid in capital for stock to account for a reverse stock split during the period. Stock Issued During Period, Shares, Reverse Stock Splits Cash in lieu of fractional shares for MGT reverse/ forward split (in shares) Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests Acquisition of subsidiary shares from non-controlling interest Adjustments To Additional Paid In Capital, Share-Based Compensation, Stock Options, Requisite Service Period Recognition Stock option compensation Statement Of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Net Cash Provided By (Used In) Operating Activities [Abstract] Cash flows from operating activities: Adjustments To Reconcile Net Income (Loss) To Cash Provided By (Used In) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Depreciation Depreciation Depreciation Gain (Loss) on Sale of Property Plant Equipment Loss on disposal of property and equipment Loss on disposal of property and equipment Share-Based Compensation Stock-based compensation expense Stock-based compensation expense Gain On Sale Of Loan Receivable Related Party Gain on sale of loan receivable - related party The net gain (loss) resulting from a sale of loans, including adjustments to record loans classified as held-for-sale at the lower-of-cost-or-market or other obligation to a related party. Gain on sale of loan receivable - related party Increase (Decrease) In Operating Assets [Abstract] (Increase)/decrease in assets Increase (Decrease) In Accounts Receivable Accounts receivable Accounts receivable Increase (Decrease) In Other Receivable Related Party Other receivable - related party Change in carrying value during the period of obligations incurred through and payable within one year (or in the operating cycle if longer) to a related party. Other receivable - related party Increase (Decrease) In Prepaid Expense and Other Assets Prepaid expenses and other current assets Prepaid expenses and other current assets Prepaid expenses and other current assets Increase (Decrease) In Inventories Inventory Inventory Increase (Decrease) In Security Deposits Security deposits Increase (Decrease) In Operating Liabilities [Abstract] Increase/(decrease) in liabilities Increase (Decrease) In Accounts Payable Accounts payable Accounts payable Accounts payable Increase (Decrease) In Accrued Liabilities Accrued expenses Accrued expenses Accrued expenses Increase (Decrease) In Other Current Liabilities Other payables Other payables Other payables Net Cash Provided By (Used In) Operating Activities Net cash used in operating activities Net cash used in operating activities Net cash used in operating activities Net cash used in operating activities Net Cash Provided By (Used In) Investing Activities [Abstract] Cash flows from investing activities: Repayments Of Related Party Debt Repayment of Dunamis loan Repayment of Dunamis loan Payments To Acquire Property, Plant, and Equipment Purchase of property and equipment Purchase of property, plant and equipment Purchase of property and equipment Purchase of property, plant and equipment Proceeds From Sale Of Equity Method Investments Receipts from sale of Moneygate Receipts Of Deferred Consideration For Sale Of Assets From Discontinued Operation Receipts of deferred consideration for sale of assets The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets. Net Cash Provided By (Used In) Investing Activities Net cash provided by/(used in) investing activities Net cash provided by/(used in) investing activities Net Cash Provided By (Used In) Financing Activities [Abstract] Cash flows from financing activities: Payments For Reverse Or Forward Stock Split Cash paid in lieu of fractional shares reverse/ forward split The outflow of cash paid in lieu of fractional shares reverse (or) forward split during the reporting period. Cash paid in lieu of fractional shares reverse/ forward split Net Cash Provided By (Used In) Financing Activities Net cash flows used in financing activities Net cash flows used in financing activities Effect Of Exchange Rate On Cash and Cash Equivalents Effects of exchange rates on cash and cash equivalents Effects of exchange rates on cash and cash equivalents Effects of exchange rates on cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Net change in cash and cash equivalents Net change in cash and cash equivalents Organization, Consolidation and Presentation Of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation Of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Accounting Policies [Abstract] Accounting Policies [Abstract] Significant Accounting Policies [Text Block] Significant Accounting Policies [Text Block] Discontinued Operations and Disposal Groups [Abstract] Discontinued Operations and Disposal Groups [Abstract] Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Cash and Cash Equivalents [Abstract] Cash and Cash Equivalents [Abstract] Cash and Cash Equivalents Disclosure [Text Block] Cash and Cash Equivalents Disclosure [Text Block] Loans Receivable Related Party [Abstract] Loans Receivable Related Party [Abstract] Loans Receivable Related Party [Text Block] Loans Receivable Related Party [Text Block] The entire disclosure for loans receivable due from related parties. Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Inventory Disclosure [Text Block] Inventory Disclosure [Text Block] Interst and Other Income Or Expense [Abstract] Interst and Other Income Or Expense [Abstract] Interst and Other Income Or Expense [Text Block] Interst and Other Income Or Expense [Text Block] The entire disclosure for interest and other interest income (or) expense during the reporting period. Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract] Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Disclosure Of Compensation Related Costs, Share-Based Payments [Text Block] Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Stockholders Equity and Noncontrolling Interest [Abstract] Stockholders Equity and Noncontrolling Interest [Abstract] Stockholders Equity and Noncontrolling Interest [Text Block] Stockholders Equity and Noncontrolling Interest [Text Block] The entire disclosure for stockholders equity and noncontrolling interest in consolidated subsidiaries. Related Party Transactions [Abstract] Related Party Transactions [Abstract] Related Party Transactions Disclosure [Text Block] Related Party Transactions [Text Block] Operating Leases Commitments and Security Deposit [Abstract] Operating Leases Commitments and Security Deposit [Abstract] Operating Leases Commitments and Security Deposit [Text Block] Operating leases, commitments and security deposit [Text Block] The entire disclosure for operating leases, commitments and security deposit. Line Of Credit Facility [Abstract] Line of Credit Facility [Abstract] Line Of Credit Facility [Text Block] Line of credit facility [Text Block] The entire disclosure for short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements. Subsequent Events [Abstract] Subsequent Events [Abstract] Subsequent Events [Text Block] Subsequent Events [Text Block] Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Voluntary Filers Entity Current Reporting Status Entity Current Reporting Status Entity Public Float Entity Public Float Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Comprehensive loss attributable to non-controlling interest Comprehensive loss attributable to non-controlling interest Comprehensive loss attributable to non-controlling interest Income (Loss) From Discontinued Operations, Net Of Tax, Including Portion Attributable To Noncontrolling Interest [Abstract] Discontinued operations EX-101.PRE 11 mgt-20120331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } ZIP 13 0001144204-12-028631-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-12-028631-xbrl.zip M4$L#!!0````(`/V!KD`INM4O`4\``!%C`@`0`!P`;6=T+3(P,3(P,S,Q+GAM M;%54"0`#_F>Q3_YGL4]U>`L``00E#@``!#D!``#L77MSXS:2_SNIRG?`^?92 M295>U,.2[9G9TO@QF1U[[+4]>=3550HF(0D)16H!TK;RZ:\;("F2HD12HISQ MC&NSB44`W3\T&MV-!D"^^N?CU";W3$CN.J_WC$9KCS#'="WNC%_O?;H]JP_V M_OGFNV]?_5>]3GY]>WU.+-?TI\SQB"D8]9A%'K@W(:=_U55I0(ET&RWX7Y_\ M;ZO7-+K-=LMH$Z-]V.L=&GUR=?%_I%X/J;ZE$JA`&T6@W3#(HE`].@DY7@"L M$8^Q_)FS!R;(SP%30-_H-GI(Z]9GTJ+S&KF@!'P>+P3 M-C_$?Q,0A",/IV/O]=[$\V:'S2;\W3#=J4+?ZG2,O:".S9T_HTH/#P\-;-]P MQ1AJMCI-++Z#3H75L=3B48-XY?VF+HRJ+I%^Z*BZQL'!05.51E4ESZH(1(WF MKQ?G-^:$36F=.]*CCIG`PM=@3]?GTNVVC?ZZ%KI&V,!Q'<>?9M>W/-'TYC/6 MA$IUJ,4$-Z-V^8V2#2PV$\Q$#5P)[J!)A2E^0 MD&"CE13VFU`:063>&E:*#U1)C+J7.>H]/>I15=/U'4_,DW4E,QMC][X9%*(2 M&O6645^HH>D+`7-U5;N@-*.AQ7AV&RC(J,X>S4EV?2S):,"=>R:][":Z+*.1 M0[DIL]NHHHPFDIO9#:`@J[HW$ROJ0TE&`U_6QY3.HC8C*N_4&`8%JYO4J>>M M;@:%@M_Y'I.Q9JCC,K.-*LG@]6BOF9:_GJ.M`!/WS2NT&H=2V8-K-B+*BAP& M,V.]K6G.A#MCPN/`/V;5%`%$]7I/\NG,CIY-U%P"LUD/36;C45I[304#;?VQ MZWCLT2,WS/308FLK_$U@ALV@E,.4#FK^WKDX_;UCU"^H0)J&ZE%8'WP"]^;J M2?B(6_@0G(0@JL?)#H;C??S^P]Z;%EA*^&>_9;QJIAMK+LTE-@$7D`EWK01C M,)O".P%S!$_#H6H9X&&:R^7?Q'I@)=IT8'@7;1:E"S`+UN&30&HYDM0NR`ME8K03,EF4;B^3I&ZU/UN)I'2KO8%NM7>I6RDY_G[C`66, MV&Y,YE"@.7SD\O=C=SIUG1O/-?^\8-,[)IY2WI$HV1B!Z6?ZH07,(3+@)O]-6+S4MU?-3-(!EN8RF*]0(8:6Q=$+4/N*O8?5ZI1]>4I3M,\O M"I2O0-?,H]QAUBD5#G?&\HO3ENP.OJA&OFHHGSUQ;8L)>?H?'[I]ZWZ)3FAM M/U\4)5]1/KH.-H9%,RQUQ^^AJ6#2^^+T9%TWOVXUB5;0G_UZ,;&"7I))E2MH M+1.C"S*9/R^9].I&=Y4L]?Q9Q_&>:O8C:_[!9\A7/[9="_PIG^LMWSUGF9(E>?3F]N+TX^W-_#W\:OF*M(*T*+P&#`):K]W+/;X@W?&!6G>H.Z&*^ZMI*:T2I2J4Z=<1M6X_!\[(J"7;J94AL:D6LV M"XLVQF_GTSK6+<9N./4TWT38]-(NM!#V9+WT/ MK04VR&2SO#%-4`55G<`<$(N9'+HJ7^^U]MZTC5;/&/03@[B&:80OO)QV.Y\5 M'$6C5?^W9A-O&Q$@/.ITML0Y-=6507C.30?T[FWUD7N`MJE#3 M05*8Z]A5A*N82AK&8#-@5X+-*+=.'V<023,0MLI@#Z5DGJQ0;IUV/X&O`-MJ M81848Z^W%I85G-KB)N MZ!R=3(66KVUT,CU:DM/68(J)H[UO;`!&^,PZY_2.VQQOD5NE.#J+D>W]+$*X=:[@V4/4@;$[CI03.KUWJ"]M,+M*)&CL=Y/>8IG/5C`*RF>_?U`&Q05W M7%Q\A-M[E41<[8-D/)IFL@6"HLN/;K\X@F41P9RT?4S?7^'&ANL,@Q1RB^8=""B6 MO!XZUFXR,4L[G7E,*T2XX>YH*82QQ=,5%9="Z8&E!-Q!B=*XZ!!:RM M1@N/K)9@7BW8;(GN'*P^R#GTO8DK^%_,*BW1S,.C_5XKM9NSAF4UT#+DMVMH M[Z7TJY)8VV@-^IWV&E2:V_:(B@HJ.@"\%:)BYY(K%53Z5/+VV*H3V2IL-]1F M\IK=,\=G[US7DJO.;*1?_[[>0Z3\7`:3*E#D[B=<*:^$.UJQVU1.)LGQB='>@F?>J6.NK/B\7L6G,+<7@9MXR"5URC$>#=8%,,I!P4%KE9 MD:=R^YVDRBWQV!I!GB+UNIL`6.SD;R^$>KN7.B26P:8"&/G;R?UR*#")"@M! M-UFO0GNT?#9L);MJD>6>3"B+;#KV#M]1[EPZZ/HO1Q>NP^;C8C>N\L[":C&M MY+`U_QQAY/(.Q;1#53%2!S^+J8'-0%\2UX5G-`XHE0;;'__E0(J]G. M?2*T&^T7JN3%$P'<9C_J*7%NOND!5`O-ZH_,6QCQC3=QRCE7HY6ZIU8:Q,Z[ MD!_Q'.RJ!U4(N'O07@UO*]9Y@DG/CM6<0^,0[EB\I9*;N##GMN^M2&JO%4/6 MW@F^-,1HM&,IVARV%4,LL+V#$%N-=KL<1%R%_,+X>`(/AO<0;8W91Q_-PN4H M\+'I_/-V\LW,?QM&W^@9`[TFV@K-D_6I2$Y_T.E4UJY3(V0XFR7ZZLUF>[TLEZ M8.5*L]X9X&(J6A[KZM$(7LARPD9,");]8I8*MK3VEU)=&^!XFJ[DF5MC/_TJ MAQWT)7P_!*]BKVPMV!BG2C'EB;&3)\7BP%(OC]A>8)U^NZ`1"UA6#C!O)[9R M?*E72U3AKE)W'8JPW07.W/GSC_!2@B:AAMC0]/C]Y7I[6"_F\ZZ%.2^.]"YF2*C5P7FT]&( MF=[EZ/31G%!GS*XAC+ATLM\:6(&93276RG#?)>R\-W,-JD%]#5'"'!=C\G(4 MC]A.V%TEB6$C=51W';\J@17?G2N,Z"JH=NL.39"F8"M?#%=IM%2<[>[0YAT% M3.V?;(A8N"9CEMIXUDM?O9%SP;R):V$D)KUI-9.^F]JN*,QZ9X"+ZVLYK+A4 M4VNR&>IWN!H`#!),LM[1/W.%IJ,7!4CWA$M3;_TS*]KYKR*D;45KW8I`_0V= M++8^KK)_.0Y5CWG%(8@QZ"]MZ15DOCO,)0.]:B&?<8;P79W:'-? M&%5$OGF(L\,2_4[T=&Q>00RRGS+V9=CO$G=^&T&M0V*T9A[Q^!14U6$/!&PB=6KZ M08U(Z.CHB$RI&'/GDUA%!VG5J`ZY#\H1+J&,1F\/86>"O$6#S+H3:G.%?WWV[ M:ZDLD#\)4_V0._@Y(*C8Z'%'`[F=,$)!A=17./#ZEN]0'\2BMWPMS%6JOP)E MA1^C4#@S&9QH3$'7@^7>B=HHE]P(\2"5]] MID82SR40B4P)?L%#5;OV;48&]58'17O-QGA"#4G0UIS8GE M$L?U@";>MH81M6ULI]DD^4,UP"J86A!8Y&Z^HC<9W0;A(,5/CE(/99K4R`^G MT&>3-F"D505WQAUD!T6@K72L=*2F0%$+-3)0#%0KK@(`XCK`".H[B-4&>*8O M!!8D&BP&+.BHU2!1%@,:2=_V]#@@#&\B&"-3F$8321CHLD4N\(H*Z1@U@K8/ M(`FFY.9`D"@E%1Q0P"2!SN!UGU"$(6%O0CWHT1P@$/8X@X4^3@?@!MI*I'\G M0:BXCON/#^M6)@B4A%CFC`K$@#C!-^@/;(4X&@MK0&`^:J=5>.K)B>O;%F(" MCZ,&"=K\X3OZ`TB1NN436F@'9N$8J&0HY7#D4S/3Z!]),G0<'^CH+_K`.$9Z M_"'J_$A]`B62`=!+BP!\P^VD7+=#5?<"`^8'9BB&4_6(P^,I_4.]RX^X#P[0 MPZ$"TT]Q-P$FDVWK:6N&K4)JV!R_Z"1I,$L7^L=LKCY+!1KX-QOPS\:3K+?_ MX(4IP7.A^HJPEC3^5W`<;^T_E#$C:(E5-D15JD6C^`#-[7D]-8;SPZPH8`48 M\L.GQH?&C^0<1@_'3CDM#*N`HM)4X.`^($3'=>I@$J"1TKN8QA#+5Y8)ZXU1$O5`"6M7AJ$Y,8FN\]9*`P*33X`PW>4#'(ET]#2B)G;W4$P@/@(*E M<'TP?9%57K"MQ7MZ[D'G$D%!5);PT3Q\?TA,!;*F\6<["]59U1",9E'WW)EB MD+-3ZG>MY[E23VB,FLVTYH[C@P_-VZO<,!T__CD$2(9Y[ M)CQP=G;83P!V%*]HA15#G/W&H(?,HG#9L\I4QQYF#(Q4'V9+2'+0T?2Q5@ZS MM4N/%1S7RU?;LX6R*N,UQ=\P6SQF3AS7=L?SR(Z-\,M>.HR)JL$*'B2F$-TAE_&8`IQ,%(0EMGSOUA$C]RZ4W`MP&NJ0(N)*,+D`OIV MSV%:!I%<3'5UI!WT-O2IQZ!)3D)=L)8O<=U#CF]U>:C8,\S8@_?&.786>?I@ M@623L<^MQ3!COVJAKQ_Z8S`L@2SC$2:FBG`BPC!AI&T)^J"C[>!K#N"CIES* MWORWB)9-[ M(13?T=Z`@P>>DPG4)38;4[L&_53K:?QL*=**+8!-5^IEQ)1"2`/_UR$,&!G$ MY:D%PT_N`T*NJ5A'6&`\009WS%.!X./,=KD7+!O5+#T[&2;4-E396EH>8*L< M9>;4O(Z%:S\L*NIH&L,B\A%FR6^N^+.1IJ.L5^!M5'1(J`]A@EI*'5^B4P3: MZ.':1'G5X%?DN)Q1D&O0#DF+2$H73U\#"8O+F2M55./Y=R@?C>_XDJRD?7[Y M,3`,,`/N6+`&6%@UB]QS"CT?V^X=6@JT07C/QQ6-]5%`TQ/Q'XBJNAA0_;O3 M:_0Q4ML@E?<2^CW3T._2"=9R[6@MA^LEI@YWJ"DJT`*`Q91@%SWR`T[WF$^\ M#DIOL#3N',%F3'&>P42RY\%J,TC"H>-Z0`.?3?(L*$V3U$D*=\PP9[/(]B00 M:/>QC*^YBNB/\8S4T%,KND`@K5`@-S.F4C(7C.D,WHC$[W[65B:,9*Q68!@# MIP5_HF6Q58")7QM>2>,8E5?Y(^4V\1Z<]E6!1](C!4+-[&DJ392DK"X@Z:[4 MR#]:C9:!SI/);$&&4-'70=3`/R5AH,!(ZJ,.81K-0NP`J9^NX!&*!,<#0*14GD4>)"3\Q M'VT[U$$@%-/(JY]#!GC2&@VK.,5B,ZCAUCYCN8 M0/`S)L[D+/K;/;-.OWPQCOF[;S\7UUP?T2FWYX=/Z9PCGJ7<\WZ4:O56+>J# M=[F%?JJVPO\H"^+:?NA!$A9DI1UDC^'^5?#:E9@9"=6O$%4')(JFK>WHBU);=HU[; M\K'LF=BG"0@L2AB#`!<7R9I??_)6-Q"@*(ND*(FQ&].2!12JLK*R\O)EYJN] MO:W=7S;T`G;V#\!\I+*\S.J1Q"\\UX)[5=:\7F/T+65505XWN@@SOF6/3C[B M_GQ7AE@?LG2@=8!`@[D#=!(DP1E&PTD_87_0]24&I"D2VT2J<\S4#JHQ>E6" M`;KDQN@#DD7P#KC"I^;=.%<1:%$8F;\"?7#+O?X7?N&[%_TJQE8>`"NC'7^7 MY$4E-Q_LI(5C.9&O)$-7'_P1?8KX/V/'M<;X4O+O,M("+!EY@=R/F:GSY1UF MW_N(D]!OPWE4%PQ;H&,X9)^X/Q9]G'Q$A'/1A8^"@;1;!.Y_V3O8[NP<[M.5 MZIU2/S`1%\Y28^)M=CGQ[X.*W,C,_+!JW!`G5NF` MR(*Q?YHKL79YF6?5A2!G0`B0HQ9O'&Z%3HZY?US&B?((1),$!B`7-'WT7"4Q MS%-N?O@\?D7?8'BJV#M5AM]5VF$@!)YEA%>D%/:H.!0@6!#MWO2U@B&<-XQ6 MQG#DX,6BBA!>,JP2MF_$I(#OH[NUJ#F4B8B\4RR3[$`&B7-.^<-%-8)3NJ3C MN5I'\:C.G*U!'0F.>_]&!X3.(?Z@G'P@DMTO^YWM7I<>>-E'%Q"GW%J6.]!9'N.S>(FBON1Q!/RC=D;3D;&G MV5:.1H#38'4O:Z$9/HWW< MN)`@,X@;Y\5.\,?OGQN_-($-]."`I$^$">H#;=C`EC&Q?<>'3%`4%0\2/02I9*2-95`C,*(41N M_4O<[FRD7@>O<"H;6\&G+-ULQ'T9OP"K,R/IGJR_'!N(&>F*Z8TVM-#PNT`T M-^-"D,HQ,C3QD#-2K+P%B;=X*$%T5^T6JY>XS*R(%DR,*A/*,<.4-#VV>-*6 MA3UE[<"`AN-DAYAQ!0;0X^I%&Y@;)!1V%SRC=F,'!VO([1$CR8C0+UZBL M*'^`$?L1A5D&,1`@U^BMK'`(]GR.]]LVFV=]SBW6DA.#"^>Z*O@8PQ4$GP#. M`JX1?P-SO9-B`K8]G.V"T4`39'YN7C2?^S3T\0LH*V#2+%817R&^\ZG@N"B> MP^)G.G0Y<\2_*;;$3"(.=537KD-1AA?G5XGE$%VJ>8US`0+KKKCWKOBPNX_&8/XE_+Z0;F9>"R,G; M6B&-@(B@>N?L\65<,V@0$4UI&/_@P1!FG:.UH5<0@?Z*R&JZIV\8:IR=XY^? M\E77RFEG&A9LC(?>K\$'H"+"78=*&:8`0@&3$);#H+P3>D[`39%&RFND<2/G M?41/G4K)1=PVM($JC^S#C8.=5O9K,AG%3FJK/Q;8.L\'^+IH_L)9J"`.!VIT7MXHU01X5@F76F0]621Y@IXC$X,P-H,I95T*! MA-NFTF&(P68X0.F$1CY(&%D&TG"LB)`N:+<(7HD<(I=YQ\<>R@!^TD"&.70( MW)]A[9;[,U3L@?(@`\76$3/)1*'[VYL[NV"EW$@L##2[+$8XSE;PV4A74:&""%118/N0A,)( ME1V]O>9I&MS0G*]4N7`E*(U7DT;H7*U_O/V0`1!Y=U$))3U;V(@#X/EN7$ M6F&.PV$Q<8-N`EL`H!67JW42G12O-2>8OLW+D*E:]RLY6H?"HRJQ]2#H8-BK MZ%FRA^XZZZD?'L^T7,DNY0K6(+AX%3WD,!:&_BF_A>!6A%0%8:CI/\OHSW)C M/E9)B:ZX3>%8G][N;KFA6(3,D'<``[7N"W+JM)1UM2[VN)]C0$`?>ZU0:`!` MIUTQ:[@)WV.:(V8DN3/P<2$--E5E,K3,TH]5$F/J%9H.FB>/7,;P\!X8F(Y" MJ0X!8@!#V*ZFBO5+![-%&4 M0XD[-?^=-EXW<@U.D2H01Q@7EP:7E2%J"E@,G89/W2'8>AK^IE.0F\14DV6$ MRJ8.MS4E?]%ZY)?@P^DGS>JX;[%5,>*BGIW6/DJ<(E#"RTSKZ)S*GS2'0MA] M*'/UWCALIXZ'&KX]`%[L(2YM-:Q[6MD'%KOZ+7"FG M`!`R:!*KW#]GG/_*ITS/PPSH.N`)3ZBU?]+&.@(:^DY^?,EMQ*([#M2)W`P% MAR]M%:$MS/)AQP4%\0*;=:KG!><[<>`M$U,B7P-LDHM8$+`9*3`8\B2U8A2B M4$QO[%36]J>^E68Y2K&8;NH'L''!0$]M>N)Y-':88W3B(\(BV_`$8V!8-NRI.1 M%5^4UCR@XU7$I7%"2SC5:&B8X?64C]14-FI20P6V39EOK$/*7HGJJD/@%W@A M.HKV[TD8?=\\BRXS],S),#@V[]XH`\G9ZNN:Y66+":!I./5E.+Y?0P%0PM&X M*ME^(?-PVA0*Y8V!KY.30G,688V"JPQ5,KS_.T9EV1QB5-1"@X`^_$=>1BV# M2H9+XJ$R_HE!3(&607`3J\00&BV!/*$JE06G?K[3;]MIX!9%81()J,DS,D#W MQ!XRB/UR7A`]-N*T3UZ6.2YF?K(%9IKL\'!5*_289BWNRR_-9&&R-DU7,@0X M6X403!75&+/TY?=U1I`[$;Q-6QFK1EJN2%*-6%2<^T2>08HI(0&V M,N*X4Y2$[(ZXX5"W'I<4TPEZ$JPDPY-+52I+2NYF]^CT%P46@]ICH139JL,* MQ6/K`MW*C)XH]-G*110\C29AO32J@ M+SP;;EB6HH4ON%@HR?4#FNZ_.&[@21\PUR+0*9'ASN%LMFZ^^TY5,*SJ/M/4 M]E!+IL[D9@;%0RV"=)9]S=V+%"D$#46KM,3JT,EK5U6T^A3I6J.X8&`-U.'M@/JP MMA]0IW*0KS#%3DU:#`8)37T9/%4Y,G.<32-JGAY?!6RR-PF0QF5SDA723V;- M2[L#-1VK>7+D:VUSN^+81?VZZ28:&_>,\P%TK[B;94]C]1T,_S"@?:E6+932 M:$XL-)(SV@$$VZMAG!;NLRPNAT(>AMRSM6(4@;P2V-I\;,5G'*:HJ+F M!N+"$122J/_N7&+92$6:H)8XF$&1XUN4.H$Y"A*%:AA!7S8-GJ$MBD#G5Z*O M%L!FFZ.,@N!,?J"50@'K-)64``E'Z*=K:UP(139A`,1(L;*OA4DKMIM$W0@' M()C#2&<@4*Q<)L?"$T=/G-15U#U!Q26;AT`6-C43:(*:ZW-S8-:QG86B7$Q2 M\JT5NG9*&>4&XPB%%!=DX9.J6GWVFOD^$21TC?B2ZTWK@J,Z$RKJ=(DNJ\P%/=F7A39]"RVP+EOW)C9./4+L'JS0<(:#JW_HJ`R*AV\[!C9(EL:6+:9LG^:OV M;6O9BZ9&A526I;6`@8%,LU&<<0N#0UPTG&Z(W<N%\*Y@/]DR MA_F+;Q\#9=1_!^N#"I3U>097:V!DZ:A`I]GPI*TRB@=N0#9'$30<'N\(2"E? MUT[':B&H'W@E!:3T&AU@';7.)V)A^',@X)%=& M4'TBS71B);D,Y28@@4^X3;]6RCC'TI>M9;Z/G0=JWF@;'/"E]HAZ1FH.UN`9 M2M$+HH1*1AMA'N>.$(>SCF5%4,\V[B>".XC5=)VA`!ZBY8$XA^:#^0$%-68- M(UP0RZ%)LAZI\+(6/%]-"#,2\L];_WT_)9E[??*:KL.6?CV>WU.GR/NE`W36 M1$C.!GN<_(1^';]H*!*`E=]SL?OQ,*))R)[_?JR`.#[A19;A MC^77,%A]SO,@O>1"95'I`G7?'YW]'AR=O0WV=[8WN]MN]HX0]RL2UT.+2E<) M)R%$LA#(R6>+(%![#A,.NR&;W]DP`8AB<#D>ZKG-_KJ+7H,_M=8@\../0(V( M,1,X2C#."M/:XES5AA0W=D/MAR';=.9MC!9EE+CWG2%Z(66`X'?8^5+`7O$] M)KA1^#A1BTM>HP^WJ5@FMYRI-]#K-)I\4E;Z!FCF+`,7>0Y28QC70=XF1,_1 M,NL(MG4C6D?B@F9^)"N6=K@"&>"?!<]':6G8_J2\5A@MY2QZ;SZ>0D!%K[B& M3^9$_0R>@JMAPUU/U[;&Z:*3!"8YPH8Z>5T0TFYK!)U4L3CS6IR>.D49 MR?M$%GB:M4UBYDZ4])[T080YD:H.A(53GDIY1>QW5$_]Y%`YA4M_A".=88#, MY#,2JS<)_((84;]:CJLLH%W/GR8[J'%XT0AL5TY&U)5D")2R4A[$K_U+,&M8 M"-LHQ%,EQPY$R<)P_5I!,%@,'6@AL:;](M4$I`E9V$*P82OD.)+X8^\B[T:M M=CW]KD;8-"&W$>?(Z@HNRI&A\'ABZ!QK3Y'M'(3,"L=8N2*7/$@P.Z=N2Y6# M=-0=SI`/[7<)OD#M'O5(XF64PTE'B6F1:JJ()Y4JZMZ0`Y)0!(Z2A&-(A:Z@ MN%0*,0\VE4IN')?6CA7P&NMY6$/`3I`V`XWRF-'0A>?2I4)2\KNW4_H5B_A@ M,FN=&FU]YY,,8;#DG"1CA[;;_83!.)A=)FSBD';-8R@33$!A[\A*]#5/S&0K M^+L!'E)]2JYX%KK%QT@F`V,H[TN:G.2JQB_R-2(PF98+4E^[[$S?>EAM MA2XZ/)UBD]LT>@U2E'+_3C\4IV35E$)5QW%"PGSF590B,G]N)45E/'8_M2@+ MS.5IC[-2$H)KG0^>LJO]EM*9>#T;V3YHWE_1".W,;V]2;I_52F)'>VVX0$&F M$=JESSMU`O60_&_]DS4S%>)0Y@3O*< M^H&]WPHE)6VP[OC.7J>_OV=I=:^)=;V)]?OWFME^MX,=@IR9_02[K>:U\K:A MVF>@RWTZ4UN5D[8R$VDBG*:;S3!%@5W[&U>^5R/20\GZQS2[\M;2JXUPU;N/ MTS%YZ=-=PXZ!IUW`VN.+"0E6_=7XT]MJ/S8NX`QCWDP-UB8%AF%-\0''=IN- MBFFEFVD[SE:8U\6TZARZY0UJBB@73N806QF4U=_. MZ::WA%/W5_BI2NEY[!<+")VX#Z2*=61:0'N$>5G;!F M$^-"VL/@8VR5%AAN(\>"#G$AHF2DSU.=^SKI;N%.@6M=>:6Q)\A.-1(ZY]W3R!U:,+TY(DX&7L#^) M=%0:6!^][5JRHBU&^EM!DU)D?W+^'!S'IH(^N6--@6(B[=*;@*S*(3"](,7P MV_8#892$0;W9=#8I<;W!5""7:[@5MP#(E5?]&:\[70C-J"]Z]?U?]W>W@UW-\Q`NE%SM_O<;HMIBO![5EDPC`;4=3.4=@Y_,8&V?@"1. M\`&44KR;7179/./JR1J+AYLNX6N!V%,2NY,?*-@_AWE.W#VDR1(74QX1"+G< MB7GB=ILI`C]AZV)2EC0L>L?7.=G>C(T@@T^7M M@NZ3U)2`LB_M=N&=@^Y&H["_K^3VK@&L97^4#O`_[VR%]967]SM;C:)]WC]- MK_3_;&^*?VC!SD4&D#9H^EV"*KE)B-:!(NR&5/.C+D+!>9A^=UT7+>U+X8Q> M8C6%E_U.?Z='QE_;)CQ+!WDK2[(0*DJ/9#8N/=&'P6^_<+C-]:!TYP7*3C&2 M_2E3NN[%!0LU+75;P&=M%4W`AW!.>#CM;UY_QTZWU]>ECY$#_7#+!+].=$7U MGV_`9;G-(YU@CB[9YEIA.(?6[F78Y-R^;KT#J!O&9<7A#9!H[RK,;:#523.A MHSP\#]Z-8K8+7=WEV]$[5VMIOI_H\))XBRU*U?^JKNN"EZ^!L[U7`P*F'K-< M#4Y2W3SUK=B*?NT_JRS,?+][6H')^U]Y16#/-?P6J`GXE1">[?^B4J/WQ(FT>MW(.WQP3.$#3HYW*Q,XR6X-)4XUW,["NN%/WV."U&#F M(&CE+W?W6)0='-8[U38.ZEK&.%L'AQ!J,&CQ9MG$8(B, M?.,Z'I27^)'M7WX-SJFVZ28VJ@C'A7H3Z)]^#6:>RXL@PH8@XQ#KD/[V8IM_ M'V.)(_[=F4BN9W&E\A)=K5I^G6=EF8U^=9\=-"R*_U$_X))MDT$,.%(R^#60 MSV_RN+".EE:S,P_H"MN(:J`;ZNEOG&.Y0OQ20`$,)$R&=$E_>]&SI6UMZZOF M;S?-/)B5WF=Z`[V'C1=VQ!F@Z0&;+\3?!?430<1I&_)34F.MC]I790 M-JFIKR%_HH:EV^BWM74JJ)2UR-(4$FD6_N4.6VK?\;82)\BCO)SAY5[M[1PW MA%_?[?0.^_?Y_B+W\OH2[NCFG;S/[ID&M`R@;UC]S-MS9YHTO^ILR*O>]N&= M/[BQY',TE[-CMH'\^U-JK:W6!G5WY_FYA9\1=S+SD7EFW]JQ#:NU8_V=E=JQ MVT^6MV>-%^M=-O)8)V_%::O&*]WM.(;B]2GW3"(/^T#']HX:P>Q[>8N2&=B5SM],_V+NK"K0T@3U%$-R;A:;I/S67VFKQPS3MZ"?9H-_9W]F?#Q?, M*F5>DR6T#"OQ(2S3Y7WIQ.+`#`#>&,4VJMRU5YQC"->2)23MTLW8N`UPL+VU MC6'6`/ZSMX"6>P_J6K`)HT5TJ0958H"CDJ-.(,2B!M[\^,=7[TIQ:E:Z87)G M$U(W_%Y/I8'AUDZ*9^>DV!,FS)63F\/I)?9WRC-9-??%4]T1<1N18N`X>%%' M(-=O'@2OR2U_=X7A)_;DB5*NNVK<_)/.N/V=5M_2I[:<282O:I34B<49=+A) MU@IZX+;;/7"O=O:W[_/Y25-BQ=?;[>P ME=F&+7W>9G._62TOR:(^^^26M!(.()\'M[=ZCI%CW3UU_5KCC#5,EGC44:_/ MR.YYZSJ`5LR@7Z2#I]?I3Q5,\['LGR[]#*OU[KKJ%8PMW?4(FFO@K9BW5O[_ ME!;#:$ISI=!H4_$*J\-C"W"Z=3N'O7D=S2=/K%LUK/DYJA?DF9R*P*/OGK=Y M9?[R^F=14`9"17\I2GCC%"-<7#?Q-'_'T<@5Q27N+PV7Z)3+RR2#6:H42+QV MP]FAQ3@AI_.'SQ5+G$>KA_0.-5GB&>A+J4DU^*&\91JI#8.7/5,P.2C"D6D6 MFV"Q/TSL[KA>5I/#WOQ-6QEC,/$6?:N[53^#,QZC>I*H(!M/AV\=*,`7+G-& MO5)(2?T=/?6?I??OBA[)@R6B&]L:2S_#4^C/XRVBUI/$EJ_@^K,ZQ".%"I(P MG:AH_B#37AG<-7P2O^1Y.H?A*$YNWMP6LV")I^-!+>@!7?IZI!0E*&8FIIQ8J5[K,VA>JGJB"LW$24V92=W.8Y9O] MWFYG>WM[6M%Z]2,N>":U0)\7PP,:;>]B9S?I0DHUY3%7'ZGAO\E9PQ65N"PP MIREP6G[Z-3U!0.-\.YH?-5:9$TXURYH9-O`NUX,$.P-L#\XU+1,N[:BK9^GD M52SK(>\4M>\Y])!OR$"4O$R9(M>22O"UP1>![KZ@L?T!7N_1C ML1$?6EWJ*QYAA0/,D^4PHG2Q&<"2L&VW1PB3?:U^1,J4&_D,?PO^A!W`)H/P MS9B;,WL%D3G-?$K+3TD(5@E5:9`<-3P8*Z!AK(S@<+Q)E[J5@]EWNJJ"4]X6 MW)/YAVL?@6QE9O1+L*/TNPFZ.QV;YLZ"K:GE&76K-WW-N=!!;T?+*S[HT@O= M'@VW%/R?3N:8>T)/:[("CCR]>B61>&Y>!N=^LXA_H`YKNI[![UJOI6JQ:C1. MLAM,7JH%HPJ[K+:0:ZL44EWYA4C-,RC'=:K\\>3(^*'[) M!]H(\J0:P=MP@17^DZ%/6,MBUN7E*_41QSKWRVS\:(_H9>V`!1/TQQ/K?A>+3H\/5*_ MLY?A0]"A%M"Y"X'6.]T.)VJ:XRME>:L:)R.BPX%??L8"W.US6IV-7_/6Y'8VR(>'Y"Y')*V9 MZ=$QTUI0+4<+NA_7WILA)S#,#S"5]4+6"[G75%I`93^':]]!]\2TPWKJ]N@I M)RL935F<`Y%N%$7WP,O;=!^K=<9;W6?GX?4+C]UXV:HQT6>U:7%(UO,(R/%:FA[ M[25-WF?Y4&'5\]?!6PVPOC]-[UE"I?$KMT6WYLT7,WUP6MW/V0-"M*\ON<0^`K-^2:Z&LWZDKH M#:O[]IH4:U*L`"F6J5BS#GTGO;H6R)^Y(/(CT?"6=O=-JZV]5K`73O[>84=Z MQ^YU^OOSVXP[*]BKMP<+/0)KX_(Y\?YBRR?5]\;?I0=(4HP+ZK"'.8HWIE5W M&99583J_-.7J3MZC#U38FW;YMQ>,)GY1!ZVL?IUO_>SZSU4.P8T MZ422/KZH41BG.H/X7/]MR:DG5'DPC,HJ3"PYDWCXL`DQK[`.7#&E8-\S8,>] MY;+C*N1!J8D\J/%/Y4&M/ANLY?7Z@#S^`[*41AR]`VD3X93PXE)54Q;8TJSA MYQ,6[OS.8?NGI]GQY@M=O<6N^7CI?/Q4FV,*T6ZM:!I^R*\D6WB;_*/SO<7@5 M#X*S:I2JO!.\O0SC?!36&O@&'^(1(@`[6+,5/H;%&+'0(E5ZS(J8JKYA"54I M^(=:Q'@K.-$%6).;(!R"ND0O\!!4(Q7K\Y;7&945IQ:855*&:01/7^2*R\=B M]53YY#56:CR_"3[F6S+?X#JKD@&5[X[3BKICA$41%Z6=!=8@C$NJ>SY"Y2Q, M@+AJ4%!9W7&82_U9=#CK;W:\+V`UTLS[A"YKB2^9XKH3VH_Q3Y>7,(^+RZSB M6;G+Y-+J,)5@E`WB(2AENO(L/KGG%!>6L;`V*A7%#*,(%+62JV)VJ`@F%=HM M32=1+N-[KH!E@/*X;O@5A\U044Z28!BG,`G\`WK6:>5`E:]./5T:41<'SE6D M8BJ8#*QX!5JM5^]35D4^>$U'(G%119<=*@ZH2\+39'.NS!ZT-G&G,I).V=S& M7/9C@-?,7V>CJ53[0*J/-X_OK*_\N&5F:_2^]GJ]ZWW MMU3;>:9.K/ZJ'\K,ET:;=@IF6H%Y!D34GWVLON+VC5*]`D\"[\_$45BBXDY..!NE))-D9-;6%JQ>JUD)R6UK-NOWE+ MC\2=A1-OL3?#O0_0UZP,DQ7;\07T=^P_]2:UBV@@NGC)LEQDY_+\):<:M6D= M/-KO<(?>$B^[N]Q`*4FR2#LWVAK:/BEW4--'T1\47ESDZ@*[6L&R\S@MXDB: MBB%9&T&QZ<#M63,)DJ4GT$CH$*U?IG'RY$EYY,*+D:'0J^LT1YH@$CM9R8-+ MK9J#097KIF2S-.@LL(-8HPXZVO6"FUAYGHO[N-,.GHX[[;$8[*>W(FV? MH2^#_9&Z,+B=@P!_V/66!\%K?(SJEMEGCD%>VM_>AW'N/_YW%*!/Q$6R9XS> M&?7?3UDZ*?S^#-,*I>/M^8@+<0W<:92Z3\A5X!ZG9^0N*(%IR]_9Q>H7CY,& MLWB'IBQ]O[O`I2_<133CT6TOSSCS/MQCV^]50.LGOKM>TV-8TV(ON;N,L__[/_\=T_^]U-(-(FDN?% M7Q>W3SZ_=+M;@8MFM>QSYY\,-4`>(#DZE((A!*%86B$D"09,DV6SZ(,$'UO/ MQ4D*1V%[KQ-<*XS61A4E/" M2`[G;!A'*L"(&X']/V3I`)-NOJ7X8/#?\-H@&VTY&_[-9G3P$$Y2#`8ZQWD& MVPI;EM,_F4P0-Z4#SV@A^1MC>.%'/.(4('O;]_O4>*Z[MX$I,/!V6HTZH!/& M@^!_JS`O50Z/PX3#P15:I'Y6BDZR'E"2`Q,!4UM4/HI3C(OC1'GVU9ADQFB< M*#>Q9A@/@81$UE='U07L#$6_-V@9F&)^Y439?2?,"2,XHGCQIMEMDD_@,I=Q$S1X>O-';W=@* M@"O?J_,<0T&.J#9[,ZY]4DXYU2:Q5L']E]')J6L1<+OP'Q6APD*\>U!F)X*+>MG=IH:< M>$G3N>GP>^.LA#$P=?0\2ZO"'LR0D&=)G/*V>^=YBR]`.P70#:[B@2I(S,`U M&(*F4(V`3`CH@&M?'V>82+>GSZV,"L^DG+JKA8Q<+YAF&X45BK$".&O8/)4U M/PE(,Q5+#'GI5H[*4L4<95.'04.#2P"X!<]T4Q*P5C=XB^"-F!Q\]*?S,/V. M#P_C?,0ZGGTM`MX\5_@?3`$>B,X#+'VMU'=0+\%P`![$C&<0/QU?ME-N.JX# MUTN?PX?3+9O*6*:]5W?,WO::DZ;4;XTNU:!*S`X,JQ)L[``3K?"< M&SKGZG^K&-F,\\FSFN$HK&5MQ_(29-5E>(6W3DQ2*,/T="G7Q^A@#F3178X2 M@N2&^@&F"MW\FI$7#,&) M&B\R8W:%%_*3:,*#_3NB"0E0_LHYCG`#BV">K55[G<#,,[[EY3 M6N7,6S)_P,S^P3P_MP1PTGRS.]%07K&@TR(CGKO32CVM2`1\D5B<9Y*+V.L= M/HD(XZ*U[Q9%FPT5]GF)$T7GUE$"5W^/E.:7W9W^[,EV3A98KHJQBM#KG=QX M(;.?#G-1D$P'W"2P]CG,RYNO8.H78418#QN(6]7PV+;KL[Q/=,S^),2@6F0W M0>F0XUG$PPR!8_SA(UAF-Y3<^`<6;Z,IQ$^<`M._A1,#A[FUO'U)@<%S! MB:40]\[A+Z8Q"L:F@R@ARZRD6C0-#6U?K4]K_-@B2+$R#(9B$ M"?Q-U4,PU."F?["_0:+D.LO)9Z,_AT+#>9C$=`G;\6+[`$3)$"Y"=GSN'!V;^E+-6IUP(5%^0HJ&#N`"Y M2UXVD>XLT"W]*)DZR#VA@R4.O4IS`RJY2`4),4Z9#A/8KHA+!])W,E,`+I#Q MT/&'C),K27.54H:I_;:!.>[_6H!Z%>;DVAW$.5PU65YL!<=<7Y'"SXT3H#/@ ME3Z$V9@RA"I`1Q*L9Z3*2RRK>.(3`=X%K61`KCYT7^?*9(X3O0R-8`Y\J^%' MW@JC?\I&8,DJ$V?GBY4N8EURT51OK)^>G>WN1D>(Q`GK0+,+,)"1/K!=RG]I MMPOO''27%>6]\\_H1O!'^^#KYY.1@7M'7CHL7\*O$FF&:BL5VR#<. MNONE/=OXA.SQEOZ!G<02,C[*P_/@W2C.*7+\2HN*WO:OWX[>F=^ZOV[`*;J( M"[XTI&PE_E/%\NS\AN3`<74>Q@XESC1.Y:@"R4"8(_<3Q^_/CMQO>%/$;EU! M=IWRZ"X=B*)4GU:!$!H'M=*T2#9W*SWQ9R,H;M"$:M>&).A(K$99/LZ0)/IY MJ>9@HBX<.3EUH_U[NK"O4Y%V%`X4.N1A[:7@5#+>MI?=3A=O;"M\]A$(`Q)0 M;Y>C0FBJ$%`'[6+!!,4PLS&K'BWC47U:+6OQL9T#]YG^]@9*0HTTD35TZ37S MCUV&#;2;)\]'0CBHG$ET1\>)P^ABPQ9]@[=WFC%2RC`2AM&HJBP&@?W[W'*T MQ[^D0.#]?QF/14>C$Z]9!'?.%0DXOP_(**I]Y1L)($A^"3^$;6D2,$#\5%P5H&!@R-*66=#`Q70(KS M/W78JWO0F60QIB1N(,=?@7QE&">F'$K;I,QB/=K-_PBO@$;S(1P,P$8*J+)$ M@*Z.%$E]"A#PWQ'<*HE&)4Q'KWU15UE"I^H#AIJ` M[=["7V-&=6E_5'#D`Q+T]J`L@:L;!GJY"_<6(U$0'XI%UCG@C]S,9]J.`<8( M3J:@\'1`E9;@]G>PG4/%8>_K+'C5^X5@KI%&K%PJ@W6A:YC+=WOHS#2@"&KP MZL!YUUR@$1S>"T7@42`'`J7`\LO#Z]2]K/4*XU9[[V.8AA=(-^%.P9RF"J0C M1=6O4]8)O:&ZH`Z-D\H3(?3FVW>GHFIN@;%DBI)3H)YJUM,4@P$,"Y(2C!\I MTR^.!YJ6D,?%;0Q9KLAO35+R/6BCB)/^?\;7:4'$@M9H\G<^9N-P9]5`0'&*8-M_SF[SF=+AC# M-R+Q7\957E3H3I$^$`ZTWW@"R9VH)X625"R\SE3[ M3",1L93!QJEMH^ES`Y>23_-WIQUC^.=JG(01GT,<1+8\-=""B5'>^Q`WJJM[.AOT07"29/(H0:33Y,V(!I MA3]P3YSQ]SG!AYX'E9)2M`9!HBYL*+FP0'UT3%VD(U%@^ZSZ<1[G\=E7TGM1 M[F*I5Y):__D?S(.IP29HU4"4C]"R2BOA=!*`\D7*4#;$V\1+3A-X!_Z=Y"25^* M&S()KSORXH#:'T5)&.,'\[@@?;8RQ@"N^,@?ETQD+:>M_X"<+53.U8'T.^FM M$]X$QLZJO*18PY"\/^$056KTL]:)Y+8:&E8)=NV*HKP2IA>VX-5XR7[H+YVY M%BI*03E^=0^E>USH:%)X!0=^V=_>:$.L)NY@ M=_ZP@Z:?B##2Z(NDAU.8Q#P76":0V8 M;X?Y`"7WM'$<+$1YK7O8/;)1+LK5LW[EFKN(8E'HR)*HGQ?4<[:<,[Z3(FL, M^YDX^JM"D0]>`2TV)L!EL\AF*\AAY:=#]O:]%R_2BDIP=#;WV)\_=GWR+6EA>JH9)O@3CQ5,87_90:&51K,NV>&[?F0&J6_/V:;^] MW:<]!2CQ"/W<(F.GB4T/J'MFH'KOKKR:-S\A7!M/K'>JQS_NDLCFB]?^U@*% MJB4#YQW/@LQ=Z')KDG6&F?A2\;X3,0)52CG4TH:!E4F-&,,1C='Y"8H/%H*Y M"4RGX>#5YR_O-KL[1ZQ679._$\%Y:*$>I6D%9_6C4J4AP-6(*PQOS M[78GYD+VX/9+;=:[:0Z[@'3H-NY!F*8@ER*-ZD"R_JXAE\=&/[LD[TL42Z4% M"A$H:0ILL<+PRC@L3=TF@F8DU"VX5-%EFB79!<*&C?,!+Q:^FVS7[?C?`EYZ MC1ZG%"18I#T&"H1)-HHC3A`AZY_B!)@IGI(U?\'O<[VP4&'4+'DL'*"6G^`]@X; M=:PH2O,WQJ^$J`AEI`_!]8NWV.]8"`+_1#?%EA,'$_\;?`DC;:PJ@OF8$44,'%$!Y:0^!>C^XP%*%@< M8:0`;2X"_R14,RGA.C59<,&++&X*$$]%`#?Q=Z%8RF.%[(E#-ZAT6V(YWB0'AB=08%%E!-K$Y#HC;USH09SA\SQSD)#?J9Q*?=F_DNXE;DL: MZ!P]@X4463%^3?S=420\+#W=VJ-QHFOXU,*`3%0$7UN/:`2VVA`.2C:CS,,W03BZL>C7'88U28>]M49Z7#2BB)T`)CM1%IA_U= MKL(RS*JC9B%2C[[15N_-T0.`]A)"I8\7_ M/4EK.5[%#,I@]P7<&C$_\>WL^`5=.B.06;^]V.R_^.NVG=3MGYO_['K39]?M M'0#Y?WJ*>".#40&F$$B0$S3TU"=5G@Z_AC].B#O@4'W.E]F:ON]/W5C3G*3[P\F_9SLV][;U56/T<-A(X\W#6I*??O=.LT"C5957!R/V"!:`*=9K#SR#+B8!A:W#_/M`E[%JD4 M$Q:/?L3%/]_2C4R;\Y'B%0X1^$MU.O2ZV_[9G9C07^\Q7ZU M.U)\S8X&K"R&R>[W%S)RU>!=F&,5J.+)+M3U3+ZC]&,JX?*D&;M9[UW* M%IO;!__YA+*0&'O$ESY?2A.OSF0$SNVJW-SQ+\J[3=5;YD=Q"VD::V7F?9Z- MOJB!&HT=Q\Y]+D]GOC-^ZV`3;:^\1+/<>@K/; M/W@,*_QY,;DYEQ7.(F5M7Q.W\PGMC30A_Z+89:\D686EUQ=NT")-6>XI?/K^ M\5S2O%>55O,7@-W]-7T7*H_6]%VD-.SN/CAY5\B]=HLLW>\_F'=M):DU-Y_+ MFJ(+NY_6U%V6<=`_7$N'Q7FOUF1=F(JU9MP%*UG]G89UE)62%G MBFL%;6[2WQ"*]68H?_P`OP0_Z)_*F['Z[05E7@[4X(7\*RP<_O6R+,=O7K^^ MOK[>^G&>)UM9?O$:3,S^:_SS:WSP!8W]>F)P"1+2_\\2+%\28.-@=V?6@/J, M"(4E+NZVL%UW?W?.B^/_,TO\G&?#N/R0%7-`*FWV=@Y]#=N.CF1]C0P7O\'_ MA5__/U!+`P04````"`#]@:Y`F.?EKE<)``!1=0``%``<`&UG="TR,#$R,#,S M,5]C86PN>&UL550)``/^9[%/_F>Q3W5X"P`!!"4.```$.0$``.U=6W/B.!9^ MGJW:_^!E7H=P2;+3324[10+IH8H$"NBN>4LI]@&T8R1&LKGLKU_)EP2P+=L! M8CF[U94.<72D<[[OZ.CH8N7FM\W"-E;`.*;DMM*XJ%<,(":U,)G=5KY/'JI? M*K_]Z^]_N_E'M?K'W:AO=*CI+H`XQJ,H,\5@&6OLS(WN?ZH_,*R!&3_\N@Q1 MU<75Q;4A/CY28J'M+\8CVAJ-JU^,9KW1-.I?6U=?6M=U8_AH5*OG:N+ZLM6\ M/F,3C7JK?MFJG[6)1JOQ:^NZ>9HF)B[PMS:NPS::K:M?6Y=UHQVV86/RYPOB M8`C_(/RV,G><9:M66Z_7%YL79E]0-JLUZ_7+6EBPXI=L;3C>*[V^#,LV:G\\ M]L?F'!:HB@EW$#'?I&0U<7*-KU^_UKS?BJ(/%TI9Z>\_F#*:WE<7, MJ4H^],]C!SD@J1E,'S`1AF)D#RG'4N=[&W'NT54Q9`/?1[U7,T1%%R9= MU.3S6L9*:IZJ)K)-U_9`Z0O%]E2&C0/$DNWY3V7M1S4I6_SIQJ;F7C.V)(6R M?6B"5CSDIXB_>/"[O#I#:"EH:#1J8#L\?")1;%3KC8"%GX/'SVW.P>'W+F-" MM[`!&[V`[37['%^N]N%ZWB,^;Q-+?NO^Y>(5LH4>O.W<(\:V(J3^0+8+"OVS MR0=V[5#>9OLF(F:&K8B/>WQ'^T%0HL;=Q<*KK8J%$X3R4T87*I##=NE[+#$H MLX#=5IIBV'&Y4)(NI0+(KAAKP+.Y(X:D`FALFR9UA;HC,$&H_F+#$S@9O$\E M5@;2U'8'7%WIQ=60P1)AJ[M9`N$@7&[@S(%E#1A9I,O`7"84`@+_J1>!/;(2 MVE&V%;ZF8&JO6!DHV;8\D83)=A9]N!I4QZ%;P@X$?8Q> ML"WF&I!AX(XI7%R>.$1;F2QESQ`/!`KVGF3@DQ+$0X/UC+E"6^:"E>'[$ MA#+/^E3B(T4_-8518/0.ITG\;=CO@P'O1[G?:DVQE/Q/^/W:?)>/`P&'9' M[4E/_+;])`H]#D?=WX5`[T>W/QB/4XYC'%O[*8]8'*O+AP>7;TPDK4-&I\K$ M;[=4`0D/LH&/8`7$A6^46ER]JQ);O.">'P-SI)/'6JEG3G%/N9CF>%K*0`9L MA4W@8Q&AE"LQB4+ZLZ.R.#VL5@M9>%T"$]:367!N0+43'"U;Q/Z<-UQ]`R)T ML07*;6N!">:.U&P%@6;*;;M,%13L;(FT1#?VLN&A9X@8`0 M]G`ZB6JYLG"78KV>$PTQX+PM9"DHVB_GZWGX]<&[`8=+<>$RW(E71D[=4@2[ M0L:'3*3'E:YY9\DU3E:?_6Y4?+R(0GP8,?:U#B-$_2(M1)0FHR@1%W&ZAXPT M%(Q4/YZ2-V,>A,7W(L9@X@K-`Q,HX7]N1`8AK,$$L6U/8,9S MQ\%SMOK1"`HUZ+YKI"^^@5W08*X#C>!2R!$0? MJ]U_'W[R*"9E>Q#PX!GQ5X[-[80API'I,4DL[Z>`5^O?+G>"4ZU>DC<$AJDE M:F&`.'3`_YYVE.D#5"C:*\^4@L<>K/H8.+.'KR)) MG5O&G"K?5?AUFMS4:`#9,^3(Z63^NO3G\!WXA#1?ZI18Y^QA_T_\CVVUZ"$L M2GCTG:]S&J]GOOQJ2Y#6WP$!]?)+DD0IR(TQ5,]Y?^X$X'\B/]PS./L$19/% MZO.4=-U1/0K-64LB+];EG806>#\A/2'(&H^O!C@Z(^&)B#PX%*7O%2D_+ MOM%Z'M_XAC"1CC,@\BCA8+IW1\/K!0VJC?-L%92>S*Q`I;_!5&>4(]$+U!3+X.EBY>6X'P@A10K,IF<%,=VR:@RWGYA MKIZ9KX[2\O<.N$(2=3OF'C4CN"ZO`U-@#.*OS2,PT#E"6V;?[F80>*UQ:K=I>R5E)[E/(!I^M:[T-@$ ML+PC>O[BHW]CRB,X4,Q81_D9SP[7J2^TBUW#\U:?EC+*A*L. M]Y1P89Q_PO*!,E]+?_%!:MW!W/2/8H+U>A(S877O5+67EO:30JSG]7@)X`1_ M\>BX!"6NDJ-=/@RZ`GAY_0OC,&#B\QHQ_XJH\=*./7";759/=U4PLNNN&>'1 M-`6)_TM)N=\CRU5-P72_Q^28MT@RS[1*U_%V MIU,P'9%T;%G;M"0BUL//IK'7>/*N!8V#3MYE:8-:>+3:O=?^J?[/@&4CMFS]6C0]U M_N[\JL8_WF/'1*L?:_=H56N]^[%VT6Q=U)H?K]]]N+YJU@;WM7J]J$M<75Y? M7!5XB5;SNGEYW2ST$JWKUOOKJXM\+C%V@;Y>XRJ\QL7UN_?7E\U:.[R&;3E_ M/B(*-6X?#OUT-F=L>=UH/#\_G[\\$OL&]U?>E%K7U.M_APW$/(M-E:N6 MV$+\5@^;U<57]=9%_;)U_D+-M5R\C-\&`OE"A1&FC+V9BA-9%\]*? M,GX(I^.V8W8=9K%5SYEBLO`FJK/:MG:\^[F!%PU/(VG7`\4:,<1`#-Z?WEH. MGW0M9`\PM<38-S:BU'MTI`BH.,B!HGY&MG@HC.8`;(`(O]P8?>M^Y=?S1*4??0T0M5KG\[&O=O?ONU?]?I#D>=[FWOIC?N_OMK;_S' M06K)QLW/TF\0G=_:^)GV'-,B8#!U^][MZHO%GUJ6XQG\'9M2>2Q@W/4*WL^RJ<$+U*A M"B^-4X2N86("^71VP>,PEW*1\%(('\QD18-]PV4FR.:&#R^_P4J*]G;;:L"] MHV&`]^61\;YQB7A,W5J4/Z7^`$2ZCMGA:B1`GMA<=]23]0R`?U>*H=]:-I`; M+L<,$[F91UOJ#G>L=@'25T=&>DR0R"*-5HM';"=@'&VC.[I;&@6X_E3.5(T7 M"^R,&#;^',VYRTO[+A,I%2&@?-Z6==2=`17=`UK>'YF6T+,;\V$3"(@TT1WJ MJ#X!J!^.#&J;2V`**6YME&36T3:ZP[JE48#KQY*,=0#$PJ;<]XAOJSO."1H& M>+>:)0'N.T*^4+?\N[B(2]Z^*L#':!J"WRH5?.&%JD/_VKI:P&]H&<*>5TR9 M0\)AC![MN/DFH6$!T&\LO.P#>))&Z_EE&^J:GW.^-K##X(5U;:_7IS,*,_'A M]>\VIF!^.F/$A?+X&1G@('[GME\LI9Q0I'T!;$D6*"3L1:PLD;FHK@&!Y=\J M@51?';H$P\NN=R+K7'%T)/8I8NY*6'^3\!%G53NT).M]DM1,.AN+H<51%%W- M+8JCM3+K>=!7JQ'-G>>73E=\\3EP63%;4G"2Z29[@1$=0I7%LM& M6O46J):QQYOUN[+!'A#,(U6V&MC(W^3!GVE+X:?(S5S:37X%"/<&6Q;%SO+/1HV1PK M4(G9XEI7(7"+U3+G[3J'!P(#M!(>L7H(L-6A/"8D5I04`6PKJU%41EPP-S12 MXB.A3U4H25)9EXC,"S\R<9+4HQ*,)*JK2\B5B8JJLB`AH/1(S-NQ-,^3E?J`K> M0M[8YKP]]8`T\>MFM]2,\';3,HDKPM1WDL<[V&CCD9BFY5]Z@"RSY]R@I<60 MO2&PS#5)[WSJS*K@IXN?PUTQ=^':?*;R,ZY'K[NDB8VVEZZKSM8J--*C\7_0N/GT[>0O+B09?U MBLTT@V-FFM=3NU8AAD[7/^=2PK>=Y$?=25[8-LSD\S?>=EXJ9WVS07'5,C)K"<())<] M,]0&*(^O5+O;+9!1@T07?W8(%#@FHBZZPQ^!-O:JJ=*9D_>K$&$I`.BR\6M' MKRP37Y7XB%%4EYU6:]%>MX.IL+#1NE(/GDTMPZGD>Z<<\^_F'SA:O0=$2;UI_?8@=4L_@3'Y+8ZHRO1,.>32/>W^GT, MOMJVGF[F>9UC>LBY$N$$>'J,7H-T7_O#C M"E@.(BL/@,P;QHJ\:A4LHU#4\SZS]5#CXN('=O^91Q3R3$-2C^J0&J-MWN>X M'G3G;:%0%V#=UTN?HU@=@KS?Y@=MKLX]5!=[V0"BDM_R\:41X5>JJ M1\LKY/'I4_'OZ)%32E63?X0V_YX`HM`!_Z=*KO7PP:M`/7M!NK,4$.Y:(+4AS3^\WV'*VV^5^7LN#T)8GN>]A-[B*4F`'+[;Y3 MM<;\^=,E6QVC;"AZSF4Y>5_I%.TO=S9T2;9+%"O.K-[,:%^T=5D?D"BRGTE\ M;W3K4V@=%H.')2$*+G!BERHXMLGZAG-R7N\XRX^3SXA:AEBVM6R72>LNTGJ6 MQU":G:7QM(/!X9Y:[!+0?[A#.><7:#\!03-X<(5:_6E0>K!==9#.S.%CZL]9 M#KCIXA"]U6[H5`*[_TO/A0Q5VO,\:7I0EB1S-F.?M$)92S5X#IF2R7-Q$Q\6 M>]M\240=4K$TN2B&M@.JE@0U*11N:2!][!^9E%P+9"Z+(>?`^B6!>`)!$DU. MEZ1('5.19.U5R;076SO53!JPME'H>Q_Q4>55S7[;R;N"V%$,164W1F*B8$<% MC=A(.#8RE1EIO\E5U5A*4R?9LRZ!LO0S'M/I4QUC\E/EJ,R@FKP^[KBT;I_@ MF,IA?(?)^ZH1EJB'O$CNV%[Z]ME>8ZPR3TK[33Y4C:LT=>2U=L>E+'ZA)94Q M6;?)QZH1EJ*-O`JO[%M,RT,J)ZUFN4:0*5F2E\8Z.4!9SD7::3MI%93A*H*^ M..'S\5EBUT=>M]+0,4YPB<41`X2"?U#3TH[=R[WW6)-607FL',DY2#GM7!K_ M_+..2\24X*V$^T:W([T\)9EII$FKJ(1803-H-M5T\H&VCZ0.MS>(HI,AF+#P M1)-QJSC"I%5R9B8#IQE4TLD_4IETPN5T,$78RV->;XND9Z!]7ZLA<#^`6@R" M\TA\>QZ"@6<^:=*DSU$DF+1*SA]EL*4C0B(O7SZN+68L(YJT2DXC96`T*K6\ M'/FXH']'.]TGK9+36!D,YIB8R(NY_U;<;HTU(/WI#:+S6QL_TQZ/20@8K))G MT)7YKP+[0+[K34_'YDC<47Q.$#]$EN8)V<*?:+,;1,B*QQRIKS%4Z1_L[-%E M/DU<+U749>T-E?YRG7B),S]:,PU37293BK/*KR?L3J?\F=:?=E^,.7)F,.3Z M]IUX921T9AJF"G1FPT6;T_VX3R6$XU[]D\4]G<^KKWRN[SFWEH,<@\\G;>Z1 M/<6^*#F^F#OK8%6@=A^,2S(D*Z5+NJ*YW+C5=I>O?!3)?JB@29>\X34);31"L;K,(3K10C;4Z* M'L(RF'GZTR%X&ZP&B+!5!Q[E+^>5=-/N9E4PU]W]2S)<=)F&PZ?&&+<-[J@1 MX)HO@8LYL)'#N`LGW+=E$!;4F">G!V+&OZ9@6"NCPQ,\(KS&KW*7.>*LB[E_>JPY.)I5=H`]L%,EW>N M)\B\/N(Z#\]:-EB%/6LI1MJ\'*[F.H2%N^*W#8,['*T M7@TXDP7$="^/_,Q&GLYH'#P%G;07([W8)9MI?LXV1@69V@,H7;RB7;$'!);( M,L/4:O`&E+;C'\+@`Y'I;E0:L(*L'PJA+N<$[\HODJ@.OYH\X2SO=U*$1@#1 MUWL:@>&*>C@>?F,JK_14Z'Q2#.Y"HZ_WLU;VSD*/EJV:A[GR2=.QCIZP?[ MU8!>S1_;E]:D,4Z/VT2T=/%RU1>UQ3_YGL4]U>`L``00E#@``!#D!``#=7>MOW#B2_WP' MW/_`RQVP#M`=V\GD9B8WLPO'CX&Q3MJ(/;-[&!P&:HEMZT8M]DAJQ[U__?$A MJ=622)%Z%.G]$*3=S:*JJ%\5BX^J^N$OS^L(/>$D#4G\XZO3-R>O$(Y]$H3Q MPX^O?KZ_FG_WZB]__K=__>'?Y_._?_QR@RZ(OUWC.$.?:)M5B`/T-
T>4_ MYK^$^"M.T"^B+T2[>O/-F_>(?OQ$XL#;S=`G;X=.OYFAMR>G;]')]Q^^^>[# M^Q-T^PG-YU,]XOV[#V_?3_B(TY,/)^\^G$SZB-,/I]]^>/]VG$?<;W&Z?\;[ MXAEO/WSS[8=W)^BL>$84QK\OO10CBH\X_?'58Y9M/AP??_WZ]D.3A M^.W)R;OCHN$KT?+#M/[ZKFA[>OSW3S=W_B->>_,P3C,O]O=4K)LVNM/O MO__^F/]*FZ;AAY33WQ#?RSAB._E"TA;LKWG1;,Z^FI^^G;\[??.\0OSY'[+=!O_X*@W7FXCQS;][3/"JG8DH28X9_7&,'[P,!^P!W\WI M,\0#_B/_^A5BC7[^1O12>0M<51T]>IX$NZ^9^*?_E>5 MNQOVV":+];'\_J`O003&XRU.0A)4DV@.\*/1CG]R3SHEX\ M5RC!N/V,^XUO20_WSWZL^E_^#%`1*$J$*)?BUH__<'\?@QY:$^YY*4@'=% MK+/D$$Q>XA?,T8\=\M]T:FHC.2AB`:(F6R M#IRR`?J5-[$`^S%YA<"R&@`%O@64QU)O.B: M.O?/?\4[)6#K;8$1VV15\O[SAHBW1+2I3=".R34L;B70:`)7AHNID'N^31+Z MR*LP];WH?["77,;!!;7W$O!*FX/A5\%P'0QY4R3:(M:8KH\"Q)K;@?%DS$.A MN0LN54!W8F5::WP51C@YI\][((G:%A^V!+;$=38E%HTW0T4[FT9X)(9A[6\K M&)K6MQT)4^'T/O'8N>/=;KTDC3'/V3]L`X;-.FOUEYS_CD0#.W`]X8E^5K-?46_:SO>4K<'1W`;RU(\Y)L_.2QX<[M('I][:$1+(=.&:CE>8)#- M=LWT<;UO;0G557:[4,$W-)U!]%B[(=4MT@: M=MP_,R*WE1K"*HQ#28;2S7>P`D5T.35+I#;WWH=LI)7#@?.Y1Z]*!0UA6I<;!+"?A57?ZA0CI#9QDJJ!$G MMP?^P=+Y[`/>DTX@2E:)S'C1@FP:P3%PXLS0$C^$<(4LQ03F/1:>DI25*VMV6HI^`86II%]H@3X3QVJ[,.-:A6ZXE3!U9.A7(R/J5P0B0H'5#R88)A099R MR0B7S,\O&WJ2%0V,!0`7"](\&.A6W4J8*!:X3?MNGQ#R_;]-B%TP9SM;NE@\OAKNN+(GJ)P&?!>!B]#/DGIAW@2832=O)<@BL&.W.@PFZ&/Y8[<1R]B M::-L[L=-(-\EO\,K%P[6+^\VCMVKZ4MW1A4\:8]XUH:?M(K_]@SQ"? M2]PXV6L'NNQ,3X)R4/U,MCBH&`LM%9700&NIE/46[+"VJ-+8#5TUEJ`XP;*H MKJ.,NBM*JT9_B]YV0!].=?D!GY'BRBA`U5;.=AT^XD#=+94UY3Z?7*VIZWC\ M0NIE![3K6MF%:RMKMFYUM*V)6K!P2_VT6#X\RXM4:S<8)1R;:TLKS@XM=$(! M>2:01Q(%.$G9CCM+!NU'6W:4<$L2'GV394FXW&;,S-V3SW042)S1$:&L/%S' M&:8HR+0"S49]$'!(VLB#U(SPVC\`B2?,4/D,E#\$59]"W4%T^!Q4/,B)C2+0 M,?L3.@KP*O3#[/4QY@^S'0DWA58U8^8F42G``*9],J+.6*5Z4]BPI":CC4B) M@W11O!55X32EJQ^+`4?:?*>"[_\\>7-RSDY/WL].O_N6'TFSO[Z;??ON;=$TY/*+RZ/[/%/LGL$G MJE&/Z-UI7CN*M;C`/EXOJ4^=?WN*:!<;[&?A$XYV;ZS%.@UZ]])E^V#F3>*; M!HK@U-6)H<*X=$]"9@`;,4HRZP>X\1D$/!C;BVZ],+B.S[U-2(%=X4RU`]I- M#+L5JB-,8W>N)$*,BKI;**>;'20+M+@_.E`L=B%^'L;(%W1VC=8H[RB4O"/' M;-K$LKID\O3M2&,O6=^(@)X';=?;B%50X[MJE)M-@A]QG%*OA;KC9(UO2)I^ MQMEB=>\]JT^)C'J"/CLR%+/E;*/H(8_\.N@#B4[0$>OF-;_2R!*YT+ZL'C>- M*'0>/74@=$3)+1Y,O4SI3.80&[`E'+:NS3`V1\*I^:>?P6XYV.QEK>%FIB\X M\\(8!Y=>PD"85CB^$'MEBLE(@QAT_M$2IH[8@@@55.BH"N*<\+6]"::75%41 M\DU/6U.(P_P;3!)38LNQ66!:45TR\_K6KV[9#4R?S6,ZHZ,VV\=E>D=>C?.M M6\_NZ;F6(.(<.FT_C4+'2'8>!6.B>XO@A&G6XO[CV22YA,\]V>)@D),]UJMST3&?6K:7=\U0?P$PR$[;"02/ M`Z.MDTY2:R'B$D%4\>)%EIA)#$R/>'%-$=IV(W`^,T8U\6+'UA[.B&LKR%ZE M;ZJ(>Z6RZ9B.]4/&[,';DW>Y-:!?_)8[#W>/&&=B,_$19Z'O18J`!3TZ$#N@ M*X+$9T*<"!U068T->''R!'F9)X_-=B,*=+9FT>SL?/QB&WOK,"UN;J&(>'$U M_?8\P>*89>.QA&W+'<*B/'&P39@%H`^CK3=L/J9_V4S&;Z1OA2DP4S8KD0F4 MI47"RQ,%_.[M+4YXY62%%Z%#;2M^02&.^AHU)42+!`E2<:F:52$4E;&="'$P M%RV/>BC#'=!1&*.`3JX>78U391)Q#"TW!"Q=$N_"HN+>>"<0K2B7J$%^5D:4 MZ"E5@\J6,K6PKU:BO(S\GL()Q=$7(U>81B20,QHB`Y1",Z1HLJ@1(EC%1!MR M"KN:4+*MHP5.AQ;U-O%/LK11'FK M9'8U^%``/215:!S292U)#A6:3"I(OX#-45Z+8T>_XXOGTEFOCE'H-&EM%@&R M#`V[P%[6Y-5([R&C`"Y.(V.[60"&!ROL*RN[D#)C(O9A*]HH@=,L;J-&#>"M M!R_"Z1?\A.,M_HF0(%47Y&AM#GLCH9WAQOT"U@SE[6:(M[1<=T.3\[R%M?BX MP6R"G@0KX-LXUU5A%])W3K/%BC/`3G]P\A3Z.+TCD7K9*R4"]IL5S#?]EY0' ML_+F_!RO($",PJ;/;"H%6:%$(,?>LM<-GK\7/,?X@6VIODRN[^$''-81[[(P M33>\T[S`&`A>W4@\%^1^-F>@=/A<3,5CUKF;`B' MD+K4`L:Z\K0A$3"[\P8G'CL$SRNZZM0`D=/`9GA6L-[(.ERT+4HINU$6I)$ M\MSLH,F3NY#32)_<"1O(,F7$MA/.*8\1732.@O681PR?EC>O)Q#U4I6KP/@ MHF::0C7KAW%"NLX5I-S9/B0N],9F&;2ATCU4I/,.B*TMED%E@JT!9Z)@S=)P M1MH%F1TDQ2P%)V7I@OKJ$>&E%KO-A9H..">(6H3F3HUHGR<;+2GL6X1!D@05 M25CU5GO)0"85`C9YA(9R-/-&Z&B&18?8Q!&V[`!K.;X.>;M:_$Z7"EBOLLFX M3%OUT+4]:=;],9"F+E_!B M`5RPD),<'^7;1*]G*+9Y;CV&2*4LQT*XJ432KW4&\X[`BZ%UVH+6FFC=AJ!W M*.)/7A@O8G;VOEA](C'>L1.X%L,D;PL6R4K7[J0./V(5R3)TW;?>\\XO7S.$H\D01A[R>XZ MP^O4.,W5E$^U<*MZJN&37&T6^PN(/1'M'XGVST3BH86>\,?.T,&#$7_RS+UD M6;`CRC+QLRT%M!0C)EQVE+%N;9E%ET<`_K[\I*:I_<[]M'8)VK93+O/IY2.. ML?K"G(S"@DUM8UMB#VG38D\>'>6M+?IEQOQ37:/:QQOM-POL6I]^W-N[0SS5 MF,/;.ZFZMMLJN:["V1EQK['C,*?2"-2:'##7-OG5:O.XE%]4:S>Y4T`^NWMI MG@K)9DX!/5;I!%O9C[%E!_5XS9TFB%1[9@;1!OM=;.CO#%)#%O-ZAC]MPX!% M+8\B!+Q);XI?M^(M9A%P_PYG>X]W8.9J\[Y@]_MZB-HY6[B?>GHLL<4<4LLN M[UJ"T17^QKIQK9S;PMM:4;2G6TLSB2]9HG)2G=I MK1=T^'=GR=#%;4!AB[:37%#?D#1D@0@O9$#-IT@3V_CII_LR#^]U_$2M`SNZ M3_EZV=*1N=)F*(V?K4MXY^I"N+=\P4N_3["7X@LL_M>)U1S>.?QEOJ&#T7[A M[URO<+H;@:'3#8.O46P<_-[9*/!OO9LV#O;M6X,KDN#P(3[?)M1#\'?WB1>G ME$-63B0.^%\1/X8Z"_YO*RRP6L0>-F-T%IRP+!,,;`_[DW.!"C90A0]^;[3" M"=JS4BT8[YZU`AC:GV/Z2\3R#[/-83Z$^-E_I$W$';_CHZA'Q(5=&?LY]8U[ MCQ7`>.7#;6YY0@^A[GPPF5T#S:A;EZK@<4AMJY;)8>PG0>?M'7F86I*NJIU, M8:L[#Q/E%3JMY@H&';VQ@\],(I1:DE//(FM=&)> MZ3='.&/O^]CN16Z[P79MAQMF+54@6:,]\(-J(J:,L:J== MZ@YF3AQ?0+=L@$21NDR!3(MZAZ'_#87`V**SU`1-J0MQ$[2-PZRHER>2AU1@D#UZ M&6(STC:EOU),^%[D;R,1!KUL6/G+VSN+^0M&L9_5/`?C&$_`A,-%L9[%JEFQ M76-QI$E`,_2:(+*1H-<( MCA;4[,['L9>$Y.PY5%T6;6]O1XUJ+$N1-4-%2XHEVM8%+1F1=RLZT`87*>9; ML0*(\?SQ/\?I!OOA*L3!!5E[8<-KJ0HJI8'%NH+U!F;RMC-4:8U^%>UM8GY" M&4"QWP6C!OX[,62E@O`GS%P_]6E4K:VM6L$EJZI2K>A7T M.#BA$C(-B([P3E!("X$HD$J:;-2]$0U0>-[D!*?6H-RM=*(<<HL$1*&F]D^:*5.>%@"9];;FVUHDK)1ETZE>5`"V9 M1]MNZ#H"*9VWT9)_M/M5`%JJ^D:^RCHUVL):I!96&U:(MYE53S:G"$[F00EW MF9=DG7L9&DQ_/+LY^WQ^.?&QHV#Z,NZ\ENT.R[K[16,!`W0ZDBE>8PJ2:EWO MNQ;[,)OTGD@6A%_P$XM]XA/@W29JS5S9OR^PNQ5]16UN!I3]L/O(M;T!5-D; MR'O+MYIX?W:N4HPE^KF7/K+3[RC$6W;FMDI$Z!:5-3](9TGCV%7?1/1VS+[X MZB4!2B>27NNN:N`?.X73Z M4QB3A*[5B]55$3;,\HI_P0%>;W@Z<84NZ_8`JL/Z8FDNHV>HZ`(QM*!*)^QR MW"T5X)']2)%?D%A4Y_[BG_E_;,.4ST#\^M]VF89!R`HQ%%K,I-?)0&='<0WQ M7%=84S!#GBIV.PG%=7,,&9B$8_X+%Z\5W.'D*?2SLT1?LDP>1 MR%9Y/@G#`?!))]2P]EXFY3[#G'.`JBS, M6(MA(KP#GG.JZ-CVJ32H3C?/MR$5NO[/TH5GYJ=>1>1K:G;/N4EFZWISFP#* M6\W<,^<4KEUF-A.%:(MBZ>:R%%J*"\MR7($FLV5LW";D*0QP\''W,U7WZ[BL M"GU&%W)/5)6QCL[TZ`PZ+:ZYL&WI1SD6BV[0QQTZ8CW1>?LU*CM#^]Z"K[@2\L7`OMZA5Y);CM[NC^B6?*Q]X6QI;C*?BDSS. MGM<_WH!UN/CE@U`S]S;]^24:%`L#F1%6*CD?R+C(`\W2XM///AO#(@;10<,T MI:8JW?NQU13.N%W@#7W?8>OY565D#YJ!&I,:@W7L5G^VIZAVF=1*'S&(14@E M;D-D7?E:X0BG-*SR.E/PHOHZ57&JU-GNE@YIQF[G;9A=4*B39@>@BJ8M5!TZ MC+"8:%ED"Z5FJ\F"'O$.4-F#/2WM+2$C8J(%8;HAJ1"SR'K<)!Y_' M$EA`>-M@IGAUJV&H=%NML)W:^ MY*Q7-[917BO6UF0^H0#@5P^EN&^]?R@'?>]+B,PL%";AAG@Q=>9Q^,0R1W[! M/`3HUJ-&0G+K4),8[)JAMC"ML_@BG[X7*\2(T9X:Y>2(T]NY1SA,-I9=*'=- M(B9;LI=M3O\0TFTFDD[GGF!O\5AN(;8\?^".&"^"0`5*MQ%?G?-=1.]`]G1& M%_!%3G*ON?I/`M$,^9&7IB*2W4O1(XZ"^8HD<]Z7E_&+@A'YBI,Y6E_2T*+! M>4GUV@O5K90TQ9G.YJI^'Z"^E(EH+:7LQ4-G4Y#TXL:$Y1,ZC M@OCU<5!<%J/*Z'$ZNWZ,,3+KKHTY+&VJW9FX2)[N+8.1QK606U:V5H$T]:R@ MK?A*+NF7EFBE#,DD,IAM8DPI@UVC(->;;GN@4)K>"Y\6J\,\-J/UCUD?8,L@ M4]%T)U7NT;JU*AHJJI#)N=704+'.16$X'@R5)#OF"#UYT18W@YR8'[]?I*1L M:<3*@P6T24*V#X]\`W3C[?C@?`VS1[X$P&B'O00=T74._9OUMC\0]7<^;1JR MY0'E(7GMSL(''BQ0"YY>QJRZ[NEGR6SZ8;<)9@%_%WB%&5XOQ9;>62QRU@C' MT<@ST^K0LJ^F*;2F0<][0WDW7-4%QL\DZPI[KEQ/R0L1\QW?5&27%O6!>1G$ M3+J&@MG,?MF2#G5NX66UZP2;&*UNM]C(8MFTU:SH5$R?%F(SDURELVQY#T70 M-+`5(I=L:9@MPTCW!KQA M1ZZL6JN1^,QGW/9?P=GD?Z\1I"/=NG#75=%O_H*FN MV)8-5;*E[W%O1TUM59W.66W[+(_@ND: M0P#KUDNB\%H&3*;M5M="O(Z`V)KM:\AD?=A>`4E%,SI6SWMPU;#I2RG$R1T# MAVR;"Q(,-6_CR6!YB:DV!QJKRPY;X&*"$X6Q,^C$T80F+1#LDO:KL)36F20S_1&MJ;@Z<(8L-T==:!X=N%A5;T!>X*5*595D MP*7GE`(T"]`5S5D4[,'];L1(["E87T'8_>:+;>RMPY3'*]IS5J:3`+848+=& M-`L":J@#G%+?YLS<$YZ1/,$'J3#.XD`GB8U!)Z`*;R1H%9KHTNU@QM>`JBR:0SLX(OZ+7U6*_9>GN0 M,X"Y^:S/!SUL)^#LD!`?XR!E91E$'@!1>5>T")&7.9)$?1(=(`J/5B<%P8(R<.=-EF^_"K27'PB,=XQ&V!9[TR!V5`[ M8U3V#JXM!G*Q*H(3SDFPL,,KT@B&!`Q"HRABS!E55_">(N#?/.F-0G8 MF+V#!>2.-QQ2Q%)E+/I&!YTCVGNIKWDV#*[#U4>@\AEVPG@!!H@J`, M7217HG1N9\EY/5JP-9:N*-(];[9.*BHG+Q*4T]HO(-]7,*X\14UT>>EDIZK% M]Y65K6_(-N-K&RJE;R0Z2V/TNE8QNI(G*<$;DG`G05H6?NK-5QU=49Q\5Y"7Z-:CDB?)KB7EZ;6^/8<@M`/C>]MN'>F@5; M<[E:83];K"Z??9X(\`N=7!8QX_=$5&]O![,I+"_1MV`VE]#`5O7)&U&=H9$ M'Z@E5M*>`1XH+?>**@EY';.XMJ2#M#E]%+)NW/IVOG>_RK#RLNQ8?T&>A)SMV>%TU2807MN M4,$.^I4QA#A'+]4^6AA\F2D==?!?C.T=8&9&-=-#;`R<16]RH^$4*HA`K:22 M>4GVND/(.^"-32H$I-9V0ZFN7QHX`BQ(/=0C<=&/Z#T!O8R9VI)XH/6B!\U@ MSLX[K=>B4SI3TA\V)/6BGQ*RW>A,1J8]@>J?N9AUI+;':XC:)T4G2/3BQ'3F MCL206MH3SG5U[8ME4+VM,')=5-1N9WSO`NO,GX.[AM;LH0/1`OPJN&>H[%42 MM46;5-9X;DS)+VU<@*W$*,K38C;&T1S;9Z4:TWT'H0/GH5TWV]M.0)V8NH'$ ML7\"V#4-:V+,MK:83:_Z?3B@0WH3@QQ_SDV+EL6TKW,&TYDY4GM'PMP0+T[; MR]TJYB)=2K`H&#TQZKCB5-+*WE:G)"M"004Y&("N&N)@@K@I%$(UR6B3NJ`2 M*EO;!1^KD\F+E4LG"*RG8"P&C/;,(N,B5NNW!%HN`TFKY]A#; M3%5AHFZ:ML#FJJZLR%HY_-2I?2BG`B[SH6)?6G[VP`US8!TWL1BP120Z`=4L M&]&-)JL:H;-84Y+9U@F5.6Y'DQ-+L.DEL:P9G0LK+53U=AVOXPPG:584HK^. M?;+&BZ2H3Z]>3FD2@[F/VL(T8<,)^7I=E.,1M"RY0$YM?65E33@HM\H,BE7' MRA"'$RE+UU)+E]H1=5&;60U(65]UO6CY=%9?_064+\!"UB?.92_3!(JO0C$( M/`='7I'1,/N&&[9$N4HS55/8ZS?B32U6YV3-^.'HR!>2YR3-TCN6(F3II6Q= MN=.-%QK8,?CEG$&#T'9S)+=SC^R?E&9BLB%M>.48T)T MQF2I/R;0%WR&*TS;?9\1M,5!N_&QRK#F[9]!/;MI.:3#,+;I<&*%/>FP]+(> MSBS71U*:67HH@"\XT/.T)%3];W"=R3&LKI'P#KZ@)@"*8A5+)KGZ%7 M5RXJI3(6Q!2?UGZ M7:9A$'J)W7/E(3:@IP&SN9UQ-0)\D7D1/>&12^/9FD[JRB>V!5 M5P,G.1(OZ]'?L/1@*5VAKT-1;(WEA,#^-@E9/=P-2<.NY7&OKL!<\9Z"-M*> M%-T@T0^J="1RF.1=H;POZTMDQP2']S2'0+SJ:0["-XB"=BV6^_7EI(HJ4Q.9 M0]7Z@GE\V2/>T8PN_@Z%3POA`QCA=1;-8TDO7S43XW&QN#8>I/-]39;-U?%- M&+/C@00'87;E^6$4*J.;M,A`??@.`1JQ#K0Y/T7C!*B@<&(YW$<48B8*I$.N M`ZVZ!ZZ%J_X!3"V]=T8N*6G@0I8Z6-?&N?7YMI29/,,)VO$HY/B!_$'WTNEV-]Z$?*2A.74%O/FUS![I!-JS#9?9^S&7)[T M(L(9NU>V'[`92C,ZR2YW;3^QV3?!3R1Z8K3Y"%>?8S/\24=9#^*>M#05,&G< M=IGB/[9T&"^?-&_(24E@$\/)&6\<$Y5-D6CKQ$0ZF0"@R=TZX--(Y]:%'7O( MU\J0**6QBGWE&6D3.TYL]DXI@TT-Z,YHV(DA4QV@2],W#^3I.,"A@#_]4$<] M_>JW2SJK9[N_X2CZ:TR^QG=TT4=B'%RGZ18G+:COI@%!O0[KC0)#O#UB!//? M&04J2)"@@0<^D!@0V-<&4X%]?21-B_U?2+2EWG*RNPHCZF4J,5]O"XSU)JL2 M<)0-D6AI$]DC,@V+8PDPFOB5H6):W)YODX3.%5^*H"*6I'VKAJ^$!!C%4L8E MN,C;HY(`"0J;H)Y.!EB,JT'4A'H'@J9%_.UV&87^542\MJ5H>SM@;!^R*`&# M:(1X*YL@'H%96+2V`*`)T;:W#YC4D*PW"7[$<1H^81$;^1EGB]6]]WR694FX MW&8LM\T]:;]OJ%AG#NT9-@'BX&%HY`NL]EB$&Q_=D#1]/4.L$4$9IJHOFJ0C\$-[?7/ M]#/]CP7DTE_^'U!+`P04````"`#]@:Y`?[LM8^(4``#M0P$`%``<`&UG="TR M,#$R,#,S,5]P&UL550)``/^9[%/_F>Q3W5X"P`!!"4.```$.0$``.T] MVW+C-K+/>ZKV'W2\K_'8DF>2V#5SMF1+FJAB6UI),V?SQ())2,:&(A6`M*U\ M_0*DJ"MQ(RF!9/R2.`JZV3>@@>Y&X_,_W^9NXP5B@GSORUGSP^59`WJV[R!O M]N7LVZ1W_O/9/__O[__S^7_/S_]].[IO='P[G$,O:#S0,5,$G<8K"IX;W3_/ MOR/X"G'C>XRK05%]^/CA4X/^^>![#EC^T'@`RT;SXP^-UF6SU;B\OOGX\\VG MR\;PH7%^?JQ/?+JZ:7TZXB>:ES>75S>71_U$\Z;YT\VG5C&?F(20;+[Q*?E& MZ^;C3S=7EXUV\@T7>;\_`0(;U#X\\N7L.0@6-Q<7KZ^O']Z>L/O!Q[.+UN7E MU44R\"P>>?-&T,[HUZMD;//BWP_W8_L9SL$Y\D@`/'L#Q="DP36OKZ\OHO]+ MAQ)T0R+X>]\&062Q4KH:W!'LO\Z38>?LI_-FZ_RJ^>&-.&=4!G_[C'T7CN"T M$7W_)E@NX)A%/K+&`0@@0SZ8]I!'Y8^`._0)8KCO M7$!(9$42`A61Y"3U%KC,/L;/$`9#@.GGGF&`;.!*J./#R0D2(KX;/':ZC^-N MA_XQ'MSW.^U)MS.>T'\^=!\GXT%O,.R.VI,^_;_M1SKH83CJ_D(!^M^[]X/Q M6,)N7NQ'96[0&T\&=[_^,KCO=$?C3K?7O^M/NO_ZUI_\EHLM$=[B+/T.D.>> MZ[^2ON<@#.U`W;X/07.2-<`SX*$_H\E\"P@B@^D00T(_%OU$Y_P]^B-$#IWV M$BIU,.6593B?`[P<3,=HYM');0.Z.MFV']+ER9L-?1?9"!*95-60Y"2U@UX@ M"6+E];WD;T*ET4'$]MFW0NBT[0"]T/5*2K0VNISD,WNCR-F_NE1Y+\!EGY/- MW72@G*3<^\`C(VA#BO")X7#IK'#HBBJU3!%D3J*8#KS`QS(2-N-R?S"`=%8Q M9SR@C@3WZ=9X#IEK?EM`C\B652EX[E7.MW^GLQ\Z=_Z<85398'"`BB#EV7<= MNN5D9A@L*9N/=$=`9PE%2D%GB314Z%/$E)/H;=N<8&JVP&:RD,TX+EA>[["` M&+#E\!Y2]1"JGCE:KSAC:(>8"J,#%VRS)7,/.JCR+A7(@]178DB=30_8R)5[ MKU20W&[JB<`_0LIC]T5AV3P8KO?YM%.%BW&,VX,S9B#L3''-SA3-'R,*5S_? M@R>8LHW=/Z!<[^"*@4Y&XQ!BY-,#2#9B]Z!/3#7=P.$@!]U;\">C?.('P,U$ M\Q;DR:A]A-GDNX8[G5RI$X'9Y+J!+)3:X)!2;6'N2'&QM>VGZ^KO.P3"MP!Z M#CO3Q[\R!!GB#NQ#?_OL^O8.?N)!!BP8UF,QF6\1<@M M55#K,I:%(HDK]B/13@%YBN0;DO,9``LJYV;S`KH!27YAW#3/+YNKR-`_5C]; MZW/BA&US4ZA/'V@U$UJW%=?&NW0#;"<8Z9\[6CL,9*U&7"RB>,>Y_8SI`D8JK]A$%.S4T*=_*LW-]6#K8UE4J3HQMTE/E-W^?.Y[48A\_$PY M)8,P8)44C$CQ.B\`M)J7%5&'&B^)DCZ=7$G)^7I"T7+4L3W$:IH*!N@*?I_J M1,0_GES$;4J&PTCIN8!G\CMCK&9I3N82(1^0G4CY)V.&O([D"W8RJ6.M9FE. MT(JF?4!^(OV?C4D_WEO%A/7H;VD'7^%XJUF:PZ^B%E)92#1Q;5@3;)>KKH?U M:*M9E?.L@('-P2I="9\O]A,1168G%(L.S<6F4N@2)#9TP-^3&UD,72S0OVJ" M(V,$M30;*/T(:G%Y#<,Z;!,"`Z*PINP.+$\B8T"-YSD.M9>N955N:J+\597S5DGL(PQ6P5/1-!:`&<^/J*I: MPD2YDEO953S$<`%04M6;5/O&0I)K6@':>%I&5>%JO/#S`]72^[K.G%JU0,'; MPXRG=U0UN4;_>HYJ]+BO)5GVC M-#.T-]1JF@Y5'4&MG#12"NMUV0@Z#HH)'P+D]+T[L$!T.=SB6+0CE`);3=/1 MKY,9B9HPZK*]I'OHH%Q\YE[GY!'&`RF$_`F/E;H M8+):IJ-PI[,H?Z`'M4:&1+%!TX1;8P;BL'MEJFPX,G,R(U M8=0EYW8H5JTML=4R'WL\D5VD,U^/+-X#\GPFV2?(4(\>C'::ME.G)J<+W)*K#"4IFER9-YCI;?DH%:+=,1VZP9-!XW1XOU M'?R"]-[=Z;V[U MWMRJI&OL5CB9>IT!CIAUHJS$$.*H1X5:#H<';?S"A\H%8CU^:N)>#WJ1M,/@ MF9[@_]QL1<4JWX9>2(Z8?CGO#S/J9DX!X92QNN5:=0.,2!>`\4:$P5O@S_JB&" MC&>0R@4'[NO7'F(,7$A&\`5Z(?SJ^PX1WXU+&UZ>L(!"@)K#0$VT>>>38#"- M^(K>Z\$OR(9D[+OB327KCMM9XZ\ MJ*M[@%[@^KD_OD-50F`\`"#4)_XND_*%6`QHO@F%EH:EO)@O#DVMA?H*D#?PV"E],'WP/;B^291(*;+9*828A&_7H#;/Q'3TJJKOX57O*[LJY^!ZYA5,? MK^XV3<`;)-TWNL.@S",/X&4D0>U2[2-^U7SG"QT+.[(@^(\85,]&*?.KV7=+ M#Z/BT!D'PGS?#'W;2&6"_R2"JEZY[XN?NK,JY9C:.]RK&D$9&EAD5/!V`XIFM>,H MVJNRZ2A8UE5YJ_=#_FM,$!ON+";I11"_JD1_QQ`0V('QOU7R6+F1EZ%!A&;4 M)3>_:\O*'8G(KRF#5)5.C2Y6\$21S;S,M^0P93K;O36JW50UZ765W`%4 M.'?P0*K52T/$Q=KE5+VWSSZ3MX`@FU4.(3<,A'?E))!6RW3$5Z@_-96G\&1\ M>YR:MO]_>@QXIA2V*5HP@X_A_`GBP71U4VS_DIANQOTQI/!W:^_#.X[W=&XT^WU[_J3[K^^]2>_&7VV^;"WD=Z[S7SX]\MX M61RJ1**N_?40)GO37S$37QR%U*9/_SJ`\7M]FCKF2 M,%/8G1%36DY/H4B5+`(S?I%/4\<27@J[>U+5QICEN[*>-U08`!I]!>V9N129FI> M:5,X1B8^YWS)NCEA`N-^A`LW]7I/9EREO'9XJ-]<_-6E?"3B*NXVV@DQ6]-B M>XQL_H!S\;Y`"U,I;PY*O(`>=W7IU[/_3%)2;,/N4(Z@`^<16R+34,10R@N# M?)/0X*JPH[[I1R\5ELND"`,Z+)H%/1(I,9H;@U@B(TBW400%<-5P+IY*(VC[ M,R_"*`S^GH2"4MY]Y)OB":5BO@>&H6M7I0D[JAC$+N%U:8[Q5[H<4\:[F7Q[ M.Z58BFL%8O(2866"-:6)U9XR6'-=7#./^(#?]8S=#<\7JRGC95*=6,W6Y=#L M_3L$JCQNG>=6J=X=(,\]UW\E?!> M=:W7S)BU*DT0^B_\E`+=[3%+IL>5%T07Q-OE-WH^[7OK9IMMNE=\B9_&E:\S M^LC*4]AYK]0`19^]FMB)[FG==&PYFZZD9_F/A>G3@5,4!W6^ALAA#_F:#B>R M.)-G(Q?N-/J9^,6M#\?XG/%ZTR(M[4@"JDM]10=2]JU1$LP=:G9.&2Z M;=M^2"6^F4Q:QG0(;KZB5T^SJM:1SFGN76W>E2;5[Z1(@.5DM=R/%@[S5;QY ME)Z)W;KL1`\9'V*X`,CIK)A8]_&UQ%B:6HN$"D+S=<+'6394><^_@RVK M.?6]%RI]'R/A`V]".//UP<4^(W(=,UB#]Q\P>UQ+2.%W;KDY3CGN+CH.,AJ(AP,E:-!]\+JF=< M,3GQV_8?(<)PI_JA[3DJ927J2,P_!U*HD>@Q7I>H/672AM")WBZ.,^+Q#:<' M&#RSFW),DI%8Q"6R:CC,OP)2K,7H\&U^JYN:X8OR4@NV,":9A3O?(U0V\=O5 M/1_'G,4Q)L9I!Q$[?N0:.NLWKCFYOX*PFW\NI!"[*5@B=6D%HB[;0G:XYM\C M*701TF.\L#1`&<]&/>0!>@XMYFPD0&;^29,"SD82_M;NJE3>*MFCT65RU1YI M@.G?KP`[TJYC2K!6RW3`-J.Z#CV-,K\U.?VH"ZZ0QD4V@'=M;_9S\";P1$UWX''Q$!/>^Q?;#O_0K=CXN./#AKKRG3D5NOA.TW. MUCO2:F](TQG4[NJC@\:ZJE*X59>S]:ZSRJM%.M-MNFQBO*0KY'?@AOKFL`=O M79D.O.:W@Q26UBF9ZC`9\!#?T9HV)./A%TM MW%(,)051UAT4+$_?06>;.!9-\EWD)&1M4SF8KK9SP%VK5^6$7`A^(SUYK^[MR/V^POD@YZD[39"CR=OKM(6O)H1>#")\#]BOUPH3+O-#$9F8R[ MI*R;=*:3OO$!*M,T+VKC$UA??YQ978`DJCK?.:'!LIQ!Y9-8#&ADSJ:3I#LUNU@K#L*Y6IXW<2C`+9@VBI":\T:70-$,4`4U9OCJ(DQ) M82IR5E6#3V[M&@@9K3^]=1)6N3/)A3+B.U+H47$7(C#C'D(L8XY[D'!4W0D2 MM\Y/NAS$ETM8*6[<_2"W6X@^L(]_@)/F"F+/H`9`EU_JHZ#Z)ZG<,F?T:B"?'J,IAN4[)RS'<^"4C46N^)T9H4("D&%[(C-A5K M4"/Y=IMDQ5!#'LS&/5AN9?(##SGE4NGYO_,`#5WL'J.\Q\';/7E]#>];*2_: M2/QC!DQ%.$N-S\H\9Q941MUH-I&G^-2,G%=U@NV<+#?/B1D([?$H47"B,E`C M;I)'E-Z)30.+GH`:.@]/CLJIS;=-7@I4'$NK)YVB=-]MK797;F^E\3.+. MLJ`JPI_I?%?FT#+A,NK1,DH]Q:5EY;VJ\XR"LHTR)0\%/6"SKBL&`HUI5"CX M,A%8(>'V%/S2.+L(QKC;D4@L+;HNX:>JAC\.GPC$Z28NB]F\K/[%*@\9\@! M,5/4M$>,4AT3#\;XS!"(EK,1$_%RXEGQ^8)1R"(E]#_^"U!+`P04````"`#] M@:Y`,XV1Z%8)``!40@``$``<`&UG="TR,#$R,#,S,2YXO' MUC@GREINMX?#84%+M,U=F?*25!+O7W\SE&0IMJ3(<8IFSP<$"27._.9%COB8 M7/QXO_#)+9.*!^*RUCQJU`@3;N!Q,;NL?1KWZ^]J/[[_^]\NOJO7OWP8#4DW M<,,%$YI<`.\=?JN==8@-U>D7O]:(LY.6L>G7U%$L]%JG+0:9U]31+/5?-LZ M.WX>$>.0J53&62+CN'7ZMG72(.U$AG+G;$&)IG+&]#5=,+6D+KNLS;5>MBQK M,=-';K"PD+MQ,SU*4?R$6736GHZ\O:'R'UC6(U`L-,J!:PE4`8FG7_ MW=W=T=W)42!G0-)H6E^NAHY1*@'SN?C]`?7]1/H)_8F%W1.J6$*.O5XJ/DM\ M9D6=:U*_!/?+$("SH+R$F`NEJ7!3);:4CDULGI^?6Z8W(15L1C7S"L'/+1GX MS(K)$JY0U6>4+M=<4ZHFAB/N0'WPA*5.M2YF@T[))Z%F*F%S@U!H MN7KH4,7W>>3X\].0QOEDSEAL;TY,G02UD@!'IR&"2;%@ZT M-Q;TIE%82N8^,C"I=,W8G%)7U]G]TJ>"ZD"N^O"\]EP@1+C(!_&TM-`T"XCJ M0,4D=]-IH1^?$JF4QT7$$#T7EU0(0)-->3,]Q=TN>1B&N#[5Z\N<&:V$'T, M3`0;GT:#K5QFQ"=IN2V\GM!FW?ETU;L>D_9UE\#?P?A?9'#=MT=7[?'`OKZP-A&RP*%BGBW>FS9$5`&D M$8_)+>:,28JX4N#J/"[UW=`O$Q2_2CR]N_<=L,-\B>QIGPO(O9SZ-X$RBG9\ MJE3\0<(X5*0MCL@QA&$-`NV.?=WM73N]+K8<>SCHML?P\*$];%]W>L3YV.N- MG0,-S`?JXY?0F3.F;RAD>3UGFH/@*!;%W<7N/WF*^\F_'\#_YT##L?95UE7. M&'YC3G'LOGW3&YE$XD!^Z=A7-Z/>1V`8?.X-;<>)@K8O2'%H3ZN%-I5%[#Y) MI9F<^$`>08'_CW5.F.R^,[8[__QH#[N]D=/M]0>=P;CW\R?XGE2)^JN+*G-QG[8,4WY'^$W(-%7Q2=71B*@_46 MUX-!SE^.>UTRD:K3%47JW&:48$2.C4DQ"UZ!D&:,>:'BZ'#?>4?(: MB*2M8%:@'P/T4..3W%7J[V=CT-K*:/.5B@Z4@!^KM84"%&C&7@1\F/ALQ'X]B8$.3 M?$[*"(K]WMSTNX$A: M@3UX^&7#)EP.!'0Q/`J[7S*!Y_61:Q^A*O;XR;;'(RR32`)$@[R-<,0BW[,( M[X<#C8:C`_=W6'TPJ M_"#J%0SHZT!T8$D"!(`T2\9J)@(5&8K#+=X>YH82QVF5+/*2/]\^[`2WP"_Q@260)O9HF)PXD7H!QHR MP&7VM".9QW6?NMQ?'VWD]A2'8&MWC/RXR7(-`IG&$`?J9R><*,C58$_O-MUB M;;TM]N_65C;E)>SV?W)3A;]P]3%B4V***UIXYWM94WRQ]+$HP[R;F]MO<'8] MJ47Y%>P[NE_X"05BEU1YF/ALNB26FT#$=^+EM1\`$D#>P3,)*]&]9CV+1>#[ M72UZ&*X79H]/)[O:`RS,?X&FP!#?U92-6?',!EU82?$#M-*2"*R0`%L"J8G8 MJ@@KJWV*BLF&@6MP2ECPJ9[PU?%5O7EW2LOTFT7!=96[:A`PK>C`OD5 M915%)PPH\ZR*M-+"K@*A1F`NH\5\K9(W]12JLMTEE5)ERN2PQ>U]E,BK/JNB M198O>=A+C[QJMDJ*9!G73_NHLE7T5D6--9-I[2-^NQBNBOR4*VKNH\%F=5T5 M^0D/-O:2O5ET5TEXPF1:.XI_K%BT2E;RI7S`A:GI'--A\\U>*E1,BAGQ>F_1 MY16)5=7)HO12D!VU*RU>K3(R$AYL[#,NMFH@*SEBDVN?V.07>NZF12"NRQ2) MZ]*-)N65E^V)TI(F51.P0ONU&G6TRC.5X"UXAV=RFBUP*U(C-*:ZK&D9XAK0 M4,&RBP?>V/!YH8R/7`7W?;QK26@5;,]`:(B]/\D@7"9".,#G6E=80[=M6@72 MEV/73Y0+6SC49_;T*A!LA?DHM:6@.ZO_`EYK*E=Y%DRIKQXQ(>J;1#Z[K$4' M$L]AV2^,S^:06]NW3-(9@Y$\8=*>XBE6()PY!$;9H<;U,/Y'#M:'N.86VP]U M4L2*'M@3YD&D#?43_;2_0]K>;V%\H3X.VIYGMI_4OZ'<&X@.77)-_1'#?UAB MYA3;6?H\,ZR?R%X^5,JM*'5(@??6(\ECDYR!A(X!UZQ_2J8#7M26W0=OSH\R M^K_"A!D(P(*]69=%?P?"7`\^YH(=V?X*GC"Z+[6RIUTV9;!#\#J!4-QCD>1^ M(*.(MY5B6O5EL,@6O\3'V\E5'_KHV0"_GO?RI\L3G'=#5R9)@%%Q.K`EM.^H M]/+22D7R;Y9&"D95G$)U0B?CDKA1)UQ^Q>?_`A6)6,RU!'UD7_ MK]32R?MO]H4T%[Z;A1&VC.LBMB-8E;XLB,\R=".#*PW1Q3W5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`/V!KD"8Y^6N5PD``%%U M```4`!@```````$```"D@4M/``!M9W0M,C`Q,C`S,S%?8V%L+GAM;%54!0`# M_F>Q3W5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`/V!KD#V!>__6P\``*WC M```4`!@```````$```"D@?!8``!M9W0M,C`Q,C`S,S%?9&5F+GAM;%54!0`# M_F>Q3W5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`/V!KD"TZJ5I[28```TX M`@`4`!@```````$```"D@9EH``!M9W0M,C`Q,C`S,S%?;&%B+GAM;%54!0`# M_F>Q3W5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`/V!KD!_NRUCXA0``.U# M`0`4`!@```````$```"D@=2/``!M9W0M,C`Q,C`S,S%?<')E+GAM;%54!0`# M_F>Q3W5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`/V!KD`SC9'H5@D``%1" M```0`!@```````$```"D@02E``!M9W0M,C`Q,C`S,S$N>'-D550%``/^9[%/ E=7@+``$$)0X```0Y`0``4$L%!@`````&``8`%`(``*2N```````` ` end XML 14 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6

Divestment of investments
3 Months Ended

Mar. 31, 2012

Discontinued Operations and Disposal Groups [Abstract]

Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]
3. Divestment of investments

On March 31, 2010, the Company sold its stock in Medicexchange and various non-core investments for consideration of £750 ($1,136). This consideration was deferred and to be paid in installments, with the final installment of £244 ($370) paid in March 2011.

In Fiscal 2009, we purchased 49% of the share capital of Moneygate Group Limited (“Moneygate”), which was accounted for under the equity method. In March 2011, we sold our entire interest in Moneygate to Committed Capital Nominees Limited for total consideration of £250 ($401), resulting in a gain on sale of £51 ($81).

X

- Details

Name: us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for the facts and circumstances leading to the completed or expected disposal, manner and timing of disposal, the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and pretax profit or loss reported in discontinued operations, the segment in which the disposal group was reported, and the classification (whether sold or classified as held for sale) and carrying value of the assets and liabilities comprising the disposal group. Includes all disposal groups, including those classified as components of the entity (discontinued operations).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6391110&loc=d3e2941-110230

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1436-107760

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6390789&loc=d3e2443-110228

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 144

-Paragraph 43-48

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1474-107760

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1020-107759

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1510-107760

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1012-107759

+ Details

Name: us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

EXCEL 15 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]F.&,U,C$T8E\W,C)B7S0V,&1?831C8U\Y9#`R M,3-D.6$S8S,B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-/3D1%3E-%1%]#3TY33TQ)1$%4141?4U1!5$5- M13$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=OF%T:6]N7V)A#I%>&-E;%=O M5]O9E]S:6=N:69I8V%N=%]A8V-O=6YT/"]X.DYA;64^#0H@("`@ M/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-A M#I7;W)K M#I7;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/E)E;&%T961?<&%R='E?=')A;G-A8W1I;VYS M/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O6QE M#I!8W1I=F53:&5E=#X-"B`@/'@Z4')O=&5C=%-T M#I0#I0#I0&UL/CPA6V5N9&EF72TM/@T*/"]H96%D/@T*("`\ M8F]D>3X-"B`@(#QP/E1H:7,@<&%G92!S:&]U;&0@8F4@;W!E;F5D('=I=&@@ M36EC'1087)T7V8X8S4R,31B7S'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA2!#96YT3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,#`P M,3`P,38P,3QS<&%N/CPO'0^+2TQ,BTS,3QS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^;6=T/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,3`M43QS<&%N/CPO'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^43$\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%]F.&,U,C$T8E\W,C)B7S0V,&1?831C8U\Y9#`R,3-D.6$S8S,-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9CAC-3(Q-&)?-S(R8E\T-C!D M7V$T8V-?.60P,C$S9#EA,V,S+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'!E;G-E6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'!E;G-EF5D.R`R+#$P-2PQ.#<@86YD(#(L,3`X+#3PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F.&,U,C$T8E\W M,C)B7S0V,&1?831C8U\Y9#`R,3-D.6$S8S,-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO9CAC-3(Q-&)?-S(R8E\T-C!D7V$T8V-?.60P,C$S9#EA M,V,S+U=O'0O:'1M;#L@8VAA'!E M;G-E*2]I;F-O;64L(&YE=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S"!B M96YE9FET+RAE>'!E;G-E*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S&-H86YG92!G M86EN+RAL;W-S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]F.&,U,C$T8E\W,C)B7S0V,&1?831C8U\Y M9#`R,3-D.6$S8S,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9CAC M-3(Q-&)?-S(R8E\T-C!D7V$T8V-?.60P,C$S9#EA,V,S+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$2!S:&%R97,@9G)O;2!N;VXM8V]N M=')O;&QI;F<@:6YT97)E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%]F.&,U,C$T8E\W,C)B7S0V,&1?831C8U\Y9#`R,3-D.6$S M8S,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9CAC-3(Q-&)?-S(R M8E\T-C!D7V$T8V-?.60P,C$S9#EA,V,S+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!E M;G-E6%B;&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M/B@Q,"D\2!A;F0@ M97%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q,"D\ M'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'`@3LG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@ M=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;CLG/E1H M92!A8V-O;7!A;GEI;F<@=6YA=61I=&5D(&-O;F1E;G-E9"!C;VYS;VQI9&%T M960@9FEN86YC:6%L('-T871E;65N=',@;V8@34=4($-A<&ET86P@26YV97-T M;65N=',L($EN8RX@*"8C.#(R,#M-1U0F(S@R,C$[+"`F(S@R,C`[=&AE($-O M;7!A;GDF(S@R,C$[+"`F(S@R,C`[=&AE($=R;W5P)B,X,C(Q.RP@)B,X,C(P M.W=E)B,X,C(Q.RP@)B,X,C(P.W5S)B,X,C(Q.RD@:&%V92!B965N('!R97!A M2P@=&AE>2!D;R!N;W0@:6YC;'5D92!A;&P@;V8@=&AE(&EN9F]R;6%T:6]N M(&%N9"!N;W1E2!A8V-O=6YT:6YG('!R:6YC:7!L97,@ M9V5N97)A;&QY(&%C8V5P=&5D(&EN('1H92!5;FET960@4W1A=&5S(&]F($%M M97)I8V$N($EN('1H92!O<&EN:6]N(&]F(&UA;F%G96UE;G0L(&%L;"!A9&IU M2!B92!E>'!E8W1E9"!F;W(@86YY('-U8G-E<75E;G0@ M<75A28C.#(Q M-SMS($%N;G5A;"!297!O3L@=&5X M="UI;F1E;G0Z(#`N-6EN.R<^)B,Q-C`[/"]P/@T*/'`@3L@=&5X="UI;F1E;G0Z(#`N M-6EN.R<^34=4($-A<&ET86P@26YV97-T;65N=',L($EN8RX@:7,@82!H;VQD M:6YG(&-O;7!A;GD@8V]M<')I2UO=VYE9"!S=6)S:61I87)Y.B8C,38P.R8C M,38P.TU'5"!#87!I=&%L($EN=F5S=&UE;G1S("A5+DLN*2!,:6UI=&5D+B!- M1U0@8VQO'!E;G-E(')E9'5C=&EO;B!P;&%N.B!-961I M8W-I9VAT($YO;6EN965S($QI;6ET960L($U'5"!);G9E2!O9B!-1U0@0V%P:71A;"!);G9E6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T M:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;CLG/B8C,38P.SPO<#X-"CQT86)L92!S M='EL93TS1"=M87)G:6XM=&]P.B`P<'0[('=I9'1H.B`Q,#`E.R!F;VYT.B`Q M,'!T('1I;65S(&YE=R!R;VUA;BP@=&EM97,L('-E6QE/3-$)W9E6QE/3-$)W1E>'0M86QI M9VXZ(&IU2!C;VUP86YY(&9O8W5S:6YG(&]N(&UE9&EC86P@ M:6UA9VEN9R!S;V9T=V%R92!D979E;&]P;65N="!A;F0@;65D:6-A;"!H87)D M=V%R92!D979I8V5S+B!4:&4@0V]M<&%N>2!C;VUM97)C:6%L:7IE2!D971E8W1I;VX@86YD(&UE87-U7!S+B8C,38P.U1H92!#040@'0@8V]U2!A;F0@86-C;W5N=&EN9R!C;W-TF5D('9I82!A(&=L;V)A;"!D:7-T6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q-RXX-7!T.R<^/"]T9#X-"CQT M9"!S='EL93TS1"=W:61T:#H@,36QE/3-$)V9O M;G0Z(#$P<'0@3LG/CQF;VYT('-T>6QE/3-$)V9O M;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE28C.#(Q-SMS('-T M;V-K:&]L9&5R&-H86YG92!R871I;R!O9B`Q+69O2!F;VQL;W=E9"!B>2!A(&9O28C.#(Q-SMS(&]U='-T86YD:6YG($-O;6UO;B!3 M=&]C:RXF(S$V,#L@5&AE(&%M96YD;65N="!D:60@;F]T(&-H86YG92!T:&4@ M<&%R('9A;'5E('!E6UE;G0@:6YS=&5A M9"!O9B!F6QE/3-$)V9O;G0Z(#$P M<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q-RXX-7!T.R<^/&9O;G0^)B,Q.#,[/"]F;VYT M/CPO=&0^#0H\=&0@3LG/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE&ES=&EN9R!O2!S:&%R97,@;V8@)B,Q-C,[,"XP M-2!P87(@=F%L=64@<&5R('-H87)E(&EN=&\@,2!N97<@;W)D:6YA2!3:&%R97,F(S@R,C$[*2!A M;F0@9F]R($U'5"!T;R!A8W%U:7)E(&%L;"!.97<@3W)D:6YA'0M86QI9VXZ(&IU3LG/E1H92!E>&-H86YG92!R871I;R!F;W(@=&AE(%)E=F5R6UE;G0@9F]R(&9R86-T:6]N86P@2!P87-S960@6QE/3-$)V9O;G0Z M(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I M;CLG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@ M;F5W(')O;6%N+"!T:6UE'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;CLG/E1H92!#;VUP M86YY(&AA2!H87,@9V5N97)A=&5D(&YE9V%T:79E(&-A2!B87-E9"!O;B!N97<@=&5C M:&YO;&]G>2!A;F0@:71S('!R:6UA2!C;VYS=6UE3LG/B8C,38P.SPO<#X-"CQP('-T M>6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU'0M M:6YD96YT.B`P+C5I;CLG/D%T($UA2XF(S$V M,#M-86YA9V5M96YT(&)E;&EE=F5S('1H870@=&AE(&-U2!T;R!M86EN=&%I;B!I=',@;W!E7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W M(')O;6%N+"!T:6UE'0M86QI M9VXZ(&IU2!O9B!S:6=N:69I8V%N="!A8V-O=6YT:6YG('!O;&EC:65S/"]B/CPO M<#X-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T M:6UE'0M86QI9VXZ(&IU3LG/CQI/E!R:6YC:7!L97,\+VD^(&]F M(#QI/F-O;G-O;&ED871I;VX\+VD^/"]P/@T*/'`@6QE/3-$)V9O;G0Z(#$P<'0@ M=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;CLG/E1H M92!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',@:6YC;'5D92!T M:&4@86-C;W5N=',@;V8@;W5R($-O;7!A;GD@<&QU2!-961I8W-I9VAT+B8C,38P.R8C,38P.U1H92!F=6YC=&EO;F%L(&-U2!O=VYE9"!S=6)S:61I87)Y(&ES('1H96ER M(&QO8V%L(&-U2!T6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU3L@=&5X="UI;F1E;G0Z(#`N-6EN.R<^5&AE('!R97!A2!A M8V-E<'1E9"!I;B!T:&4@56YI=&5D(%-T871E3LG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$ M)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z M(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU2!C;VYS:61E3L@=&5X="UI M;F1E;G0Z(#`N-6EN.R<^)B,Q-C`[/"]P/@T*/'`@3LG/CQI/E)E=F5N=64@4F5C;V=N M:71I;VX\+VD^/"]P/@T*/'`@3LG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)V9O;G0Z M(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N M+"!T:6UE'0M86QI9VXZ(&IU M2!R96-O9VYI>F5S(')E=F5N=64@=VAE;B!I="!I2!I3L@=&5X="UI;F1E;G0Z(#`N-6EN.R<^4V]F M='=A6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N M+"!T:6UE'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P+C5I;CLG/B8C,38P.SPO<#X-"CQP('-T M>6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU'0M M:6YD96YT.B`P+C5I;CLG/E1H92!#;VUP86YY(&QI8V5NF%T:6]N('-O;'5T:6]N('!A2!R M96-E:79E2!O9F9E6UE;G0@,S`M-#4@9&%Y2!R96=A6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O M;6%N+"!T:6UE'0M86QI9VXZ M(&IU2!O9B!O=&AE3LG/B8C,38P.SPO<#X-"CQP M('-T>6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;CLG/E-E2!O=F5R('1H92!T97)M M(&]F('1H92!M86EN=&5N86YC92!A;F0@3LG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@=&EM M97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;CLG/DUU;'1I M<&QE+65L96UE;G0@87)R86YG96UE;G1S("8C.#(Q,CL@=&AE($-O;7!A;GD@ M96YT97)S(&EN=&\@87)R86YG96UE;G1S('=I=&@@3L@ M=&5X="UI;F1E;G0Z(#`N-6EN.R<^2&%R9'=A65A2X@5&AE(')I2!R979I97=S('1H92!R:7-K M(&]F('=A2!A;F0@86QL(&%P<')O<')I871E('!R;W9I2!I2!P3L@=&5X="UI;F1E;G0Z(#`N-6EN.R<^)B,Q-C`[/"]P/@T*/'`@ M3L@=&5X M="UI;F1E;G0Z(#`N-6EN.R<^365D:6-#3R`\2!G96YE3LG M/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W M(')O;6%N+"!T:6UE'0M86QI M9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N M+"!T:6UE'0M86QI9VXZ(&IU M2!R96-O9VYI>F5S(&-O;7!E;G-A=&EO;B!E>'!E;G-E(&9O6UE;G1S+B8C,38P.R8C,38P.U5N9&5R(&9A M:7(@=F%L=64@'!E8W1E M9"!T;R!V97-T(&]V97(@=&AE(')E<75I6QE/3-$)V9O M;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M+C5I;CLG/E1H92!F86ER('9A;'5E(&]F(&5A8V@@;W!T:6]N(&%W87)D(&ES M(&5S=&EM871E9"!O;B!T:&4@9&%T92!O9B!G2P@=&AE M(')I'!E8W1E9"!V;VQA=&EL:71Y(&ES(&-A;&-U M;&%T960@8F%S960@;VX@=&AE(&AI2!O9B!O M=7(@8V]M;6]N('-T;V-K(&]V97(@=&AE(&5X<&5C=&5D(&]P=&EO;B!L:69E M(&%N9"!O=&AE3LG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)V9O;G0Z M(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I M;CLG/D1E=&5R;6EN:6YG('1H92!A<'!R;W!R:6%T92!F86ER('9A;'5E(&UO M9&5L(&%N9"!C86QC=6QA=&EN9R!T:&4@9F%I2!F;W(@=&AO2!D:69F97)E;G0@9G)O;2!O=7(@97-T:6UA=&4L('1H M92!E<75I='DM8F%S960@8V]M<&5N2!D:69F97)E;G0@9G)O;2!W:&%T('1H92!#;VUP86YY M(&AA3LG/CQI M/B8C,38P.SPO:3X\+W`^#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T('1I;65S M(&YE=R!R;VUA;BP@=&EM97,L('-E6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU'0M M:6YD96YT.B`P+C5I;CLG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)V9O;G0Z M(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I M;CLG/E=E(&%C8V]U;G0@9F]R(&EN=F5N=&]R>2!A="!T:&4@;&]W97(@;V8@ M8V]S="`H9FER2!S=7!P;&EE7-I M8V%L(&EN=F5N=&]R>2!C;W5N=',@=&\@;6%I;G1A:6X@8V]N=')O;',@86YD M(&]B=&%I;B!A8V-U&-L M=7-I=F4@9&ES=')I8G5T;W(@;W(@*&EI*2!P;&%C960@:6X@86X@97AT97)N M86P@=&AI2!A;F0@ M6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W M(')O;6%N+"!T:6UE'0M86QI M9VXZ(&IU2!I;F-U2!B96EN9R!E2!R97!OF%T:6]N(&]V97(@=&AE(')E;6%I;FEN9R!E3L@ M=&5X="UI;F1E;G0Z(#`N-6EN.R<^5&AE($-O;7!A;GD@8V]N8VQU9&5D('1H M870@8V%P:71A;&EZ:6YG('-U8V@@97AP96YD:71U'!E;G-E9"!O;B!T:&4@365D:6-S:6=H="!P3LG/CQI/E!R;W!E3L@=&5X="UI;F1E;G0Z(#`N-6EN.R<^)B,Q-C`[/"]P/@T*/'`@3L@=&5X="UI M;F1E;G0Z(#`N-6EN.R<^4')O<&5R='D@86YD(&5Q=6EP;65N="!A6QE/3-$)V9O;G0Z(#$P M<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;CLG M/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W M(')O;6%N+"!T:6UE'0M86QI M9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O M;6%N+"!T:6UE'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P+C5I;CLG/B8C,38P.SPO<#X-"CQP M('-T>6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;CLG/E1H92!A8V-O=6YT28C.#(Q-SMS(&9O2!A2X@1F]R('1H97-E('-U8G-I9&EA'!E;G-E(&%C8V]U;G1S(&%R92!T2!E>&-H86YG92!R871E6QE/3-$)V9O M;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU3L@=&5X="UI;F1E;G0Z(#`N-6EN.R<^)B,Q-C`[/"]P/@T* M/'`@3L@ M=&5X="UI;F1E;G0Z(#`N-6EN.R<^5&AE($-O;7!A;GD@87!P;&EE&5S+B!4:&ES(&-L87)I M9FEE&5S(')E8V]G;FEZ960@:6X@9FEN86YC:6%L('-T871E;65N=',@86YD M(')E<75I&EN9R!A=71H;W)I='DN($%S(&]F($UA'!E8W0@=&AA="!T:&4@86UO=6YT(&]F M('5N28C.#(Q-SMS('!O;&EC>2!IF4@:6YT97)E"!M M871T97)S(&EN('1H92!I;F-O;64@=&%X('!R;W9I"!Y96%R3L@=&5X="UI;F1E;G0Z(#`N-6EN.R<^ M)B,Q-C`[/"]P/@T*/'`@3L@=&5X="UI;F1E;G0Z(#`N-6EN.R<^1&5F97)R960@=&%X M97,@87)E(&-O;7!U=&5D(&)A"!R97!O&5S M(&%N9"!T87AE"!A'!E8W1E9"!R979E2!T:&%N(&YO="!T;R!B92!R96%L:7IE M9"XF(S$V,#L\+W`^#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T('1I;65S(&YE M=R!R;VUA;BP@=&EM97,L('-E6QE/3-$ M)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU3L@=&5X="UI;F1E;G0Z(#`N M-6EN.R<^0F%S:6,@;&]S2!D M:79I9&EN9R!N970@;&]S2!T:&4@=V5I9VAT960@879E2!S M:&%R97,N/"]P/@T*/'`@3LG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)V9O;G0Z(#$P M<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;CLG M/E1H92!C;VUP=71A=&EO;B!O9B!D:6QU=&5D(&QO2!A&-L=61E9"!W:71H(&$@=V5I9VAT960@879E&5R8VES92!P3L@=&5X="UI;F1E;G0Z(#`N-6EN.R<^)B,Q-C`[/"]P/@T*/'`@3L@=&5X="UI;F1E M;G0Z(#`N-6EN.R<^0V]M<')E:&5N2!T3L@=&5X="UI;F1E;G0Z(#`N-6EN.R<^)B,Q-C`[/"]P/@T*/'`@ M3L@=&5X M="UI;F1E;G0Z(#`N-6EN.R<^26X@2G5N92`R,#$Q+"!T:&4@1FEN86YC:6%L M($%C8V]U;G1I;F<@4W1A;F1A2!T;R!P28C.#(Q-SMS(&-O;F1E;G-E M9"!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',N/"]P/@T*/'`@ M3L@=&5X M="UI;F1E;G0Z(#`N-6EN.R<^)B,Q-C`[/"]P/@T*/'`@3LG/CQI/E-E9VUE;G0@6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@ M;F5W(')O;6%N+"!T:6UE'0M M86QI9VXZ(&IU2!O<&5R871E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F.&,U,C$T M8E\W,C)B7S0V,&1?831C8U\Y9#`R,3-D.6$S8S,-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO9CAC-3(Q-&)?-S(R8E\T-C!D7V$T8V-?.60P,C$S M9#EA,V,S+U=O'0O:'1M;#L@8VAA'0@0FQO8VM=/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<"!S='EL93TS1"=F;VYT M.B`Q,'!T('1I;65S(&YE=R!R;VUA;BP@=&EM97,L('-E6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N M+"!T:6UE'0M86QI9VXZ(&IU M&-H86YG92!A;F0@=F%R:6]U6=A=&4@1W)O=7`@3&EM M:71E9"`H)B,X,C(P.TUO;F5Y9V%T928C.#(R,3LI+"!W:&EC:"!W87,@86-C M;W5N=&5D(&9O'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0@ M0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<"!S='EL M93TS1"=F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;BP@=&EM97,L('-E3LG/B8C M,38P.SPO<#X-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O M;6%N+"!T:6UE'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P+C5I;CLG/D-A7,@;W(@;&5S3LG/CQI/D-O;F-E;G1R M871I;VYS/"]I/CPO<#X-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@ M;F5W(')O;6%N+"!T:6UE'0M M86QI9VXZ(&IU28C,38P.VAE;&0F(S$V,#LD,RPP,C$@86YD("0S M+#$R,R!O9B!I=',@8V%S:"8C,38P.V%N9"!C87-H(&5Q=6EV86QE;G1S(&%T M($UA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$3LG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)V9O;G0Z M(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU3LG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)V9O;G0Z(#$P M<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;CLG M/D]N(%-E<'1E;6)E2`V M+"`R,#$Q(&%N9"!&96)R=6%R>2`Q,"P@,C`Q,2!R97-P96-T:79E;'DN)B,Q M-C`[)B,Q-C`[1'5N86UI3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]F.&,U,C$T8E\W,C)B7S0V,&1?831C8U\Y9#`R,3-D M.6$S8S,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9CAC-3(Q-&)? M-S(R8E\T-C!D7V$T8V-?.60P,C$S9#EA,V,S+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M3QB2!$:7-C;&]S=7)E(%M!8G-T'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$=&5X=#X\<"!S='EL93TS1"=F;VYT.B`Q,'!T('1I;65S(&YE M=R!R;VUA;BP@=&EM97,L('-E3PO8CX\+W`^#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T('1I;65S(&YE=R!R M;VUA;BP@=&EM97,L('-E3L@=&5X="UI;F1E;G0Z(#`N-6EN.R<^ M)B,Q-C`[070@36%R8V@@,S$L(#(P,3(@86YD($1E8V5M8F5R(#,Q+"`R,#$Q M+"!-961I8T-/(#QS=6(^,CPO'1087)T7V8X8S4R,31B7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'!E;G-E*3QB'!E;G-E(%M!8G-T'0@0FQO8VM=/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#X\<"!S='EL93TS1"=F;VYT.B`Q,'!T('1I M;65S(&YE=R!R;VUA;BP@=&EM97,L('-E'!E;G-E*3PO8CX\+W`^#0H\ M<"!S='EL93TS1"=F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;BP@=&EM97,L M('-E6QE/3-$)V9O;G0Z(#$P<'0@=&EM M97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;CLG/D9O65A'!E;G-E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F M.&,U,C$T8E\W,C)B7S0V,&1?831C8U\Y9#`R,3-D.6$S8S,-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9CAC-3(Q-&)?-S(R8E\T-C!D7V$T8V-? M.60P,C$S9#EA,V,S+U=O'0O:'1M;#L@8VAA6QE/3-$)V9O;G0Z(#$P<'0@=&EM M97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU3LG/CQB/D-A M;F-E;&QA=&EO;B!O9B!C97)T86EN('-H87)E(&]P=&EO;B!P;&%N3PO8CX\+W`^#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T('1I M;65S(&YE=R!R;VUA;BP@=&EM97,L('-E3L@=&5X="UI;F1E;G0Z M(#`N-6EN.R<^/&9O;G0@&ES=&EN9R!O2!S:&%R97,@;V8@)B,Q M-C,[(#`N,#4@<&%R('9A;'5E(&EN=&\@;VYE(&YE=R!O2!S:&%R M92!W87,@9'5L>2!P87-S960N($%S(&$@2!C86YC96QL M960@=VET:"!I;6UE9&EA=&4@969F96-T(&%L;"!R961U;F1A;G0@;W!T:6]N M('!L86YS('=I=&@@=&AE(&5X8V5P=&EO;B!O9B!0;&%N($HN($%L;"!P6QE M/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P+C5I;CLG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)V9O;G0Z(#$P M<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;CLG M/DUE9&EC3LG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@ M=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;CLG/E!L M86X@2B`F(S@R,3([(&]N($UA>2`Q-"P@,C`P.2P@=V4@87!P2!G'1H&5R8VES86)L92X\+W`^#0H\<"!S='EL93TS1"=F;VYT M.B`Q,'!T('1I;65S(&YE=R!R;VUA;BP@=&EM97,L('-E6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE M'0M:6YD96YT.B`Y<'0[)SXF M(S$V,#L\+W`^#0H\=&%B;&4@6QE/3-$)W9E'0M:6YD96YT.B`Y<'0[('!A9&1I;F'0M86QI M9VXZ(&-E;G1E6QE M/3-$)W9E6QE/3-$)W9E6QE/3-$)V9O M;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)V9O;G0Z(#$P M<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N M+"!T:6UE'0M86QI9VXZ(&-E M;G1E6QE/3-$ M)W9E&5R8VES928C,38P.U!R:6-E/"]B/CPO M<#X-"CPO=&0^#0H\=&0@6QE M/3-$)W=I9'1H.B`T,"4[('9E6QE M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ('1O<#L@=&5X="UA;&EG M;CH@6QE/3-$)W=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ('1O<#LG/B8C,38S.SPO=&0^#0H\=&0@6QE/3-$)W=I9'1H.B`Q)3L@=F5R M=&EC86PM86QI9VXZ('1O<#LG/B8C,38P.SPO=&0^#0H\=&0@6QE/3-$ M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ('1O<#L@=&5X="UA;&EG;CH@ M6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ('1O<#LG/B8C,38S.SPO=&0^#0H\=&0@6QE/3-$ M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ('1O<#LG/BD\+W1D/@T*/"]T M6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CH@=&]P.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL M93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R<^)B,Q-C`[/"]T9#X-"CQT9"!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R<^)B,Q-C`[/"]T9#X-"CQT M9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!T97AT+6%L:6=N.B!R M:6=H=#LG/B8C,38P.SPO=&0^#0H\=&0@6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL M93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R<^)B,Q-C`[/"]T9#X-"CPO='(^ M#0H\='(@6QE/3-$)W9E'0M:6YD96YT.B`M,C=P=#LG/D=R86YT960\+W1D M/@T*/'1D('-T>6QE/3-$)W9E'0M86QI M9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CH@=&]P.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=V97)T M:6-A;"UA;&EG;CH@=&]P.R!T97AT+6%L:6=N.B!R:6=H=#LG/B8C.#(Q,CL\ M+W1D/@T*/'1D('-T>6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CH@=&]P.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!T97AT+6%L:6=N.B!R:6=H=#LG/B8C M.#(Q,CL\+W1D/@T*/'1D('-T>6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X-"CQT M9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R<^)B,Q-C`[/"]T9#X- M"CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R<^)B,Q-C`[/"]T M9#X-"CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R<^)B,Q-C`[ M/"]T9#X-"CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!T97AT M+6%L:6=N.B!R:6=H=#LG/B8C,38P.SPO=&0^#0H\=&0@6QE/3-$)V)A8VMG6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O='1O;3H@ M,7!T.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CH@=&]P.R!B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@6QE/3-$ M)W9E'0M86QI9VXZ(')I9VAT.R!B;W)D M97(M8F]T=&]M.B!B;&%C:R`Q<'0@6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E M6QE/3-$ M)W9E6QE M/3-$)W9E'0M86QI9VXZ(')I9VAT.R<^ M)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P M.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@ M=&]P.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CH@=&]P.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CH@=&]P.R!T97AT+6%L:6=N.B!R:6=H=#LG/B8C,38P.SPO=&0^#0H\ M=&0@6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!P861D:6YG+6)O='1O M;3H@,7!T.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CH@=&]P.R!B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@ M6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)V9O;G0Z M(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE6QE/3-$ M)W9E'0M M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M=V5I M9VAT.B!B;VQD.R!P861D:6YG+6)O='1O;3H@,7!T.R<^)B,Q-C`[/"]T9#X- M"CQT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@=&5X="UA;&EG;CH@ M8V5N=&5R.R<@8V]L6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE M'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!P861D:6YG+6)O='1O;3H@,7!T M.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L M9#L@<&%D9&EN9RUB;W1T;VTZ(#%P=#LG/B8C,38P.SPO=&0^#0H\=&0@6QE/3-$)V9O;G0Z M(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M=V5I9VAT M.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([(&)O6QE/3-$)V9O;G0M=V5I9VAT.B!B M;VQD.R!P861D:6YG+6)O='1O;3H@,7!T.R<^)B,Q-C`[/"]T9#X-"CQT9"!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O M;6%N+"!T:6UE'0M86QI9VXZ M(&-E;G1E6QE/3-$)V9O;G0M=V5I M9VAT.B!B;VQD.R!P861D:6YG+6)O='1O;3H@,7!T.R<^)B,Q-C`[/"]T9#X- M"CPO='(^#0H\='(@6QE/3-$)W=I M9'1H.B`R."4[)SY-961I8W-I9VAT(%!L86X@2CPO=&0^#0H\=&0@'0M86QI9VXZ(')I9VAT.R<^-CPO=&0^ M#0H\=&0@'0M86QI9VXZ(')I9VAT.R<^)B,Q-C`[ M/"]T9#X-"CQT9"!S='EL93TS1"=W:61T:#H@,24[)SXF(S$V,#L\+W1D/@T* M/'1D('-T>6QE/3-$)W=I9'1H.B`Y)3L@=&5X="UA;&EG;CH@6QE/3-$)W=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^ M#0H\=&0@'0M86QI9VXZ(')I M9VAT.R<^,CDL,C4P/"]T9#X-"CQT9"!S='EL93TS1"=W:61T:#H@,24[)SXF M(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG M;CH@6QE/3-$)W=I9'1H.B`Q M)3LG/B0\+W1D/@T*/'1D('-T>6QE/3-$)W=I9'1H.B`V)3L@=&5X="UA;&EG M;CH@6QE/3-$)W=I9'1H.B`Q M)3LG/B8C,38P.SPO=&0^#0H\=&0@'0M86QI9VXZ(')I9VAT.R<^-3PO=&0^#0H\=&0@'0M86QI9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS M1"=W:61T:#H@,24[)SXF(S$V,SL\+W1D/@T*/'1D('-T>6QE/3-$)W=I9'1H M.B`V)3L@=&5X="UA;&EG;CH@6QE/3-$)W=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^#0H\=&0@3L@=&5X="UI;F1E;G0Z(#`N-6EN.R<^3VX@ M3F]V96UB97(@,S`L(#(P,3`L($1A=FED(%-U;6YE2!A9G1E2!-&ES=&EN9R!O<'1I;VYS(&AA M3LG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@=&EM M97,@;F5W(')O;6%N+"!T:6UE'0M:6YD96YT.B`P+C5I;CLG/E1H92!#;VUP86YY(&AA6EN9R!# M;VYD96YS960@0V]N6QE/3-$)W=I9'1H.B`W,"4[(&)O M6QE/3-$)W9E6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#$P<'0@=&EM M97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!P861D:6YG+6)O='1O;3H@,7!T M.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L M9#L@=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!B;&%C:R`Q M<'0@6QE/3-$ M)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([(&)O6QE/3-$)W=I9'1H.B`W,"4[('1E>'0M86QI M9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M,C=P=#L@<&%D9&EN9RUL969T.B`R M-W!T.R<^4V5L;&EN9RP@9V5N97)A;"!A;F0@861M:6YI6QE/3-$)W=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^#0H\=&0@ M6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA M;&EG;CH@;&5F=#LG/B0\+W1D/@T*/'1D('-T>6QE/3-$)W=I9'1H.B`Q,B4[ M('1E>'0M86QI9VXZ(')I9VAT.R<^,SPO=&0^#0H\=&0@'0M86QI9VXZ(')I9VAT.R<^-SPO=&0^#0H\=&0@'0M M86QI9VXZ(')I9VAT.R<^,30\+W1D/@T*/'1D('-T>6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/@T* M/"]T'0M86QI9VXZ(&QE9G0[)SXD/"]T9#X- M"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT.R<^,3<\+W1D/@T*/'1D('-T>6QE/3-$)W!A M9&1I;F'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\ M+W1D/@T*/"]T3LG/D]F('1H92!S=&]C:RUB87-E9"!E>'!E;G-E(&9O M3LG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@ M;F5W(')O;6%N+"!T:6UE'0M M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M=V5I M9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([(&)O'0M86QI9VXZ(&-E M;G1E6QE/3-$)W=I9'1H M.B`Q)3L@=&5X="UA;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^#0H\=&0@'0M86QI9VXZ(&QE9G0[)SXF(S$V,SL\+W1D/@T*/'1D M('-T>6QE/3-$)W=I9'1H.B`Q,"4[('1E>'0M86QI9VXZ(')I9VAT.R<^-#4L M-3`P/"]T9#X-"CQT9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ M(&QE9G0[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3LG M/B8C,38P.SPO=&0^#0H\=&0@6QE/3-$ M)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^#0H\ M+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R<^)B,X,C$R.SPO=&0^#0H\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/@T*/'1D M/B8C,38P.SPO=&0^#0H\=&0@6QE/3-$)W1E>'0M:6YD96YT.B`M,C=P=#L@<&%D9&EN9RUL969T M.B`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`Q<'0@ M'0M86QI9VXZ(')I9VAT.R<^)B,X,C$R.SPO=&0^#0H\=&0@ M6QE/3-$)W9E'0M86QI9VXZ(&QE M9G0[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V)O'0M86QI9VXZ(&QE9G0[)SXF M(S$V,SL\+W1D/@T*/'1D('-T>6QE/3-$)V)O6QE/3-$)W!A9&1I;F'0M86QI9VXZ M(&QE9G0[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0[ M)SXF(S$V,#L\+W1D/@T*/"]T6QE/3-$)V9O M;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]F.&,U,C$T8E\W,C)B7S0V,&1?831C8U\Y M9#`R,3-D.6$S8S,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9CAC M-3(Q-&)?-S(R8E\T-C!D7V$T8V-?.60P,C$S9#EA,V,S+U=O'0O:'1M;#L@8VAA2!A;F0@ M3F]N8V]N=')O;&QI;F<@26YT97)E'0@0FQO8VM=/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<"!S='EL93TS1"=F;VYT.B`Q,'!T M('1I;65S(&YE=R!R;VUA;BP@=&EM97,L('-E2!A M;F0@;F]N+6-O;G1R;VQL:6YG(&EN=&5R97-T/"]B/CPO<#X-"CQP('-T>6QE M/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE2!H87,@ M;F]N+6-O;G1R;VQL:6YG(&EN=F5S=&]R6QE M/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([(&)O M6QE/3-$)W!A9&1I;F6QE/3-$)W=I9'1H.B`X-24[ M('1E>'0M:6YD96YT.B`M,C=P=#L@<&%D9&EN9RUL969T.B`R-W!T.R<^3F]N M+6-O;G1R;VQL:6YG(&EN=&5R97-T(&%T($IA;G5A'0M86QI9VXZ(&QE9G0[)SXD/"]T9#X- M"CQT9"!S='EL93TS1"=W:61T:#H@,3(E.R!T97AT+6%L:6=N.B!R:6=H=#LG M/C4L,CDS/"]T9#X-"CQT9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI M9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/@T*/"]T6QE/3-$)W1E>'0M:6YD96YT.B`M,C=P=#L@<&%D9&EN M9RUL969T.B`R-W!T.R<^3F]N+6-O;G1R;VQL:6YG('-H87)E(&]F(&QO6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[)SXI/"]T9#X-"CPO='(^#0H\='(@6QE/3-$)W1E>'0M:6YD96YT.B`M,C=P=#L@<&%D9&EN9RUL M969T.B`R-W!T.R<^3F]N+6-O;G1R;VQL:6YG(&EN=&5R97-T('-H87)E(&]F M('-T;V-K+6)A'!E;G-E/"]T9#X-"CQT9#XF M(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF M(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^ M,34\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V M,#L\+W1D/@T*/"]T6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M,C=P=#L@<&%D M9&EN9RUL969T.B`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`P+C5I;CLG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$ M)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M:6YD96YT.B`P+C5I;CLG/CPO<#X-"CQP('-T M>6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M:6YD96YT.B`P+C5I;CLG/DEN($IA M;G5A2!S:&%R97,@9G)O;2!A('-H87)E:&]L9&5R M(&9O6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M:6YD96YT.B`P+C5I;CLG/E1H92!F M;VQL;W=I;F<@6QE/3-$)V9O;G0M M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([(&)O6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT M97([(&)O6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&QE9G0[ M)SXD/"]T9#X-"CQT9"!S='EL93TS1"=W:61T:#H@,3`E.R!T97AT+6%L:6=N M.B!R:6=H=#LG/B@T-S`\+W1D/@T*/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@ M=&5X="UA;&EG;CH@;&5F=#LG/BD\+W1D/@T*/'1D('-T>6QE/3-$)W=I9'1H M.B`Q)3LG/B8C,38P.SPO=&0^#0H\=&0@6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F=#LG/BD\+W1D/@T* M/"]T6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W9E'0M86QI9VXZ(')I M9VAT.R<^,BPS.3(\+W1D/@T*/'1D('-T>6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/@T*/'1D('-T M>6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('!A9&1I;F'0M86QI9VXZ(&QE9G0[)SXD M/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@ M'0M86QI9VXZ(')I9VAT.R<^*#$L-#DR/"]T9#X-"CQT9"!S M='EL93TS1"=P861D:6YG+6)O='1O;3H@,7!T.R!T97AT+6%L:6=N.B!L969T M.R<^*3PO=&0^#0H\+W1R/@T*/"]T86)L93X-"CQP('-T>6QE/3-$)V9O;G0Z M(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!4'0@0FQO8VM=/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<"!S='EL93TS1"=F;VYT.B`Q M,'!T('1I;65S(&YE=R!R;VUA;BP@=&EM97,L('-E6QE/3-$)V9O;G0Z M(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P M<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU6=A=&4N)B,Q-C`[($]N M(&%C<75I2!E;G1E6=A=&4@86YD(&]T:&5R(&YO;BUR96QA=&5D('!A3LG M/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W M(')O;6%N+"!T:6UE'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P+C5I;CLG/E1H6=A=&4F(S@R,3<[3LG/CQI/D1U;F%M:7,@0V%P:71A;#PO:3X\ M+W`^#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;BP@ M=&EM97,L('-E&5C=71I=F4@3V9F:6-E2`V+"`R,#$Q(&%N9"!&96)R=6%R>2`Q,"P@,C`Q,2P@6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W M(')O;6%N+"!T:6UE'0M86QI M9VXZ(&IU2`R,#$Q+"!T:&4@0V]M<&%N>2P@9F]L;&]W:6YG(&-O M;G-U;'1A=&EO;B!W:71H(&ET2!A2!I3LG/CQI/DQA9&1C M87`@5F%L=64@4&%R=&YE3L@=&5X="UI;F1E;G0Z(#`N-6EN M.R<^3VX@07!R:6P@,3(L(#(P,3$L('1H92!#;VUP86YY(&5N=&5R960@:6YT M;R!A(%)E=F]L=FEN9R!,:6YE(&]F($-R961I="!A;F0@4V5C=7)I='D@06=R M965M96YT('=I=&@@3&%D9&-A<"!F;W(@=7`@=&\@)#4P,"!F;W(@82!F:69T M965N(&UO;G1H('1E&EM=6T@;&]A;B!A;6]U;G0@86QO;F<@=VET:"!A;B!E:6=H="`H M."4I('!E2!F=6YD6QE/3-$)V9O M;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU3LG/B8C,38P.SPO<#X-"CQP('-T>6QE M/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P+C5I;CLG/D5F9F5C=&EV92!*=6QY(#(P,3`L('1H92!#;VUP86YY M(&5N=&5R960@:6YT;R!A('-E2!A="!S=6-H('1I;64N(%1H92!$-$0@ M6UE;G0@8V]N M=')A8W1S('=I=&@@34=4+B!/;B!E>&5C=71I;F<@=&AE(&-O;G1R86-T('=I M=&@@1#1$+"!4:6T@4&%T97)S;VXM0G)O=VX@86YD($%L;&%N(%)O=VQE>2!T M97)M:6YA=&5D('1H96ER(&5M<&QO>6UE;G0@8V]N=')A8W1S('=I=&@@34=4 M+"!B=70@3LG/B8C,38P.SPO<#X-"CQP('-T M>6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU'0M M:6YD96YT.B`P+C5I;CLG/DEN($1E8V5M8F5R(#(P,3`L($UR+B!0871E2`R M,#$Q+"!-&5C=71E9"!A;F0@9&5L:79E6UE;G1S('1O(&)E(&UA9&4@8GD@ M=&AE($-O;7!A;GD@=&\@1#1$(&]F(&$@)B,Q-C,[,3$P("@D,36UE;G0@87)R86YG96UE;G1S M('=I=&@@=&AE($-O;7!A;GD@86YD(&-E2!A8V-R=65D(&%N9"!E M>'!E;G-E9"!A;&P@3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F.&,U,C$T M8E\W,C)B7S0V,&1?831C8U\Y9#`R,3-D.6$S8S,-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO9CAC-3(Q-&)?-S(R8E\T-C!D7V$T8V-?.60P,C$S M9#EA,V,S+U=O'0O:'1M;#L@8VAA2!D97!O2!D97!O M'0^/'`@3LG/CQB/C$Q+B`F(S$V,#L@)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q M-C`[)B,Q-C`[3W!E3LG/B8C,38P.SPO<#X-"CQP('-T>6QE M/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P+C5I;CLG/DEN(#(P,#8L('=E(&5X96-U=&5D(&$@,3`M>65A2!I;B!A9'9A;F-E+B!4:&4@0V]M<&%N>2!E>&5R8VES960@:71S M(')I9VAT('1O('1E2!R96YT86P@<&%Y M;65N=',@;V8@)B,Q-C,[."`H)#$S*2!A;&]N9R!W:71H(&$@2!M;W9E9"!T;R!A('-M86QL97(@;V9F:6-E(&EN('1H92!S M86UE(&QO8V%T:6]N('=I=&@@;6]N=&@M=&\M;6]N=&@@6UE M;G1S(&]F("8C,38S.S(@*"0T*2!A;F0@82!R96YT86P@9&5P;W-I="!O9B`F M(S$V,SLT("@D-BDN/"]P/@T*/'`@3L@=&5X="UI;F1E;G0Z(#`N-6EN.R<^26X@4V5P=&5M8F5R(#(P,3$L M('1H92!#;VUP86YY(&5N=&5R960@:6YT;R!A(#,Y(&UO;G1H(&QE87-E(&%G M6\L($IA<&%N+"!W87,@8VQO6UE;G0@86=R965M96YT('=I M=&@@86X@96UP;&]Y964@870@82!B87-E('-A;&%R>2!O9B`D,3`L,#`P('!E M3L@=&5X="UI;F1E;G0Z M(#`N-6EN.R<^)B,Q-C`[/"]P/@T*/'`@3L@=&5X="UI;F1E;G0Z(#`N-6EN.R<^3VX@ M36%R8V@@,3(L(#(P,3(L('1H92!#;VUP86YY(&5N=&5R960@:6YT;R!A(&]N M92!Y96%R(&9I;F%N8VEA;"!A9'9I2!A;F0@8V]N6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O M;6%N+"!T:6UE'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P+C5I;CLG/B8C,38P.SPO<#X-"CQP M('-T>6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;CLG/E1H92!F;VQL;W=I;F<@:7,@82!S8VAE9'5L M92!O9B!T:&4@9G5T=7)E(&UI;FEM=6T@<&%Y;65N=',@3LG/B8C,38P.SPO<#X-"CQT86)L M92!A;&EG;CTS1&-E;G1E6QE/3-$ M)W9E6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F M=#LG/B0\+W1D/@T*/'1D('-T>6QE/3-$)W=I9'1H.B`Q,"4[('1E>'0M86QI M9VXZ(')I9VAT.R<^.34\+W1D/@T*/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@ M=&5X="UA;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^#0H\+W1R/@T*/'1R('-T M>6QE/3-$)W9E6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R<^-S@\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[)SXF(S$V,#L\+W1D/@T*/"]T'0M86QI9VXZ(&QE9G0[)SXF(S$V M,#L\+W1D/@T*/'1D('-T>6QE/3-$)V)O6QE/3-$)W9E6QE/3-$)V9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'`@3LG/CQB/C$R+B8C M,38P.R`F(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V M,#LF(S$V,#LF(S$V,#M,:6YE(&]F(&-R961I="!F86-I;&ET>3PO8CX\+W`^ M#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;BP@=&EM M97,L('-E3L@=&5X="UI;F1E;G0Z(#`N-6EN.R<^3VX@07!R:6P@ M,3(L(#(P,3$L('1H92!#;VUP86YY(&5N=&5R960@:6YT;R!A(%)E=F]L=FEN M9R!,:6YE(&]F($-R961I="!A;F0@4V5C=7)I='D@06=R965M96YT('=I=&@@ M3&%D9&-A<"!F;W(@=7`@=&\@)#4P,"!F;W(@82!F:69T965N(&UO;G1H('1E M&EM=6T@ M;&]A;B!A;6]U;G0@86QO;F<@=VET:"!A;B!E:6=H="`H."4I('!E2!F=6YD'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^/'`@3L@;6%R9VEN.B`P<'0@,'!X.R!F;VYT M.B`Q,'!T('1I;65S(&YE=R!R;VUA;BP@=&EM97,L('-E6QE M/3-$)W1E>'0M86QI9VXZ(&IU#L@9F]N M=#H@,3!P="!T:6UE#L@9F]N=#H@,3!P="!T:6UE2!F:6QE9"!A('!R96QI;6EN87)Y('!R;WAY('-T871E;65N="`H4%)%+3$T M02D@86YD('=I;&P@:&]L9"!I=',@06YN=6%L($UE971I;F<@;V8@4W1O8VMH M;VQD97)S(&]N($UA>2`S,"P@,C`Q,BX\+W`^#0H\<"!S='EL93TS1"=T97AT M+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XZ(#!P="`P<'@[(&9O;G0Z(#$P<'0@ M=&EM97,@;F5W(')O;6%N+"!T:6UE#L@9F]N=#H@,3!P="!T:6UE2`Q,"P@,C`Q,BP@=&AE($-O M;7!A;GD@86YN;W5N8V5D('1H870@:71S($)O87)D(&]F($1I#L@9F]N=#H@,3!P="!T:6UE6QE/3-$)W1E>'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;CL@;6%R9VEN.B`P M<'0@,'!X.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;BP@=&EM97,L('-E M2!I;G1E2!S=&%K92!I;B!-1U0@1V%M:6YG M+"!);F,N.R!F=6QL('1E6QE/3-$)W1E>'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P+C5I;CL@;6%R9VEN.B`P<'0@ M,'!X.R!F;VYT.B`Q,'!T('1I;65S(&YE=R!R;VUA;BP@=&EM97,L('-E3L@=&5X="UI;F1E;G0Z(#`N-6EN.R!M87)G:6XZ(#!P="`P<'@[(&9O;G0Z M(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE6UE;G0@8GD@ M34=4(&]F("0R,#`L,#`P+"!P;'5S('1H92!I65A'1087)T7V8X8S4R,31B7S XML 16 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6

Summary of significant accounting policies
3 Months Ended

Mar. 31, 2012

Accounting Policies [Abstract]

Significant Accounting Policies [Text Block]
2. Summary of significant accounting policies

Principles of consolidation

The consolidated financial statements include the accounts of our Company plus wholly owned subsidiaries and our majority owned subsidiary Medicsight. The functional currency of our majority owned subsidiary is their local currency, GBP. All intercompany transactions and balances have been eliminated. All foreign currency translation gains and losses arising on consolidation were recorded in stockholders’ equity as a component of accumulated other comprehensive income/ (loss). Non-controlling interest represents the minority equity investment in any of the MGT group of companies, plus the minorities’ share of the net operating result and other components of equity relating to the non-controlling interest.

Use of estimates

The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amount of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Cash and cash equivalents

The Company considers investments with original maturities of three months or less to be cash equivalents.

Revenue Recognition

Medicsight

The Company recognizes revenue when it is realized or realizable and earned. The Company considers revenue realized or realizable and earned when there is persuasive evidence of an arrangement and that the product has been shipped or the services have been provided to the customer, the sales price is fixed or determinable and collectability is probable.

Software — License fee revenue is derived from the licensing of computer software. Maintenance revenue is derived from software maintenance. Our software licenses are generally sold as part of an arrangement that includes maintenance and support.

The Company licenses software and sells maintenance contracts through visualization solution partners and original equipment manufacturers. The Company receives regular sales reporting detailing the number of licenses sold by original equipment manufacturers, value-added resellers and independent distributors (collectively, “Resellers”) to end users. The Company generally offers terms that require payment 30-45 days from invoicing. Provided the Reseller: (i) assumes all risk of the purchase, (ii) has the ability and obligation to pay regardless of receiving payment from the end user, and (iii) all other revenue recognition criteria are met, license revenue from Resellers is recognized upon shipment of its product to vendors (“sell-in basis”).

Revenue from license fees is recognized when notification of shipment to the end user has occurred, there are no significant Company obligations with regard to implementation and the Company’s services are not considered essential to the functionality of other elements of the arrangement.

Services — Revenue from maintenance and support arrangements is deferred and recognized rateably over the term of the maintenance and support arrangements.

Multiple-element arrangements — the Company enters into arrangements with resellers that include a combination of software products, maintenance and support. For such arrangements, the Company recognizes revenue using the Multiple-Deliverable Revenue Arrangements. The Company allocates the total arrangement fee among the various elements of the arrangement based on the fair value of each of the undelivered elements. The fair value of maintenance and support services is established based on renewal rates.

Hardware — Revenue is derived from the sale of our MedicCO ₂ LON product. This product is an automated CO ₂ insufflation device, and is generally sold as part of an arrangement that includes a one year warranty. The risk of incurring warranty related expense is mitigated by the warranty contractually agreed with the supplier. The Company reviews the risk of warranty liabilities on a regular basis, and makes any and all appropriate provisions accordingly. At the present time, the Company feels that the warranty liability is insignificant and has therefore not made any provision.

MedicCO ₂ LON is sold exclusively through our distribution partner Medrad Inc. Revenue is recognized as orders are satisfied and goods are delivered to our distribution partner. The Company generally offers terms which require payments within 30-45 days from invoicing.

Equity-based compensation

The Company recognizes compensation expense for all equity-based payments. Under fair value recognition provisions, the Company recognizes equity-based compensation net of an estimated forfeiture rate and recognizes compensation cost only for those shares expected to vest over the requisite service period of the award.

The fair value of each option award is estimated on the date of grant using the Black-Scholes option valuation model. The Black-Scholes option valuation model requires the development of assumptions that are input into the model. These assumptions are the expected stock volatility, the risk-free interest rate, the option’s expected life and the dividend yield on the underlying stock. Expected volatility is calculated based on the historical volatility of our common stock over the expected option life and other appropriate factors. Risk-free interest rates are calculated based on continuously compounded risk-free rates for the appropriate term. The dividend yield is assumed to be zero as the Company has never paid or declared any cash dividends on our common stock and does not intend to pay dividends on our common stock in the foreseeable future. The expected forfeiture rate is estimated based on historical experience.

Determining the appropriate fair value model and calculating the fair value of equity-based payment awards requires the input of the subjective assumptions described above. The assumptions used in calculating the fair value of equity-based payment awards represent management’s best estimates, which involve inherent uncertainties and the application of management’s judgment. As a result, if factors change and the Company uses different assumptions, our equity-based compensation expense could be materially different in the future. In addition, the Company is required to estimate the expected forfeiture rate and recognize expense only for those shares expected to vest. If our actual forfeiture rate is materially different from our estimate, the equity-based compensation expense could be significantly different from what the Company has recorded in the current period.

Inventory

We account for inventory at the lower of cost (first-in, first-out) or market. Cost is determined to be purchased cost for the finished MedicCO ₂LON product from the third party supplier. We perform full physical inventory counts to maintain controls and obtain accurate data. The MedicCO ₂ LON product is either (i) sold to our exclusive distributor or (ii) placed in an external third party secure warehouse facility and remains our property. Once the units are shipped to the distributor it is deemed that the ownership is transferred to the distributor and the goods are delivered. Reserves for slow-moving and obsolete inventories are provided based on historical experience and product demand. Management evaluates the adequacy of these reserves periodically based on forecasted sales and market trends.

Research and development

The Company incurs costs in connection with the development of software products that are intended for sale. Costs incurred prior to technological feasibility being established for the product are expensed as incurred. Technological feasibility is established upon completion of a detail program design or, in its absence, completion of a working model. Thereafter, all software production costs are capitalized and subsequently reported at the lower of unamortized cost or net realizable value. Capitalized costs are amortized based on current and future revenue for each product with an annual minimum equal to the straight-line amortization over the remaining estimated economic life of the product. Amortization commences when the product is available for general release to customers.

The Company concluded that capitalizing such expenditures on completion of a working model was inappropriate because the Company did not incur any material software production costs and therefore expenses were all research and development costs. Our research and development costs are comprised of staff, consultancy and other costs expensed on the Medicsight products.

Property and equipment

Property and equipment are stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method on the various asset classes over their estimated useful lives, which range from two to five years. Leasehold improvements are depreciated over the term of the lease.

Foreign currency translation

The accounts of the Company’s foreign subsidiaries are maintained using the local currency as the functional currency. For these subsidiaries, assets and liabilities are translated into U.S. dollars at period-end exchange rates, and income and expense accounts are translated at average monthly exchange rates. Net gains and losses from foreign currency translation are excluded from operating results and are accumulated as a separate component of stockholders’ equity.

Gains and losses on foreign currency transactions are reflected in selling, general and administrative expenses in the income statement.

Income taxes

The Company applies the elements of FASB ASC 740-10 “Income Taxes — overall” regarding accounting for uncertainty in income taxes. This clarifies the accounting for uncertainty in income taxes recognized in financial statements and requires the impact of a tax position to be recognized in the financial statements if that position is more likely than not of being sustained by the taxing authority. As of March 31, 2012 and December 31, 2011, the Company did not have any unrecognized tax benefits. The Company does not expect that the amount of unrecognized tax benefits will significantly increase or decrease within the next twelve months. The Company’s policy is to recognize interest and penalties related to tax matters in the income tax provision in the Consolidated Statements of Operations. There was no interest and penalties for the three months ended March 31, 2012 and 2011. Tax years beginning in 2009 are generally subject to examination by taxing authorities, although net operating losses from all years are subject to examinations and adjustments for at least three years following the year in which the attributes are used.

Deferred taxes are computed based on the tax liability or benefit in future years of the reversal of temporary differences in the recognition of income or deduction of expenses between financial and tax reporting purposes. The net difference, if any, between the provision for taxes and taxes currently payable is reflected in the balance sheet as deferred taxes. Deferred tax assets and/or liabilities, if any, are classified as current and non-current based on the classification of the related asset or liability for financial reporting purposes, or based on the expected reversal date for deferred taxes that are not related to an asset or liability. Valuation allowances are recorded to reduce deferred tax assets to that amount which is more likely than not to be realized.

Loss per share

Basic loss per share is calculated by dividing net loss attributable to the ordinary shareholders by the weighted average number of common shares outstanding during the period. Diluted loss per share is calculated by dividing the net loss attributable to the ordinary shareholders by the sum of the weighted average number of common shares outstanding and the diluted potential ordinary shares.

The computation of diluted loss per share for the three months ended March 31, 2012, and 2011, excludes all options at our Medicsight subsidiary as they are anti-dilutive. For the three months ended March 31, 2012, there were 6 options excluded with a weighted average exercise price of $46,376 per share. For the three months ended March 31, 2011, there were 33 options excluded with a weighted average exercise price of $71,500 per share.

Comprehensive income / (loss)

Comprehensive income/ (loss) includes net income/ (loss) and items defined as other comprehensive income/ (loss). Items defined as other comprehensive income/ (loss), include foreign currency translation adjustments and are separately classified in the consolidated financial statements. Such items are reported in the Condensed Consolidated Statement of Comprehensive Loss.

In June 2011, the Financial Accounting Standards Board (“FASB”) issued ASU 2011-05 which provides new guidance on the presentation of comprehensive income. ASU 2011-05 eliminates the option to report other comprehensive income and its components in the statement of changes in stockholders’ equity and instead requires an entity to present the total of comprehensive income, the components of net income and the components of other comprehensive income either in a single continuous statement or in two separate but consecutive statements. This guidance is effective for fiscal years, and interim period within those years, beginning after December 15, 2011, with early adoption permitted. The adoption of this ASU only requires a change in the format of the current presentation. The Company adopted this guidance on January 1, 2012, and its adoption did not significantly impact the Company’s condensed consolidated financial statements.

Segment reporting

The Company operates in one main operational segment, Medicsight, a medical imaging and device hardware company, with MGT providing corporate management services.

X

- Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for all significant accounting policies of the reporting entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18743-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18854-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 22

-Paragraph 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18861-107790

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18726-107790

+ Details

Name: us-gaap_SignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 17 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified

Mar. 31, 2012

Dec. 31, 2011

Assets

Cash and cash equivalents $ 3,342 $ 3,704

Accounts receivable 118 84

Prepaid expenses and other current assets 155 327

Inventory 56 89

Total current assets 3,671 4,204

Property and equipment, at cost, net 32 28

Security deposits 65 201

Total assets 3,768 4,433

Liabilities

Accounts payable 261 213

Accrued expenses 395 502

Other payables 44 71

Total current liabilities 700 786

Stockholders' (deficit)/equity

Common stock, $0.001 par value: 75,000,000 shares authorized; 2,105,187 and 2,108,732 shares issued and outstanding at March 31, 2012 and December 31, 2011 respectively. 2 2

Additional paid-in capital 285,644 283,240

Accumulated other comprehensive loss (5,828) (4,861)

Accumulated deficit (280,497) (280,027)

Total stockholders' deficit (679) (1,646)

Non-controlling interest 3,747 5,293

Total equity 3,068 3,647

Total stockholders' equity, liabilities and non-controlling interest $ 3,768 $ 4,433

X

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Subparagraph a

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccountsPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3

-Subparagraph a(1)

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 4

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3-4)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e653-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 14, 17, 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Staff Position (FSP)

-Number FAS115-1/124-1

-Paragraph 15D

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e637-108580

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e681-108580

+ Details

Name: us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.30(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AdditionalPaidInCapitalCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 7

-Section 03

-Paragraph 12

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Topic 210

-SubTopic 10

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

-Section S99

-Name Accounting Standards Codification

-Publisher FASB

-Paragraph 1

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Concepts (CON)

-Number 6

-Paragraph 25

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 18

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.18)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_AssetsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6801-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Section 45

-SubTopic 10

-Topic 210

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

-Publisher FASB

-Name Accounting Standards Codification

-Paragraph 1

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 9

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.9)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits are not generally reported as cash and cash equivalents. Includes cash and cash equivalents associated with the entity's continuing operations. Excludes cash and cash equivalents associated with the disposal group (and discontinued operation).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 7

-Footnote 1

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3044-108585

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 8, 9

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 7, 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Carrying amount (lower of cost or market) as of the balance sheet date of inventories less all valuation and other allowances. Excludes noncurrent inventory balances (expected to remain on hand past one year or one operating cycle, if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 35

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6386567&loc=d3e3927-108312

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_LiabilitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Total of all Liabilities and Stockholders' Equity items (or Partners' Capital, as applicable), including the portion of equity attributable to noncontrolling interests, if any.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 32

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.32)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 7

-Section 03

-Paragraph 25

+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 21

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.21)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A3

-Appendix A

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 27

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 7

-Section 03

-Paragraph 20

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Name Accounting Research Bulletin (ARB)

-Publisher AICPA

-Number 51

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_MinorityInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Aggregate carrying amount, as of the balance sheet date, of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered and of liabilities not separately disclosed in the balance sheet. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6911-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6904-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Chapter 3

-Section A

-Paragraph 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 6

-Paragraph 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_OtherLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The total of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer, and the aggregate carrying amount of current assets, as of the balance sheet date, not separately presented elsewhere in the balance sheet. Current assets are expected to be realized or consumed within one year (or the normal operating cycle, if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 8

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Section A

-Paragraph 4

-Chapter 3

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Section 45

-SubTopic 10

-Topic 210

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

-Publisher FASB

-Name Accounting Standards Codification

-Paragraph 1

+ Details

Name: us-gaap_PrepaidExpenseAndOtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Tangible assets that are held by an entity for use in the production or supply of goods and services, for rental to others, or for administrative purposes and that are expected to provide economic benefit for more than one year; net of accumulated depreciation. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 7

-Section 03

-Paragraph 8

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 13

-Subparagraph a

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 12

-Paragraph 5

-Subparagraph b, c

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The cumulative amount of the reporting entity's undistributed earnings or deficit.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.31(a)(3))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.8,17)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_SecurityDeposit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A3

-Appendix A

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=6228006&loc=d3e74512-122707

+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Total of Stockholders' Equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity including portions attributable to both the parent and noncontrolling interests (previously referred to as minority interest), if any. The entity including portions attributable to the parent and noncontrolling interests is sometimes referred to as the economic entity. This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4568740-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4I

-URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4590271-111686

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Name Accounting Research Bulletin (ARB)

-Publisher AICPA

-Number 51

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A3

-Appendix A

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 25

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4568447-111683

+ Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 18 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
3 Months Ended

Mar. 31, 2012

Mar. 31, 2011

Cash flows from operating activities:

Net loss before non-controlling interest $ (679) $ (2,493)

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation 7 16

Loss on disposal of property and equipment 2 0

Stock-based compensation expense 32 17

Gain on sale of loan receivable - related party 0 (81)

(Increase)/decrease in assets

Accounts receivable (31) 23

Other receivable - related party 0 16

Prepaid expenses and other current assets 166 (469)

Inventory 36 0

Security deposits 128 0

Increase/(decrease) in liabilities

Accounts payable 42 372

Accrued expenses (108) (228)

Other payables (10) (37)

Net cash used in operating activities (415) (2,864)

Cash flows from investing activities:

Repayment of Dunamis loan 0 1,100

Purchase of property and equipment (10) 0

Receipts from sale of Moneygate 0 401

Receipts of deferred consideration for sale of assets 0 370

Net cash provided by/(used in) investing activities (10) 1,871

Cash flows from financing activities:

Cash paid in lieu of fractional shares reverse/ forward split (5) 0

Net cash flows used in financing activities (5) 0

Effects of exchange rates on cash and cash equivalents 68 392

Net change in cash and cash equivalents (362) (601)

Cash and cash equivalents, beginning of period 3,704 8,434

Cash and cash equivalents, end of period $ 3,342 $ 7,833

X

- Definition

The net gain (loss) resulting from a sale of loans, including adjustments to record loans classified as held-for-sale at the lower-of-cost-or-market or other obligation to a related party.

+ References

No definition available.

+ Details

Name: mgt_GainOnSaleOfLoanReceivableRelatedParty

Namespace Prefix: mgt_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Change in carrying value during the period of obligations incurred through and payable within one year (or in the operating cycle if longer) to a related party.

+ References

No definition available.

+ Details

Name: mgt_IncreaseDecreaseInOtherReceivableRelatedParty

Namespace Prefix: mgt_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The outflow of cash paid in lieu of fractional shares reverse (or) forward split during the reporting period.

+ References

No definition available.

+ Details

Name: mgt_PaymentsForReverseOrForwardStockSplit

Namespace Prefix: mgt_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.

+ References

No definition available.

+ Details

Name: mgt_ReceiptsOfDeferredConsiderationForSaleOfAssetsFromDiscontinuedOperation

Namespace Prefix: mgt_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits are not generally reported as cash and cash equivalents. Includes cash and cash equivalents associated with the entity's continuing operations. Excludes cash and cash equivalents associated with the disposal group (and discontinued operation).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 7

-Footnote 1

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3044-108585

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 8, 9

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 7, 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The increase (decrease) during the reporting period in cash and cash equivalents. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition

The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_Depreciation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The effect of exchange rate changes on cash balances held in foreign currencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 25

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 230

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450594&loc=d3e33268-110906

+ Details

Name: us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The difference between the sale price or salvage price and the book value of a property, plant, and equipment asset that was sold or retired during the reporting period. This element refers to the gain (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_GainLossOnSaleOfPropertyPlantEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInInventories

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_IncreaseDecreaseInOperatingAssetsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in other current operating liabilities not separately disclosed in the statement of cash flows.

+ References

No definition available.

+ Details

Name: us-gaap_IncreaseDecreaseInOtherCurrentLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets,or income taxes.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in security deposits.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInSecurityDeposits

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The net cash inflow or outflow from financing activity for the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The net cash inflow or outflow from investing activity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3536-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3213-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 17

-Subparagraph c

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 12

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3179-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 16

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

+ Details

Name: us-gaap_ProceedsFromSaleOfEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591551-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A1, A4, A5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph c(1)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 29

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-Subparagraph (a),(c)

-URI http://asc.fasb.org/extlink&oid=6921930&loc=SL4573702-111684

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591552-111686

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 5

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4569616-111683

+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 18

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 20

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_RepaymentsOfRelatedPartyDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 19 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "
"+ text.join( "

\n" ) +"
"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "
" + text[p] + "
\n"; } } }else{ formatted = '
' + raw + '
'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+'
'+formatted+'
'+ "\n"+'
'+ "\n"+'
'+raw+'
'+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } } XML 20 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6

Organization, basis of presentation and liquidity
3 Months Ended

Mar. 31, 2012

Organization, Consolidation and Presentation Of Financial Statements [Abstract]

Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]
1. Organization, basis of presentation and liquidity

The accompanying unaudited condensed consolidated financial statements of MGT Capital Investments, Inc. (“MGT”, “the Company”, “the Group”, “we”, “us”) have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, they do not include all of the information and notes required by accounting principles generally accepted in the United States of America. In the opinion of management, all adjustments, consisting only of normal recurring adjustments, have been included. Operating results for the three months ended March 31, 2012, are not necessarily indicative of the results that may be expected for any subsequent quarter or for the year ending December 31, 2012. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2011. The condensed consolidated financial statements include the accounts of the Company and its majority owned subsidiaries. All intercompany accounts and transactions have been eliminated.

MGT Capital Investments, Inc. is a holding company comprised of MGT, the parent company, and its wholly-owned subsidiary: MGT Capital Investments (U.K.) Limited. MGT closed the following non-essential subsidiaries during the quarter ended March 31, 2012, as part of its expense reduction plan: Medicsight Nominees Limited, MGT Investments (Gibraltar) Limited and MGT Capital Investments Limited a subsidiary of MGT Capital Investments (U.K.) Limited. In addition we also have a controlling interest in our operating subsidiary, Medicsight Ltd, (“Medicsight”) including its wholly owned subsidiaries.

· Medicsight is a medical technology company focusing on medical imaging software development and medical hardware devices. The Company commercializes Computer-Aided Detection (“CAD”) applications which analyze Computer Tomography (“CT”) scans to assist radiologists in the early detection and measurement of colorectal polyps. The CAD software received a CE Mark in 2009, which allows for sales in the European Union. In 2011, Medicsight’s software also received clearance from the U.S. Food and Drug Administration. Revenue is presently limited as Medicsight attempts to commercialize its recent U.S. approval. In late July 2011, Medicsight was informed by the Japanese Ministry of Health, Labor and Welfare (“MHLW”) that several statistical data errors were encountered in their review of the application for approval of its ColonCAD software for use in CT Colonography procedures. Following informal guidance from MHLW, during August 2011, the Company decided to withdraw the current submission and is assessing the next course of action. In the meantime, the Board of Directors of Medicsight closed the Tokyo office as part of an overall program of expense reduction and corporate simplification. In addition to closing the Tokyo office, management of Medicsight has closed several non-essential subsidiaries; Medicsight KK and Medicsight PTY Limited, citing the unjustifiably high legal, regulatory and accounting costs of maintaining such entities. However, in order to better exploit the recent FDA approval of ColonCAD, Medicsight has opened a U.S. subsidiary (Medicsight, Inc.) in New York. Medicsight has also developed an automated CO₂medical inflation device and associated disposable tubing (MedicCO ₂LON) that is being commercialized via a global distributor.

· On March 21, 2012, MGT effected a reverse split (the “Reverse Split”), immediately followed by a forward split (the “Forward Split” and together with the Reverse Split, the “Reverse/Forward Split”). At our March 20, 2012, Special Meeting of Stockholders, the Company’s stockholders approved the proposal to amend the Company’s Certificate of Incorporation to effect a Reverse/Forward Split of the Company’s Common Stock, $0.01 par value per share at an exchange ratio of 1-for-500 shares of the Company’s outstanding Common Stock, immediately followed by a forward split of the Company’s outstanding Common Stock, at an exchange ratio of 15-for-1 shares of the Company’s outstanding Common Stock. The amendment did not change the par value per share or the number of authorized shares of Common Stock. As a result of the Reverse Split, stockholders holding fewer than 500 shares of Common Stock, at the time of the reversal, received a cash payment instead of fractional shares and would no longer have an interest in the Company. All share and per share amounts have been retrospectively adjusted for all periods presented to give effect to the Reverse/Forward Split.

· On March 26, 2012, at Medicsight’s General Meeting, stockholders approved a resolution to Reverse Split the Company’s existing ordinary shares of £0.05 par value per share into 1 new ordinary share of £16,250 par value per share (the “New Ordinary Shares”) and for MGT to acquire all New Ordinary Shares representing the fractions of shares left over following the Reverse Split.

The exchange ratio for the Reverse Split was 1-for-325,000. As a result of the Reverse Split, stockholders holding fewer than 325,000 shares were cancelled and not entitled to a cash payment for fractional shares. As of March 31, 2012, MGT holds 318 shares (66.5%) of the 478 issued share capital of Medicsight. Medicsight was previously listed on the AIM market of the London Stock Exchange until September 2011, when its shares were cancelled based upon a duly passed shareholder resolution and Medicsight became private. All share amounts have been retrospectively adjusted for all periods presented to give effect to the Reverse Split.

The Company has incurred significant operating losses since inception and continues to generate losses from operations. As a result, the Company has generated negative cash flows from operations and has an accumulated deficit of $280,497 at March 31, 2012. The Company is operating in a developing industry based on new technology and its primary source of funds to date has been through the issuance of securities. While the Company is optimistic and believes appropriate actions are being taken, there can be no assurance that management’s efforts will be successful or that the products the Company develops and markets will be accepted by consumers.

At March 31, 2012, Medicsight’s and MGT’s cash and cash equivalents were $3,021 and $321, respectively. Management believes that the current level of working capital will be sufficient to allow the Company to maintain its operations into May 2013.

X

- Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 22

-Paragraph 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Name Statement of Position (SOP)

-Publisher AICPA

-Number 94-6

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Name FASB Interpretation (FIN)

-Publisher FASB

-Number 46R

-Paragraph 4, 14, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 21 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6

CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] (USD $)

Mar. 31, 2012

Dec. 31, 2011

Common stock, par value (in dollars per share) $ 0.001 $ 0.001

Common stock, shares authorized 75,000,000 75,000,000

Common stock, shares issued 2,105,187 2,108,732

Common stock, shares outstanding 2,105,187 2,108,732

X

- Definition

Face amount or stated value of common stock per share; generally not indicative of the fair market value per share.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of common shares permitted to be issued by an entity's charter and bylaws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of shares of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares represent the ownership interest of the common shareholders. Shares outstanding equals shares issued minus shares held in treasury and other adjustments, if any.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

XML 22 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6

Operating leases, commitments and security deposit
3 Months Ended

Mar. 31, 2012

Operating Leases Commitments and Security Deposit [Abstract]

Operating leases, commitments and security deposit [Text Block]
11. Operating leases, commitments and security deposit

In 2006, we executed a 10-year agreement with Pirbright Holdings Limited, to lease office space in London, United Kingdom. Under this lease agreement, the property rent, services and related costs were approximately £330 ($516) per annum, paid quarterly in advance. The Company exercised its right to terminate the lease upon completion of the fifth year (August 2011) and has found an alternative UK office location with no long-term lease commitment. This commitment is on a month-to-month basis and began on August 1, 2011 with total monthly rental payments of £8 ($13) along with a rental deposit of £16 ($25). In February, 2012, the Company moved to a smaller office in the same location with month-to-month rental payments of £2 ($4) and a rental deposit of £4 ($6).

In September 2011, the Company entered into a 39 month lease agreement for office space located in Harrison, New York, United States terminating on November 30, 2014. Under the agreement our total rental payments over the 39 month lease period are $240, inclusive of three months of free rent and a refundable rental deposit of $39.

A satellite office in Tokyo, Japan, was closed in January 2012, and the rental deposit of $128 was refunded to us.

In January 2012, the Company entered into a two year employment agreement with an employee at a base salary of $10,000 per month, with potential bonus payments as outlined in the agreement. This agreement provides for a maximum severance period of 12 months in the event of termination without cause as defined in the agreement.

On March 12, 2012, the Company entered into a one year financial advisory and consulting agreement with a national investment banking firm. The agreement can be canceled with two weeks written notice, three months from the date of the agreement. Under the agreement our total payments over the twelve month period are $60.

The following is a schedule of the future minimum payments required under operating leases and commitments that have initial or remaining non-cancellable terms in excess of one year:

Year Ending

2012 (remaining nine months) $ 95

2013 78

2014 56

Total $ 229

The total lease rental expense was $36 and $143 for the three months ended March 31, 2012 and 2011, respectively.

X

- Details

Name: mgt_OperatingLeasesCommitmentsAndSecurityDepositAbstract

Namespace Prefix: mgt_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for operating leases, commitments and security deposit.

+ References

No definition available.

+ Details

Name: mgt_OperatingLeasesCommitmentsAndSecurityDepositTextBlock

Namespace Prefix: mgt_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 23 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6

DOCUMENT AND ENTITY INFORMATION
3 Months Ended

Mar. 31, 2012

May 14, 2012

Entity Registrant Name MGT CAPITAL INVESTMENTS INC

Entity Central Index Key 0001001601

Current Fiscal Year End Date --12-31

Entity Filer Category Smaller Reporting Company

Trading Symbol mgt

Entity Common Stock, Shares Outstanding 2,105,187

Document Type 10-Q

Amendment Flag false

Document Period End Date Mar. 31, 2012

Document Fiscal Period Focus Q1

Document Fiscal Year Focus 2012

X

- Definition

If the value is true, then the document as an amendment to previously-filed/accepted document.

+ References

No definition available.

+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition

End date of current fiscal year in the format --MM-DD.

+ References

No definition available.

+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition

This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.

+ References

No definition available.

+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition

This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.

+ References

No definition available.

+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition

The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.

+ References

No definition available.

+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition

The type of document being provided (such as 10-K, 10-Q, N-1A, etc). The document type is limited to the same value as the supporting SEC submission type, minus any "/A" suffix. The acceptable values are as follows: S-1, S-3, S-4, S-11, F-1, F-3, F-4, F-9, F-10, 6-K, 8-K, 10, 10-K, 10-Q, 20-F, 40-F, N-1A, 485BPOS, 497, NCSR, N-CSR, N-CSRS, N-Q, 10-KT, 10-QT, 20-FT, POS AM and Other.

+ References

No definition available.

+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate number of shares outstanding of each of registrant's classes of common stock, as of latest practicable date. Where multiple classes exist define each class by adding class of stock items such as Common Class A [Member], Common Class B [Member] onto the Instrument [Domain] of the Entity Listings, Instrument

+ References

No definition available.

+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, or (4) Smaller Reporting Company. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.

+ References

No definition available.

+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name: dei_TradingSymbol

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

XML 24 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6

Line of credit facility
3 Months Ended

Mar. 31, 2012

Line Of Credit Facility [Abstract]

Line of credit facility [Text Block]
12. Line of credit facility

On April 12, 2011, the Company entered into a Revolving Line of Credit and Security Agreement with Laddcap for up to $500 for a fifteen month term. The Agreement encompasses a standby commitment fee of two (2%) percent of the maximum loan amount along with an eight (8%) percent interest charge on any funds drawn. The Company has fully accrued the commitment fee of $10 and expensed $2 associated to the facility for the three months ended March 31, 2012. Laddcap is a related party as the Managing Partner and beneficial owner of LaddCap is a 10% plus shareholder and Chief Executive Officer of MGT. No amounts have been drawn down against the facility as of the date of the filing of the Company’s Form 10-Q for the quarterly period ended March 31, 2012.

X

- Definition

The entire disclosure for short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements.

+ References

No definition available.

+ Details

Name: mgt_LineOfCreditFacilityTextBlock

Namespace Prefix: mgt_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_LineOfCreditFacilityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 25 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended

Mar. 31, 2012

Mar. 31, 2011

Revenues $ 213 $ 47

Cost of revenue 36 4

Gross profit 177 43

Operating expenses

Selling, general and administrative 813 2,198

Research and development cost 41 440

Operating Expenses, Total 854 2,638

Operating loss (677) (2,595)

Interest and other (expense)/income, net (2) 21

Gain on sale of Moneygate 0 81

Nonoperating Income (Expense) (2) 102

Net loss before income taxes (679) (2,493)

Income tax benefit/(expense) 0 0

Net loss before non-controlling interest (679) (2,493)

Net loss attributable to non-controlling interest 209 1,001

Net loss attributable to MGT Capital Investments, Inc. (470) (1,492)

Net loss as reported (679) (2,493)

Other comprehensive loss

Unrealized foreign exchange gain/(loss) 73 350

Comprehensive loss (606) (2,143)

Comprehensive loss attributable to non-controlling interest (175) (854)

Comprehensive loss attributable to MGT Capital Investments, Inc. $ (431) $ (1,289)

Per share data:

Basic and diluted loss per share (in dollars per share) $ (0.22) $ (1.27)

Weighted average number of common shares outstanding (in shares) 2,108,338 1,171,518

X

- Definition

The net amount of the gain received on sale of moneygate during the period.

+ References

No definition available.

+ Details

Name: mgt_GainOnSaleOfMoneygate

Namespace Prefix: mgt_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The average number of shares or units issued and outstanding that are used in calculating basic and diluted EPS.

+ References

No definition available.

+ Details

Name: mgt_WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted

Namespace Prefix: mgt_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the reporting entity. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, but excludes any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e540-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 30

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A5

-Appendix A

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph c(3)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 8, 9, 10, 11, 12, 13, 14

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6508144

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e557-108580

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to noncontrolling interests, if any. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4613674-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591552-111686

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 30

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph c(3)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A5

-Appendix A

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4569643-111683

+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the economic entity, including both controlling (parent) and noncontrolling interests. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, including any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591552-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4569616-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A5

-Appendix A

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 29

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 2

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.2(a),(d))

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_CostOfGoodsAndServicesSold

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

No definition available.

+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1,2)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_GrossProfit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 10

+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The sum of the current income tax expense or benefit and the deferred income tax expense or benefit pertaining to continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Income Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6515339

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (a),(b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Article 4

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 45

-Subparagraph a, b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e565-108580

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A7

-Appendix A

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 10, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 87-21

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 19

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28, 29, 30

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The portion of net Income or Loss attributable to the noncontrolling interest (if any) deducted in order to derive the portion attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=6921930&loc=SL4573702-111684

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591551-111686

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph c(1)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A1, A4, A5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591552-111686

+ Details

Name: us-gaap_NetIncomeLossAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 7

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.7)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_NonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.

+ References

No definition available.

+ Details

Name: us-gaap_OperatingExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_OperatingExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The net result for the period of deducting operating expenses from operating revenues.

+ References

No definition available.

+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Adjustment that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency of the reporting entity, net of tax.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 30

-Section 45

-Paragraph 20

-Subparagraph (b),(c)

-URI http://asc.fasb.org/extlink&oid=6915805&loc=d3e32211-110900

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 55

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6920433&loc=d3e998-108581

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 24

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph c(3)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 14, 17, 19, 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 52

-Paragraph 13, 20, 31

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 9

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.9)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherNonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591551-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A1, A4, A5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph c(1)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 29

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-Subparagraph (a),(c)

-URI http://asc.fasb.org/extlink&oid=6921930&loc=SL4573702-111684

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591552-111686

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 5

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4569616-111683

+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 985

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 730

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141

-Paragraph 51

-Subparagraph g

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 2

-Paragraph 12, 13

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 86

-Paragraph 11, 12

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_ResearchAndDevelopmentExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 1

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(a))

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_SalesRevenueGoodsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Chapter 4

-Paragraph 5A

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 4

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 30

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6386349&loc=d3e3636-108311

+ Details

Name: us-gaap_SellingGeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 26 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6

Inventory
3 Months Ended

Mar. 31, 2012

Inventory Disclosure [Abstract]

Inventory Disclosure [Text Block]
6. Inventory

At March 31, 2012 and December 31, 2011, MedicCO ₂ LON Limited, a subsidiary of Medicsight, held finished goods inventory comprised of insufflation devices and administration kits totaling $56 and $89, respectively.

X

- Details

Name: us-gaap_InventoryDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Chapter 3

-Section A

-Paragraph 9

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 6

-Subparagraph a, b, c

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766

+ Details

Name: us-gaap_InventoryDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 27 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6

Loans receivable - related party
3 Months Ended

Mar. 31, 2012

Loans Receivable Related Party [Abstract]

Loans Receivable Related Party [Text Block]
5. Loans receivable — related party

Dunamis Capital

On September 6, 2010, Medicsight made a short-term loan of $1,100 (£711) to Dunamis repayable by December 31, 2010, along with $36 (£23) of interest. Dunamis paid back the principal of $1,100 (£711) and interest of $48 (£31) on February 6, 2011 and February 10, 2011 respectively. Dunamis had provided the assets of the business as collateral against the loan made by Medicsight. Dunamis was considered a related party, as two former directors of Medicsight were also directors of Dunamis Capital (see note 10).

X

- Details

Name: mgt_LoansReceivableRelatedPartyAbstract

Namespace Prefix: mgt_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for loans receivable due from related parties.

+ References

No definition available.

+ Details

Name: mgt_LoansReceivableRelatedPartyTextBlock

Namespace Prefix: mgt_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 28 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6

Subsequent events
3 Months Ended

Mar. 31, 2012

Subsequent Events [Abstract]

Subsequent Events [Text Block]
13. Subsequent events

On April 30, 2012, the Company filed a preliminary proxy statement (PRE-14A) and will hold its Annual Meeting of Stockholders on May 30, 2012.

On May 10, 2012, the Company announced that its Board of Directors has decided to pursue the acquisition of patents and underlying technologies with the intent of commercializing and/or enforcing the economic rights to such inventions.

On the same date, MGT also announced that it has agreed to acquire U.S. Patent #7,892,088, entitled “Gaming Device Having a Second Separate Bonusing Event.” The patent acquisition was made via a newly formed subsidiary, MGT Gaming, Inc., in which MGT will hold a majority interest. The invention specifically relates to gaming systems linked to an interactive sign, and includes all filed continuation patents. The sellers will retain a significant minority stake in MGT Gaming, Inc.; full terms will be disclosed upon the closing of the transactions contemplated in the agreement, which is subject to customary closing conditions.

Major financial terms include an upfront payment by MGT of $200,000, plus the issuance of 350,000 four-year common stock warrants with a $4.00 exercise price.

X

- Details

Name: us-gaap_SubsequentEventsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.

+ References

No definition available.

+ Details

Name: us-gaap_SubsequentEventsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 29 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6

Stockholders equity and non-controlling interest
3 Months Ended

Mar. 31, 2012

Stockholders Equity and Noncontrolling Interest [Abstract]

Stockholders Equity and Noncontrolling Interest [Text Block]
9. Stockholders equity and non-controlling interest

The Company has non-controlling investors in Medicsight as follows:

Medicsight

Non-controlling interest at January 1, 2012 $ 5,293

Non-controlling share of losses (209 )

Non-controlling interest share of stock-based compensation expense 15

Non-controlling interest share of other comprehensive income 34

Decrease in non-controlling interest from share consolidation of Medicsight’s stock (1,386 )

Non-controlling interest at March 31, 2012 $ 3,747

In January 2012, the Company purchased 1 share of Medicsight ordinary shares from a shareholder for consideration of £0.01 ($ .016).

The following schedule presents the effects of changes in MGT’s ownership interest in Medicsight on the equity attributable to MGT:

Three months ended

March 31,
2012 March 31,
2011

Net loss attributable to MGT Capital Investments, Inc. $ (470 ) $ (1,492 )

Transfers (to) from the non-controlling interest:

Increase in MGT’s paid in capital from Medicsight Share Consolidation 2,392 —

Changes from the net loss attributable to MGT Capital Investments, Inc. and transfers from non-controlling interest $ 1,922 $ (1,492 )

X

- Details

Name: mgt_StockholdersEquityAndNoncontrollingInterestAbstract

Namespace Prefix: mgt_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for stockholders equity and noncontrolling interest in consolidated subsidiaries.

+ References

No definition available.

+ Details

Name: mgt_StockholdersEquityAndNoncontrollingInterestTextBlock

Namespace Prefix: mgt_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 30 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6

Interest and other income / (expense)
3 Months Ended

Mar. 31, 2012

Interst and Other Income Or Expense [Abstract]

Interst and Other Income Or Expense [Text Block]
7. Interest and other income/ (expense)

For the three months ended March 31, 2012, interest and other income/ (expense) was comprised of interest expense of $2. For the same period last year, interest income and other income/ (expenses) included interest income of $21.

X

- Details

Name: mgt_InterstAndOtherIncomeOrExpenseAbstract

Namespace Prefix: mgt_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for interest and other interest income (or) expense during the reporting period.

+ References

No definition available.

+ Details

Name: mgt_InterstAndOtherIncomeOrExpenseTextBlock

Namespace Prefix: mgt_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 31 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6

Stock-based compensation
3 Months Ended

Mar. 31, 2012

Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]

Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
8. Stock-based compensation

Cancellation of certain share option plans of the Company

Following Medicsight’s general meeting on March 26, 2012 (see Note 1), a shareholder resolution approving the Reverse Split of 1-for-325,000 of the Company’s existing ordinary shares of £ 0.05 par value into one new ordinary share was duly passed. As a result of the reverse split, option holders under certain existing share option plans are no longer entitled to options under those plans as option holders’ share entitlement is now less than one as a result of the Reverse Split. Following the share reversal, the Company cancelled with immediate effect all redundant option plans with the exception of Plan J. All previously unrecognized stock based compensation expense was accelerated.

Medicsight has the following Stock Option Plan:

Plan J — on May 14, 2009, we approved and subsequently granted options for 24 shares under stock option plan “J”. Options under this plan vest in equal one-sixths for each six months that employees have been employed for 6, 12, 18, 24, 30 and 36 months from the grant date. At March 31, 2012, there were 6 options outstanding, of which 5 were exercisable.

No grants were issued in the three months ended March 31, 2012.

The following table summarizes stock option activity for the three months ended March 31, 2012, under all option plans:

Outstanding Exercisable

Number of Shares
Weighted-Average

Exercise Price

Number of

Shares

Weighted-Average

Exercise Price

Outstanding at December 31, 2011 11 £ 35,750 ($58,500) 10 £ 78,000 ($68,250 )

Granted — —

Exercised — —

Forfeited/ Cancelled 5 £ 19,500 ($30,917 )

Outstanding at March 31, 2012 6 £ 29,250 ($46,376 ) 5 £ 29,250 ($46,376 )



The following is a summary of the status of stock options outstanding at March 31, 2012:

Outstanding options Exercisable options

Number
Remaining

contractual life

(years)

Average

exercise price
Number
Average

exercise price

Medicsight Plan J 6 7.2 £ 29,250 $ 46,376 5 £ 29,250 $ 46,376

On November 30, 2010, David Sumner, Chairman of Medicsight Limited, resigned from his position within the group. Immediately after his resignation, a two year consultancy agreement was signed whereby Mr. Sumner would continue to assist the group in its commercial needs. As part of this agreement, Mr. Sumner was to continue to vest in his existing Medicsight Plan J options throughout the consultancy period. A modification of the 6 existing options has been accounted for, and is not considered to be material to the overall financial statements. The Company is no longer receiving services under this consulting agreement. As such, all expenses and related stock-based compensation were accelerated at December 31, 2011.

The Company has recorded the following amounts related to its share-based compensation expense in the accompanying Condensed Consolidated Statements of Operations:

Three months ended

March 31,

2012 2011

Selling, general and administrative $ 25 $ 3

Research and development 7 14

Total $ 32 $ 17

Of the stock-based expense for the three months ended March 31, 2012, $15 was allocated to non-controlling interest.

The aggregate intrinsic value for options outstanding and exercisable at March 31, 2012 and 2011, was $nil.

A summary of non-vested options at March 31, 2012, and the change during the three months ended March 31, 2012, is presented below:

Options Weighted Average
Grant Date Fair
Value

Nonvested options at January 1, 2012 1 £ 45,500 $ 71,500

Granted — — —

Vested — £ — $ —

Forfeited/Cancelled — £ — $ —

Nonvested options at March 31, 2012 1 £ 45,500 $ 71,500

Unrecognized compensation cost

As of March 31, 2012, there was no unrecognized compensation cost related to non-vested share-based compensation arrangements.

X

- Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Statement of Position (SOP)

-Number 93-6

-Paragraph 53

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 123R

-Paragraph 64, 65, A240

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 40

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 32 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6

Related party transactions
3 Months Ended

Mar. 31, 2012

Related Party Transactions [Abstract]

Related Party Transactions [Text Block]
10. Related party transactions

Moneygate Group

In Fiscal 2009, we purchased 49% of the share capital of Moneygate. On acquisition we provided loan facilities of £250 ($387) for working capital and £2,000 ($3,094) for acquisitions and subsequently entered into various transactions with Moneygate and other non-related parties.

Through its disposal in March 2011, Moneygate was a related party as the Company had significant influence over its operations as a result of representation on Moneygate’s board of directors. Due to this significant influence, we accounted for it under the equity method. In March 2011, we sold our entire interest in Moneygate to Committed Capital Nominees Limited for total consideration of £250 ($401), resulting in a gain on sale of £51 ($81).

Dunamis Capital

Allan Rowley, former Chief Executive Officer and former Chief Financial Officer of MGT and former Chief Executive Officer of Medicsight, along with David Sumner, former Chairman of Medicsight, are both directors of Dunamis. Dunamis is a United Arab Emirates (“UAE”) registered company regulated by the Dubai Financial Services Authority (“DFSA”). Dunamis is 100% owned by David Sumner and was set up by Mr. Sumner with Allan Rowley’s financial consulting assistance, as a corporate financing and advisory firm. On September 6, 2010, Medicsight made a short-term loan of $1,100 (£711) to Dunamis. Dunamis paid back the principal of $1,100 (£711) and interest of $48 (£30) on February 6, 2011 and February 10, 2011, respectively.

In February 2011, the Company, following consultation with its nominated advisor noted that as a result of Mr. Sumner’s relationships with both Dunamis and Medicsight, the Loan constituted a related party transaction under Rule 13 of AIM Rules for Companies. Rule 13 requires that an AIM company must issue notification without delay as soon as the terms of a transaction with a related party are agreed. The independent directors, having consulted with the Company’s nominated adviser, considered the terms of the transaction fair and reasonable insofar as shareholders were concerned. On February 18, 2011, the Company issued a notice detailing the terms of the transaction with the related party.

Laddcap Value Partners III LLC (“Laddcap”)

On April 12, 2011, the Company entered into a Revolving Line of Credit and Security Agreement with Laddcap for up to $500 for a fifteen month term. The Agreement encompasses a standby commitment fee of two (2%) percent of the maximum loan amount along with an eight (8%) percent interest charge on any funds drawn. Laddcap is a related party as the Managing Partner and beneficial owner of Laddcap is a 10% plus shareholder and CEO of MGT. No amounts have been drawn down against the facility as of the date of the filing of the Company’s Form 10-Q for the quarterly period ended March 31, 2012.

D4D Limited

Effective July 2010, the Company entered into a service agreement with D4D Limited (“D4D”), a company that offers Executive Services for small and mid-cap companies. D4D is owned by Tim Paterson-Brown and Allan Rowley, and pursuant to the agreement, provided the services of Chairman, Chief Executive Officer and Chief Financial Officer of the Company at such time. The D4D service agreement provided the services of Tim Paterson-Brown and Allan Rowley on similar remuneration to their previous employment contracts with MGT. On executing the contract with D4D, Tim Paterson-Brown and Allan Rowley terminated their employment contracts with MGT, but still held the offices of Chairman and Chief Executive Officer and Chief Financial Officer, respectively.

In December 2010, Mr. Paterson-Brown resigned as Chairman and CEO, and was replaced by Mr. Rowley as CEO. In February 2011, Mr. Rowley resigned as CEO.

In April 2011, the agreement with D4D was renegotiated and a settlement agreement between MGT and D4D, Messrs. Paterson-Brown and Rowley was executed and delivered. The financial terms included payments to be made by the Company to D4D of a £110 ($170) settlement fee, a £80 ($124) payment for recoverable local taxes, £17 ($25) for estimated legal expenses, and the assignment of 3 shares of MDST common stock held by the Company to D4D. The common stock was delivered to D4D in April 2011, and had a fair value of $71 on the date of transfer. The parties, upon the terms and subject to the conditions of the settlement agreement and to the extent permitted by law, settled all claims arising out of the D4D Agreement and the respective directorships and employment arrangements with the Company and certain of its affiliates. The Company has fully accrued and expensed all related costs. During the three months ended March 31, 2011, MGT and Medicsight made payments to D4D, totaling $304.

X

- Details

Name: us-gaap_RelatedPartyTransactionsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for related party transactions, including the nature of the relationship(s), a description of the transactions, the amount of the transactions, the effects of any change in the method of establishing the terms of the transaction from the previous period, stated interest rate, expiration date, terms and manner of settlement per the agreement with the related party, and amounts due to or from related parties. If the entity and one or more other entities are under common ownership or management control and this control affects the operating results or financial position, disclosure includes the nature of the control relationship even if there are no transactions between the entities. Disclosure may also include the aggregate amount of current and deferred tax expense for each statement of earnings presented where the entity is a member of a group that files a consolidated tax return, the amount of any tax related balances due to or from affiliates as of the date of each statement of financial position presented, the principal provisions of the method by which the consolidated amount of current and deferred tax expense is allocated to the members of the group and the nature and effect of any changes in that method. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 3A

-Section 04

-Paragraph b

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 57

-Paragraph 1-4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39678-107864

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 4

-Section 08

-Paragraph k

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864

+ Details

Name: us-gaap_RelatedPartyTransactionsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 33 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' (DEFICIT)/EQUITY (USD $)
In Thousands

Common Stock [Member]

Additional Paid-In Capital [Member]

Accumulated Other Comprehensive Income (Loss) [Member]

Retained Earnings [Member]

Stockholders Equity, Total [Member]

Noncontrolling Interest [Member]

Total

BALANCE at Dec. 31, 2011 $ 2 $ 283,240 $ (4,861) $ (280,027) $ (1,646) $ 5,293 $ 3,647

BALANCE (in shares) at Dec. 31, 2011 2,109

Cash in lieu of fractional shares for MGT reverse/ forward split 0 (5) 0 0 (5) 0 (5)

Cash in lieu of fractional shares for MGT reverse/ forward split (in shares) (4)

Acquisition of subsidiary shares from non-controlling interest 2,392 (1,006) 1,386 (1,386) 0

Stock option compensation 17 17 15 32

Net loss for the period 0 0 0 (470) (470) (209) (679)

Translation adjustment 0 0 39 0 39 34 73

BALANCE at Mar. 31, 2012 $ 2 $ 285,644 $ (5,828) $ (280,497) $ (679) $ 3,747 $ 3,068

BALANCE (in shares) at Mar. 31, 2012 2,105

X

- Definition

Aggregate adjustment to additional paid in capital for stock to account for a reverse stock split during the period.

+ References

No definition available.

+ Details

Name: mgt_AdjustmentsToAdditionalPaidInCapitalReverseStockSplit

Namespace Prefix: mgt_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

This element represents the amount of recognized equity-based compensation related to stock options during the period, that is, the amount recognized as expense in the income statement (or as asset if compensation is capitalized).

+ References

No definition available.

+ Details

Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph c(2)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 23

-URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4569655-111683

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4616395-111683

+ Details

Name: us-gaap_MinorityInterestDecreaseFromRedemptions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Adjustment that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency of the reporting entity, net of tax.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 30

-Section 45

-Paragraph 20

-Subparagraph (b),(c)

-URI http://asc.fasb.org/extlink&oid=6915805&loc=d3e32211-110900

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 55

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6920433&loc=d3e998-108581

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 24

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph c(3)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 14, 17, 19, 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 52

-Paragraph 13, 20, 31

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591551-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A1, A4, A5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph c(1)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 29

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-Subparagraph (a),(c)

-URI http://asc.fasb.org/extlink&oid=6921930&loc=SL4573702-111684

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591552-111686

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 5

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4569616-111683

+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Number of shares issued and outstanding as of the balance sheet date.

+ References

No definition available.

+ Details

Name: us-gaap_SharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total of Stockholders' Equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity including portions attributable to both the parent and noncontrolling interests (previously referred to as minority interest), if any. The entity including portions attributable to the parent and noncontrolling interests is sometimes referred to as the economic entity. This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4568740-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4I

-URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4590271-111686

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Name Accounting Research Bulletin (ARB)

-Publisher AICPA

-Number 51

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A3

-Appendix A

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 25

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4568447-111683

+ Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Reduction in the number of shares during the period as a result of a reverse stock split.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 34 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6

Cash and cash equivalents
3 Months Ended

Mar. 31, 2012

Cash and Cash Equivalents [Abstract]

Cash and Cash Equivalents Disclosure [Text Block]
4. Cash and cash equivalents

We invest our cash in short-term deposits with major banks. As of March 31, 2012, we held $3,342 of cash and cash equivalents.

Cash and cash equivalents consist of cash and temporary investments with maturities of 90 days or less when purchased.

Concentrations

The Company held $3,021 and $3,123 of its cash and cash equivalents at March 31, 2012 and December 31, 2011, respectively, through Medicsight, its majority owned subsidiary, at financial institutions in Europe and United Arab Emirates (“UAE”). Cash held in foreign institutions is not insured by the Federal Deposit Insurance Corporation.

X

- Details

Name: us-gaap_CashAndCashEquivalentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for cash and cash equivalent footnotes, which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4273-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 7

-Footnote 1

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 8, 9, 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 6.H.3)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13728-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 6

-Section H

-Subsection 3

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

+ Details

Name: us-gaap_CashAndCashEquivalentsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 35 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 25 96 1 false 6 0 false 3 false false R1.htm 001 - Document - DOCUMENT AND ENTITY INFORMATION Sheet http://mgt.com/role/DocumentAndEntityInformation DOCUMENT AND ENTITY INFORMATION true false R2.htm 002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://mgt.com/role/StatementOfFinancialPositionClassified CONDENSED CONSOLIDATED BALANCE SHEETS false false R3.htm 003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] Sheet http://mgt.com/role/BalanceSheetParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] false false R4.htm 004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Sheet http://mgt.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS false false R5.htm 005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' (DEFICIT)/EQUITY Sheet http://mgt.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSDEFICITEQUITY CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' (DEFICIT)/EQUITY false false R6.htm 006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://mgt.com/role/StatementOfCashFlowsIndirect CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS false false R7.htm 007 - Disclosure - Organization, basis of presentation and liquidity Sheet http://mgt.com/role/OrganizationBasisOfPresentationAndLiquidity Organization, basis of presentation and liquidity false false R8.htm 008 - Disclosure - Summary of significant accounting policies Sheet http://mgt.com/role/SummaryOfSignificantAccountingPolicies Summary of significant accounting policies false false R9.htm 009 - Disclosure - Divestment of investments Sheet http://mgt.com/role/DivestmentOfInvestmentsAndDiscontinuedActivities Divestment of investments false false R10.htm 010 - Disclosure - Cash and cash equivalents Sheet http://mgt.com/role/CashAndCashEquivalents Cash and cash equivalents false false R11.htm 011 - Disclosure - Loans receivable - related party Sheet http://mgt.com/role/LoansReceivableRelatedParty Loans receivable - related party false false R12.htm 012 - Disclosure - Inventory Sheet http://mgt.com/role/Inventory Inventory false false R13.htm 013 - Disclosure - Interest and other income / (expense) Sheet http://mgt.com/role/InterestAndOtherIncomeAndExpense Interest and other income / (expense) false false R14.htm 014 - Disclosure - Stock-based compensation Sheet http://mgt.com/role/StockBasedCompensation Stock-based compensation false false R15.htm 015 - Disclosure - Stockholders equity and non-controlling interest Sheet http://mgt.com/role/StockholdersEquityAndNonControllingInterest Stockholders equity and non-controlling interest false false R16.htm 016 - Disclosure - Related party transactions Sheet http://mgt.com/role/RelatedPartyTransactions Related party transactions false false R17.htm 017 - Disclosure - Operating leases, commitments and security deposit Sheet http://mgt.com/role/OperatingLeasesCommitmentsAndSecurityDeposit Operating leases, commitments and security deposit false false R18.htm 018 - Disclosure - Line of credit facility Sheet http://mgt.com/role/LineOfCreditFacility Line of credit facility false false R19.htm 019 - Disclosure - Subsequent events Sheet http://mgt.com/role/SubsequentEvents Subsequent events false false All Reports Book All Reports Process Flow-Through: 002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Mar. 31, 2011' Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: 003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] Process Flow-Through: 004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Process Flow-Through: 006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS mgt-20120331.xml mgt-20120331.xsd mgt-20120331_cal.xml mgt-20120331_def.xml mgt-20120331_lab.xml mgt-20120331_pre.xml true true

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $) In Thousands, unless otherwise specified	Mar. 31, 2012	Dec. 31, 2011
Assets
Cash and cash equivalents	$ 3,342	$ 3,704
Accounts receivable	118	84
Prepaid expenses and other current assets	155	327
Inventory	56	89
Total current assets	3,671	4,204
Property and equipment, at cost, net	32	28
Security deposits	65	201
Total assets	3,768	4,433
Liabilities
Accounts payable	261	213
Accrued expenses	395	502
Other payables	44	71
Total current liabilities	700	786
Stockholders' (deficit)/equity
Common stock, $0.001 par value: 75,000,000 shares authorized; 2,105,187 and 2,108,732 shares issued and outstanding at March 31, 2012 and December 31, 2011 respectively.	2	2
Additional paid-in capital	285,644	283,240
Accumulated other comprehensive loss	(5,828)	(4,861)
Accumulated deficit	(280,497)	(280,027)
Total stockholders' deficit	(679)	(1,646)
Non-controlling interest	3,747	5,293
Total equity	3,068	3,647
Total stockholders' equity, liabilities and non-controlling interest	$ 3,768	$ 4,433

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Cash flows from operating activities:
Net loss before non-controlling interest	$ (679)	$ (2,493)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	7	16
Loss on disposal of property and equipment	2	0
Stock-based compensation expense	32	17
Gain on sale of loan receivable - related party	0	(81)
(Increase)/decrease in assets
Accounts receivable	(31)	23
Other receivable - related party	0	16
Prepaid expenses and other current assets	166	(469)
Inventory	36	0
Security deposits	128	0
Increase/(decrease) in liabilities
Accounts payable	42	372
Accrued expenses	(108)	(228)
Other payables	(10)	(37)
Net cash used in operating activities	(415)	(2,864)
Cash flows from investing activities:
Repayment of Dunamis loan	0	1,100
Purchase of property and equipment	(10)	0
Receipts from sale of Moneygate	0	401
Receipts of deferred consideration for sale of assets	0	370
Net cash provided by/(used in) investing activities	(10)	1,871
Cash flows from financing activities:
Cash paid in lieu of fractional shares reverse/ forward split	(5)	0
Net cash flows used in financing activities	(5)	0
Effects of exchange rates on cash and cash equivalents	68	392
Net change in cash and cash equivalents	(362)	(601)
Cash and cash equivalents, beginning of period	3,704	8,434
Cash and cash equivalents, end of period	$ 3,342	$ 7,833

CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] (USD $)	Mar. 31, 2012	Dec. 31, 2011
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	75,000,000	75,000,000
Common stock, shares issued	2,105,187	2,108,732
Common stock, shares outstanding	2,105,187	2,108,732

DOCUMENT AND ENTITY INFORMATION	3 Months Ended
DOCUMENT AND ENTITY INFORMATION	Mar. 31, 2012	May 14, 2012
Entity Registrant Name	MGT CAPITAL INVESTMENTS INC
Entity Central Index Key	0001001601
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Trading Symbol	mgt
Entity Common Stock, Shares Outstanding		2,105,187
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2012
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2012

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' (DEFICIT)/EQUITY (USD $) In Thousands	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Retained Earnings [Member]	Stockholders Equity, Total [Member]	Noncontrolling Interest [Member]	Total
BALANCE at Dec. 31, 2011	$ 2	$ 283,240	$ (4,861)	$ (280,027)	$ (1,646)	$ 5,293	$ 3,647
BALANCE (in shares) at Dec. 31, 2011	2,109
Cash in lieu of fractional shares for MGT reverse/ forward split	0	(5)	0	0	(5)	0	(5)
Cash in lieu of fractional shares for MGT reverse/ forward split (in shares)	(4)
Acquisition of subsidiary shares from non-controlling interest		2,392	(1,006)		1,386	(1,386)	0
Stock option compensation		17			17	15	32
Net loss for the period	0	0	0	(470)	(470)	(209)	(679)
Translation adjustment	0	0	39	0	39	34	73
BALANCE at Mar. 31, 2012	$ 2	$ 285,644	$ (5,828)	$ (280,497)	$ (679)	$ 3,747	$ 3,068
BALANCE (in shares) at Mar. 31, 2012	2,105